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ABSTRACT 
ABSTRACT 
 
Alzheimer’s disease is characterised by the misfolding and aggregation of a native 
peptide, Aβ, for which there are several isoforms, Aβ(1-40) being the most common, and 
Aβ(1-42) being most closely associated with Alzheimer’s disease. Upon misfolding, Aβ 
self-associates to form a number of aggregate species. What triggers this process of 
misfolding-aggregation, and determines which aggregate species forms, is not known. 
One possible determinant is metal homeostasis, which in Alzheimer’s patients is 
deregulated.  
  
Chapter 3 characterises how physiologically relevant levels of Cu2+ influence the 
misfolding pathway of Aβ. A ThT fluorescence assay found that Cu2+ is able to 
accelerate formation of Aβ(1-40) amyloid fibres; however, for Aβ(1-42), Cu2+ abolished fibre 
formation. Electron microscopy revealed that this is because Cu2+ stabilised Aβ(1-42) 
oligomers. These oligomers more readily disrupted lipid membranes than mature 
amyloid fibres, suggesting that the elevated levels of Cu2+ and the greater Aβ(1-42) 
synaptotoxicity in Alzheimer’s disease may be related. Chapter 4 investigates the effect 
of Zn2+ on Aβ misfolding. Trace levels of Zn2+ are demonstrated to entirely abolish fibre 
growth, for both Aβ(1-40) and Aβ(1-42). It is found that that Zn2+ likely exerts such a 
dramatic effect through a rapid exchange of Zn2+ between Aβ molecules. Chapter 5 
found that Cu2+ accelerated Aβ(1-40) fibre growth regardless of growth conditions, 
despite growth conditions influencing fibril morphology. It was also found that Cu2+ 
generated Aβ(1-40) fibres did not exhibit an altered stability, further suggesting that the 
effect of Cu2+ upon Aβ(1-40) is limited to fibril growth kinetics, in contrast to the effect of 
Cu2+ on Aβ(1-42), as well as the effect of Zn2+ upon either peptide. The present research 
has identified a diversity of significant interactions between Aβ, and Cu2+ and Zn2+, 
highlighting a potential role for these metal ions in Alzheimer’s disease.  
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CHAPTER 1: Introduction 
1.1 ALZHEIMER’S DISEASE 
 
1.1.1 Prevalence  
 
Alzheimer’s disease (AD) is a global concern; affecting approximately 30 million people 
worldwide, it is both the most common neurodegenerative disease and the second 
most burdensome chronic condition after blindness (Prince et al, 2009; Querfurth & 
LaFerla, 2010). This is reflected by its high economic impact, which is thought to be 
US$315 billion a year worldwide (Prince et al, 2009). Unfortunately, these numbers are 
set to rise, with it being estimated that by 2040 there will be 81.1 million cases of the 
disease (Ferri et al, 2005). This is largely because the risk of onset is much greater for 
individuals older than 65 years of age, with risk doubling for every 5 years after 65; 
thus, as life expectancy rises so too does AD incidence. However, there are other 
factors contributing towards increases in AD. For instance, high cholesterol and 
smoking lead to hypertension, which in turn is associated with elevated risk of AD 
(Breteler et al, 1998; Ravona-Springer et al, 2003), and there has been mounting 
evidence for the coincidence of AD and diabetes, with some even suggesting that AD 
should be considered as type-III diabetes (de la Monte & Wands, 2008). These factors 
are particularly worrisome for developing countries, as their adoption of westernised 
diets and smoking places them at much greater risk than previously; this is 
underscored by the forecast that AD incidence shall increase at a rate 3 fold greater in 
developing countries than developed countries (Ferri et al, 2005). However, perhaps 
the most significant contributor towards rising prevalence of AD is the fact that no 
effective treatments have been developed. From this it is clear that furthering our 
understanding of this disease is imperative.   
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1.1.2 Symptoms 
 
Besides ultimately leading to death (typically within 8 years after diagnosis), AD is 
associated with a plethora of progressive symptoms (Forstl & Kurz, 1999; Prince et al, 
2009). At early stages, it is very difficult to identify someone with AD, as initial 
symptoms include only mild impairment of both memory and executive functioning, 
which may be misattributed to stress or fatigue  (Waldemar et al, 2007). Apathy may 
also be present at these early stages. Although typically overshadowed by the more 
dramatic symptoms that characterise AD, it is important to remember that apathy 
affects up to 92 % of individuals with AD (Mega et al, 1996), and may result in 
behaviours such as low social engagement, indifference, lack of insight, and blunted 
emotional response (Landes et al, 2001). Such behaviours may compound difficulty in 
identifying AD sufferers at early stages.  
 
As the disease progresses, the symptoms become much more apparent, with 
impairment of recent memories becoming so severe that patients have been reported 
as appearing to “live in the past” (Beatty et al, 1988). Loss of vocabulary also occurs, 
which leads to increasing difficulty in communication, and motor impairment (apraxia) 
manifests, causing sufferers to struggle with both household tasks and balance. Long-
term memory, which was initially intact, deteriorates, resulting in patients eventually 
becoming unable to recognise even close relatives (Forstl & Kurz, 1999). Additionally, 
apathy advances, leading to the requirement of support and management for patients, 
as they come to rely on others to initiate behaviours, even when they are still physically 
capable of carrying out the activities themselves (Landes et al, 2001). In late stage 
Alzheimer’s disease, symptoms worsen significantly, with patients completely losing 
the faculty of speech, and becoming physically incapable of manoeuvring or even 
feeding themselves, resulting in their full dependence upon care-givers (Förstl & Kurz, 
1999).  
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1.1.3 Pathology and Diagnosis 
 
Despite behavioural symptoms facilitating psychological testing of AD, alternative 
methods of diagnosis are often needed. At a neurological level, AD is characterised by 
a significant shrinkage in the brain areas associated with learning and memory, as 
shown in figure 1.01, due to a substantial loss of synapses and neurons. This enables 
imaging techniques, such as magnetic resonance imaging and positron emission 
tomography, to be used for diagnosis (Ballard et al, 2011). However, such imaging 
techniques are not entirely effective at differentiating between different forms of 
dementia. To improve accuracy, biomarkers in the cerebrospinal fluid (CSF), such as 
oxidative stress and inflammation, are at times used (Mattsson et al, 2009; Welge et al, 
2009); however, the only definitive diagnosis available at present is post mortem. This 
relies on the identification of the two core pathological hallmarks of Alzheimer’s disease 
first identified by Alois Alzheimer, the extracellular Amyloid-β (Aβ) plaques and 
intracellular tau tangles (Alzheimer et al, 1995).  
 
1.2 AMYLOID-β AND TAU 
 
1.2.1 Amyloid Precursor Protein  
 
The characteristic plaques of AD are comprised of aggregated Aβ, a peptide which is 
cleaved from the amyloid-precursor protein (APP). The APP gene is located on 
chromosome 21, with the protein resembling a glycosylated cell-receptor (Kang et al, 
1987). Alternative splicing yields several isoforms of APP which are differentially 
expressed, with the most prevalent neuronal isoform being 695 amino acids long 
(Mattson, 1997). The APP gene itself has been evolutionarily conserved in both 
sequence and expression (Wasco et al, 1992; Wasco et al, 1993), as has likely been 
its role, which has been supported by the observation that the human APP gene can   
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Figure 1.01 Shrinkage of Brain Regions in Alzheimer’s Disease.  
Alzheimer’s disease causes shrinkage of brain regions involved in learning and 
memory; this is evident in this figure, as the individual with Alzheimer’s disease 
portrays a marked shrinkage of gyri in the temporal and frontal lobes (A) compared 
to a healthy individual (B). Consequently, Alzheimer’s patients suffer large 
decreases in their energy metabolism in the frontal and temporal lobes. This is 
evident in the positron emission tomography images (C & D) showing glucose 
uptake (red and yellow indicate high levels of glucose uptake), which compare a 
healthy individual (C) and an individual with Alzheimer’s disease (D). Reprinted by 
permission from Macmillan Publishers Ltd: Nature, (Mattson, 2004), copyright (2004). 
 
 
Figure 1.01. Shrinkage of Brain Regions in Alzheimer’s Disease.  
Alzheimer’s disease causes shrinkage of brain regions involved in learning and 
memory; this is evident in this figure, as the individual with Alzheimer’s disease 
portrays a marked shrinkage of gyri in the temporal and frontal lobes (A) compared 
to a healthy individual (B). Consequently, Alzheimer’s patients suffer large 
decreases in their energy metabolism in the frontal and temporal lobes. This is 
evident in the positron emission tomography images (C & D) showing glucose 
uptake (red and yellow indicate high levels of glucose uptake), which compare a 
healthy individual (C) and an individual with Alzheimer’s disease (D). This figure has 
been adapted from Mattson (2004). 
 
C 
B 
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rescue APP knockout Drosophila (Luo et al, 1992). However, despite an apparent 
conservation of function across phyla, the precise role of APP is still not entirely clear, 
although it has been proposed that APP is important for neuronal development, as 
increases in APP expression coincide with neuronal differentiation and neurite 
outgrowth (Salbaum & Ruddle, 1994); this also supports the notion that APP is 
important for synaptic plasticity (Mattson, 1994). Notably, not only full-length APP is 
important for neuronal maintenance, as the proteolytically derived fragments also 
appear to exhibit critical physiological activities (Mattson et al, 1992). Understanding 
the proteolytic processing of APP is crucial for elucidating the origin of pathological Aβ. 
 
1.2.2 Amyloid Precursor Protein Trafficking and Processing 
 
APP undergoes classical N-glycosylation and O-glycosylation as it passes through the 
rough endoplasmic reticulum and Golgi apparatus (Mattson, 1997; Weidemann et al, 
1989). As it exits from the late Golgi into secretory vesicles, and is ultimately inserted 
into the cell membrane, additions of sulphate and phosphate further increase APP 
complexity; these additions are dependent on such variables as cell-cycle, and regulate 
APP metabolism (Hung & Selkoe, 1994; Suzuki et al, 1994). Once at the cell surface, 
APP is rapidly internalised, due to its “YENTPY” domain; indeed, the estimated half-life 
for surface APP is less than ten minutes (Koo et al, 1996). After internalisation it is 
delivered to endosomes, where it may be recycled, or alternatively passed onto 
lysosomes for digestion (Haass et al, 1992). There are three proteinases, the 
secretases, which may cleave APP at various stages of the trafficking process. 
 
Cleavage by α-secretase may occur in trans-Golgi vesicles, secretory vesicles, or the 
cell membrane itself. As its cleavage site resides within the Aβ sequence, it prevents 
Aβ production, and may be considered the principal step in “non-amyloidogenic” APP 
processing (Mattson, 1997), as shown in figure 1.02. Following cleavage, the  
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Figure 1.02 APP Cleavage. 
Amyloidogenic processing of APP may commence with β-secretase, with Aβ 
being generated following subsequent γ-secretase cleavage. Alternatively, non-
amyloidogenic processing may commence with α-secretase activity. This figure 
was reproduced from (Lichtenthaler, 2011), © 2010.  
 
 
Figure 1.05 APP Cleavage. 
Amyloidogenic processing of APP may commence with β-secretase, with Aβ 
being generated following subsequent γ-secretase cleavage. Alternatively, non-
amyloidogenic processing may commence with α-secretase activity. This figure 
was Modified from (Lichtenthaler, 2011). 
 
 
Figure 1.04 APP Mutations.Figure 1.05 APP Cleavage. 
Amyloidogenic processing of APP may commence with β-secretase, with Aβ 
being generated following subsequent γ-secretase cleavage. Alternatively, non-
amyloidogenic processing may commence with α-secretase activity. This figure 
was Modified from (Lichtenthaler, 2011). 
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extracellular fragment, APPsα, is released, and the c-terminal fragment (αCTF) 
remains anchored to the membrane, where it may be cleaved further (De Strooper & 
Annaert, 2000). Interestingly, the activity of α-secretase appears to increase with 
electrical activity and activation of muscarinic acetylcholine receptors (Mattson, 1997), 
providing an explanation as to why neuronal activity has been found to be protective 
against AD. 
 
The principal step in “amyloidogenic” processing is β-secretase cleavage. Cleavage by 
β-secretase, as for α-secretase, may occur at the trans-Golgi vesicles, secretory 
vesicles, or cell membrane. Cleavage typically occurs at the Asp1 of the Aβ sequence, 
releasing APPsβ into the extracellular space, and retaining the βCTF in the membrane, 
which may be further cleaved to release Aβ. Several independent studies have 
identified a candidate β-secretase, BACE-1 (beta-site APP-cleaving enzyme-1); an 
aspartyl protease that functions optimally at low pH (Parvathy et al, 1999; Sinha et al, 
1999; Vassar et al, 1999; Yan et al, 1999). Additionally, decline in BACE-1 activity has 
been found to coincide with lowered cholesterol level (Frears et al, 1999; Simons et al, 
1998). This is as reduction in cholesterol causes loss of lipid “rafts”; these 
microdomains are thought to be crucial for coordinating the presentation of APP to 
BACE-1 (Simons et al, 1998). The correlation between cholesterol and β-site cleavage 
is particularly interesting, due to the correlation between high cholesterol diets and an 
increased risk of AD (Kivipelto & Solomon, 2006). BACE-1 has also been shown to 
cleave APP at the Glu11 of Aβ, releasing a shorter form of Aβ that has been identified 
to comprise the cores of Aβ plaques (Masters et al, 1985; Naslund et al, 1994); 
however, the significance of these shorter Aβ peptides are not yet understood.  
 
In APP processing, γ-secretase is involved in both amyloidogenic and non-
amyloidogenic processing, and is thought to occur after the endocytosis of both αCTF 
and βCTF, presumably as part of an endosomal-lysosomal compartment (Higaki et al, 
1995; Knops et al, 1995). The γ-secretase cleavage site is within the transmembrane 
 Page 20 
CHAPTER 1: Introduction 
region of αCTF and βCTF; thus, γ-secretase must hydrolyse a peptide bond in a 
hydrophobic environment, an impressive feat for which the molecular mechanism 
unfortunately remains unclear (De Strooper & Annaert, 2000). There is some flexibility 
within the γ-secretase cleavage site, which results in the generation of several Aβ 
peptides of varying length, typically between 38 and 43 residues long (Mattson, 1997). 
 
1.2.3 Function of Aβ 
 
In a healthy individual Aβ is found to be released at distal axons and synapses 
(Lazarov et al, 2002; Sheng et al, 2002); consequently, Aβ function is unlikely limited to 
the pathogenic. However, the physiological role of Aβ remains controversial (Hiltunen 
et al, 2009). Some research has demonstrated the capacity of Aβ to act as a 
neurotrophic factor, increasing the growth rate of neural stem cells independently of 
soluble factors released by the cells (Lopez-Toledano & Shelanski, 2004), suggesting 
that it may be important physiologically to neuronal survival. Others have also 
proposed that Aβ has a protective role in vivo, though through its inherent oxidative 
activity instead, as Aβ displays antioxidant properties capable of protecting against 
transition metal induced oxidation in the brain (Baruch-Suchodolsky & Fischer, 2009; 
Zou et al, 2002).  
 
Alternatively, Aβ may be important for synaptic plasticity and memory formation, as 
siRNA and antibodies directed against Aβ reduce long-term potentiation (LTP) and 
memory, with addition of human Aβ able to rescue these functions (Puzzo et al, 2011). 
A role of Aβ in memory formation is supported by studies showing that levels of Aβ 
follow a circadian rhythm, increasing with wakefulness and falling in sleep (Kang et al, 
2009), with sleep thought by many to have an important role in memory consolidation 
(Stickgold & Walker, 2005). Furthermore, it has been demonstrated that lack of sleep is 
associated with brain shrinkage and ventricle expansion akin to that which is typical in 
AD (Lo et al, 2014).  
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Adding to the broad repertoire of putative functions already proposed, Aβ has also 
exhibited the ability to influence transcription, specifically, increasing expression of 
BACE-1, which in turn regulates APP processing and its own production. It is thought 
Aβ does this through either itself acting as a transcription factor (Bailey et al, 2011), or, 
alternatively, as a signalling peptide (Tabaton et al, 2010). There is also the possibility 
that Aβ may function as a cholesterol transporter, with it being demonstrated that 
increases in Aβ were associated with a redistribution of cholesterol from the plasma 
membrane to the Golgi apparatus (Igbavboa et al, 2009). This possibility is particularly 
striking, as cholesterol is understood to be an important risk factor for AD (Kivipelto & 
Solomon, 2006).  
 
Unfortunately, at this point it is not clear which possible role is correct, nor if Aβ may 
even have multiple functions. However, somewhat surprisingly, animal studies in mice 
demonstrate that Aβ is not essential, as complete depletion of Aβ through knockout of 
the BASE-1 gene did not result in any major side effects (Luo et al, 2003). 
 
1.2.4 Aβ Catabolism 
 
In the brain, Aβ levels are controlled through a balancing of its production, from APP, 
and its removal, either via perivascular drainage, or by the action of amyloid-degrading 
enzymes (ADEs). In sporadic forms of AD, no change in Aβ production is observed; 
however, Aβ is seen to accumulate regardless (Funato et al, 1998). Furthermore, in 
mice with amyloid deposits the half-life of Aβ is seen to double, from ~2 hrs to ~4 hrs 
(Cirrito et al, 2003). For these reasons, there has been growing interest in Aβ 
catabolism.  
 
There are more than 20 ADEs; however, the general consensus is that a zinc-
metalloprotease, neprilysin, is the major ADE in Aβ catabolism (Nalivaeva et al, 2012; 
 Page 22 
CHAPTER 1: Introduction 
Shirotani et al, 2001). Neprilysin levels are reduced in individuals with AD (Wang et al, 
2005), and are also seen to decline in response to events that are associated with 
increased AD risk, such as ischemia and hypoxia (Fisk et al, 2007; Nalivaevaa et al, 
2004). These studies highlight the potential importance of Aβ catabolism for a healthy 
brain.  
 
1.2.5 Tau 
 
Though not a focus of my PhD, the second hallmark of AD, the tau tangles, are not 
only notable for their coincidence with Alzheimer’s disease, but for their importance in a 
range of neurodegenerative diseases, the “tauopathies”. These include frontotemporal 
dementia, dementia puglistica, and progressive supranuclear palsy (Hutton et al, 1998; 
Roberts, 1988; Williams & Lees, 2009). Tau is not a single protein, but in fact a family 
of proteins, ranging from 352 – 441 amino acids in length, that are produced by the 
alternative splicing of a single gene on chromosome 17, MAPT (microtubule-associated 
protein tau) (Goedert et al, 1989). The tau proteins are abundant in the neurons, where 
they modulate both the flexibility and stability of axonal microtubules in distal axonal 
regions through their direct interaction with tubulin. It is this interaction that promotes 
the assembly of tubulin into microtubules.  
 
Tau proteins are regulated through phosphorylation, with kinases such as PKN, which 
disrupts microtubule association (Taniguchi et al, 2001). There are a great number of 
potential phosphorylation sites in the tau proteins, 79 being present on the longest 
isoform. Of these, 30 have been found to be phosphorylated in non-pathological tau 
protein (Billingsley & Kincaid, 1997). Pathological tau is hyperphosphorylated, and 
aggregates into oligomers, β-sheets, and ultimately neurofibrillary tangles, though it is 
not clear whether hyperphosphorylation precedes or follows aggregation (Ballard et al, 
2011). Whichever the case may be, once tau aggregation commences it perpetuates 
itself through recruiting more tau and spreading to additional brain regions. This has 
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been clearly demonstrated by the injection of pathological tau into wild-type mice, 
which induced formation of tau tangles consisting of endogenous tau (Clavaguera et al, 
2009). Tauopathy symptoms do not arise from a loss of tau function, as tau knockout 
mice do not present neurodegenerative symptoms (Harada et al, 1994). Instead, the 
tau aggregates themselves are neurotoxic (Meraz-Rios et al, 2010).  
 
Of particular interest is the interaction between Aβ and tau. The affinity of Aβ for tau is 
almost 1000-fold greater than the affinity of tau for itself, and formation of Aβ-tau 
promotes tau phosphorylation (Guo et al, 2006). Thus, it would seem that Aβ may be 
an important mediator of tau aggregation in AD. This is supported by the observation 
that phosphorylated tau is bound to both monomeric and oligomeric Aβ in the damaged 
neurons of AD patients and mouse models, and that these interactions are increased 
with disease progression (Manczak & Reddy, 2013), presumably with Aβ aggregation 
upstream of tau aggregation.  
 
1.3 AMYLOID CASCADE HYPOTHESIS OF ALZHEIMER’S DISEASE 
 
1.3.1 Genetic Support for an Amyloid Cascade 
 
There has been some controversy as to the identity of the causative agent in 
Alzheimer’s disease; however, there generally seems to be more to support Aβ 
aggregation preceding tau aggregation. The foundation for the “amyloid cascade 
hypothesis”, which proposes that Aβ aggregation is the primary event in AD, may be 
considered to have first been laid down upon the observation that individuals with  
Down’s syndrome invariably develop AD (Olson & Shaw, 1969). This discovery was 
particularly significant as those with Down’s syndrome possess three copies of 
chromosome 21, the chromosome containing the APP gene. Consequently, individual’s 
with Down’s syndrome accumulate high levels of Aβ, as is characteristic of AD 
(Glenner & Wong, 1984). The concept of an amyloid hypothesis was further 
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established upon the discovery of a mutation within the Aβ sequence of APP, the Dutch 
mutation (E693Q). This was the earliest demonstration that mutations within APP may 
lead to enhanced amyloid deposition, while also illustrating the capacity of Aβ to 
aggregate independently of other AD correlates. The Dutch mutation leads to extensive  
Aβ plaque deposition in cerebral vessel walls, where it may lead to cerebral 
haemorrhage, apoptosis of cerebral endothelial cells, and AD itself (Levy et al, 1990; 
Miravalle et al, 2000; Van Broeckhoven et al, 1990). 
 
Since the discovery of the Dutch mutation, there have been many more APP mutations 
found that are associated with AD, as shown in figure 1.03 (Benilova et al, 2012). 
Though these autosomal dominant mutations account for no more than 5 % of AD 
cases, and confer an “early-onset” form of the disease rather than a typical 
progression, they provide useful insights as to the role of Aβ in AD. For instance, it is 
apparent that many of these mutations cluster at secretase cleavage sites, where they 
promote the amyloidogenic pathway of APP, increasing Aβ production (Cai et al, 1993; 
Citron et al, 1992; Suzuki et al, 1994). This may be achieved through an inhibition of α-
secretase activity, such as for the Flemish mutation (A692G), or a potentiation of β-
secretase activity, as in the Swedish mutation (K670N/M671L) (Haass et al, 1995; 
Hardy, 1997). Additionally, several mutations in APP that lead to early-onset AD 
increase the aggregative properties of Aβ, such as the Arctic mutation (E693G) 
(Nilsberth et al, 2001). Additionally, there are over 100 mutations associated with early-
onset AD that occur in the γ-secretase complex; these mutations influence the length 
distribution of Aβ peptides, promoting generation of longer, more hydrophobic 
alloforms, that aggregate more readily (Citron et al, 1997; Duff et al, 1996; Scheuner et 
al, 1996). 
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Figure 1.03 APP Mutations. 
Red arrows indicate cleavage sites, and shaded grey indicates region within the plasma 
membrane. This figure shows mutations within APP that are associated with AD, some of 
which increase Aβ production (blue), increase Aβ self-association (black), or alter the ratio of 
Aβ isoforms (green). Reprinted by permission from Macmillan Publishers Ltd: Nature 
Neuroscience, (Benilova et al, 2012), copyright (2012). 
 
 
Figure 1.09 Amyloid Cascade Hypothesis.Figure 1.010 APP Mutations. 
Red arrows indicate cleavage sites, and shaded grey indicates region within the plasma 
membrane. This figure shows mutations within APP that are associated with AD, some of 
which increase Aβ production (blue), increase Aβ self-association (black), or alter the ratio of 
Aβ isoforms. Figure adapted from (Benilova et al, 2012). 
 
 
Figure 1.09 Amyloid Cascade Hypothesis.Figure 1.010 APP Mutations. 
Red arrows indicate cleavage sites, and shaded grey indicates region within the plasma 
membrane. This figure shows mutations within APP that are associated with AD, some of 
which increase Aβ production (blue), increase Aβ self-association (black), or alter the ratio of 
Aβ isoforms. Figure adapted from (Benilova et al, 2012). 
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There also exist mutations outside of APP that do not lead to early-onset forms of the 
disease, but still are strongly associated with disease risk. Most notable is the ɛ4 allele 
of the apolipoprotein E (APOE) gene, which in heterozygotes increases AD risk by a 
factor of 4, and in homozygotes increases risk by a factor of 8 (Corder et al, 1993). 
APOE codes for a protein involved in cholesterol transport; however, for reasons that 
are not clear, the ɛ4 allele reduces Aβ clearance, and elevates Aβ aggregation 
(Mattson, 2004; Roses, 1997); both of which are crucial to AD pathology.  
 
The number of mutations that directly affect Aβ, and in turn are associated with AD, 
strongly supports amyloid deposition as the initiator of AD. However, a further 
observation that has been critical in establishing the amyloid cascade hypothesis 
involves mutations that directly affect tau. Such mutations are observed to cause 
frontotemporal dementia with parkinsonism, rather than AD (Poorkaj et al, 1998; Puzzo 
et al, 2011; Spillantini et al, 1998). As frontotemporal dementia is characterised by both 
an extensive deposition of tau tangles, and profound, fatal, neurodegeneration, but 
does not induce Aβ deposition, it may be concluded that even under the most extreme 
of circumstances tau is not able to induce Aβ aggregation. Thus, though AD is a 
multifaceted disease, there is much evidence to implicate Aβ accumulation as the 
primary factor from which everything else follows, including tau tangle formation, 
validating the use of an amyloid-centric model for AD pathology.  
 
1.3.2 Amyloid Cascade Hypothesis 
 
The amyloid cascade hypothesis, as shown in figure 1.04, posits that AD begins with 
the accumulation and aggregation of Aβ (in particular self-assembly into oligomeric and 
protofibrillar species), and that this may occur due to genetic mutations, reductions in 
Aβ catabolism, and yet to be identified triggers, which are likely to be numerous (Hardy, 
2006). This basic premise is the cornerstone upon which every iteration of the amyloid 
cascade hypothesis has rested; however, the details of the steps that follow, and their 
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Figure 1.04 Amyloid Cascade Hypothesis. 
A representative schematic of the amyloid cascade hypothesis. Reprinted by permission 
from Macmillan Publishers Ltd: Nature Reviews Molecular Cell Biology, (Haass & Selkoe, 
2007), copyright (2007). 
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relative importance, are more contentious. Generally, it is believed that though the 
large Aβ plaques themselves may not be toxic, smaller intermediate species are, and 
these smaller assemblies can interact with and perturb synapses. In parallel to this, 
diffuse Aβ aggregates accumulate in the parenchyma, and incur inflammatory 
responses. This extended exposure to Aβ aggregates, both at the synapse and in the 
parenchyma, leads to neuronal degeneration, loss of ion homeostasis, and oxidative 
stress (Haass & Selkoe, 2007). Subsequently, the altered neurological environment, or 
perhaps a direct interaction between Aβ and tau (Guo et al, 2006), leads to 
hyperphosphorylation of tau, which then associates into tangles, exacerbating 
neuropathology through disruption of axonal transport and enhanced neurotoxicity 
(Haass & Selkoe, 2007). This culminates in a positive feedback of neurodegeneration, 
leading to the progressive symptoms of neuronal dysfunction typical of AD.     
 
Though initially developed as a model for AD, the amyloid cascade hypothesis has now 
found broader application. This is as the misfolded structure of Aβ adopted in AD has 
been found to be a common feature of many protein misfolding diseases, including 
Parkinson’s (Der-Sarkissian et al, 2003) and Huntington’s (Scherzinger et al, 1999). As 
such, it is important for not just AD, but for protein misfolding diseases in general, to 
elucidate the misfolding pathway of Aβ. 
 
1.4 AMYLOID-β MISFOLDING 
 
1.4.1 Aβ Primary Sequence 
 
As shall be discussed later, the two most notable alloforms of Aβ are 40 and 42 amino 
acids long, consisting of the following sequence: 
 
          5            10           15          20           25          30         35           40 
DAEFR HDSGY EVHHQ KLVFF AEDVG SNKGA IIGLM VGGVV / IA 
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Blue amino acids represent hydrophilic residues, whereas the red indicates 
hydrophobic. While the N-terminal is mainly hydrophilic, there are two major 
hydrophobic regions: the central hydrophobic core, from residues 17 – 21, and the C-
terminus, from residues 29 – 40/42. The bulky side chains of these hydrophobic 
residues increase the propensity of Aβ to form β-sheet structures. Also of note are 
residues involved in Aβ’s chelation of metal ions (particularly the histidines), indicated 
here by underlining. 
 
1.4.2 Monomeric Aβ Structure 
 
Monomeric Aβ is generally considered to be an intrinsically disordered peptide, having 
no defined tertiary structure, and exhibiting a high degree of flexibility (Uversky et al, 
2008). Early nuclear magnetic resonance (NMR) data demonstrated that monomeric 
Aβ adopts a metastable “collapsed coil” secondary structure; a compact series of 
loops, turns, and strands, with no β-sheet or α-helical structure (Zhang et al, 2000). 
More recent studies have emphasised that there are in fact a diverse range of 
morphologies available for monomeric Aβ, with Aβ exhibiting a capacity to adopt both 
α-helical and β-sheet motifs (Sgourakis et al, 2011; Vivekanandan et al, 2011). The 
diverse ensemble of structures that are rapidly sampled by monomeric Aβ has been 
suggested to provide a starting point for misfolding and aggregation (Sgourakis et al, 
2011; Yang & Teplow, 2008), which may proceed down two primary pathways, as 
shown in figure 1.05a (Faller et al, 2013). 
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Figure 1.05 Aβ Aggregative Pathways. 
(A) A representative schematic of amyloid-β aggregation, highlighting the alternative 
routes of amorphous aggregation, and fibrillogenesis, the second of which is thought 
essential to Alzheimer’s disease pathology. Reprinted with permission from (Faller et al, 
2013), copyright (2013) American Chemical Society. (B) Kinetics of amyloid 
fibrillogenesis. The entropic cost for nucleus formation that creates a kinetic barrier that 
may be overcome with addition of a seed. Reprinted from (Eichner & Radford, 2011), 
Copyright (2011), with permission from Elsevier. 
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1.4.3 Plaques 
 
The characteristic Aβ “plaques” of AD, are composed partly of amorphous aggregates 
of the peptide; unordered precipitates of Aβ that arise from aberrant interactions 
following adoption of a β-sheet rich fold, and are comprised themselves of a diverse 
range of aggregates (Goncalves et al, 2010); and amyloid fibres, a much more orderly 
aggregative pathway proceeding the adoption of a β-sheet rich fold in Aβ. Though 
initially considered as a crucial mediator of AD pathology (Alzheimer et al, 1995), it is 
now generally considered that the plaques are a by-product of the disease, and though 
they may be in equilibrium with more toxic aggregate species, they are not the primary 
perpetuator. Evidence for this is provided by the clinical trial of an Aβ vaccine, which 
though it removed plaques did not prevent progressive neurodegeneration (Holmes et 
al, 2008). Additionally, it has been demonstrated that oligomers and protofibrils much 
better correlate with disease progression than plaques (Lue et al, 1999). The pathway 
towards generating oligomers and protofibrils involves the more ordered aggregative 
pathway of fibrillogenesis, and as such is of more relevance to disease aetiology than 
amorphous aggregation.  
 
1.4.4 Amyloid Fibre Structure 
 
It has been determined with X-ray fibre diffraction that Aβ may self-associate into fibres 
with a cross-β structure, in which β-sheets are orientated nearly perpendicular to the 
fibril axis, with intermolecular hydrogen bonding parallel to the axis (Eanes & Glenner, 
1968; Geddes et al, 1968; Sikorski et al, 2003). This has been expanded upon with 
electron paramagnetic resonance (EPR), which has been used to identify the location 
and contacts of β-sheet strands within the fibre (Torok et al, 2002). This identified that 
though there are regions of mobility, such as in the N-terminus and between residues 
23 – 26 (which likely contains a bend or turn region), the Aβ fibre structure is generally 
ordered and specific, forming in register parallel β-sheets within the fibre. This has 
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been supported with hydrogen/deuterium exchange, which shows that about half of the 
backbone amide protons are protected from exchange, indicative of their being within 
highly structured core regions of the fibre (Kheterpal et al, 2003).  
 
Electron and atomic-force microscopy have been used to delineate the topological 
character of amyloid fibres, revealing that they are long, straight, non-branching 
structures, that themselves are composed of a number of protofilaments that entwine 
one another to form the complete fibre (Goldsbury et al, 1999; Jimenez et al, 2002; 
Serpell et al, 2000). Insights into the atomic organisation of the cross-β motif have also 
been advanced using X-ray crystallography (Nelson & Eisenberg, 2006; Sawaya et al, 
2007). Small fragments from a variety of amyloidogenic proteins were used, revealing 
that for amyloid structures pairs of β-sheets join via a dry “steric zipper” configuration: 
an interdigitating of sidechains. It has been proposed that such an interaction may drive 
the association of β-sheets in early stages of amyloid fibre formation.    
 
Interestingly, it is now known that more than 20 other proteins involved in disease can 
misfold and form these cross-β amyloid fibrils (Sunde et al, 1997). This observation, 
combined with the existence of functional amyloids in yeast (Wickner, 1994), bacteria 
(Chapman et al, 2002), and even humans (Fowler et al, 2006), supports the notion that 
amyloid assemblies were probably a prominent early fold in the evolution of life, that 
has since been retained (Chernoff, 2004; Eichner & Radford, 2011). However, the 
diversity of proteins that form pathological amyloid structures not only serves to further 
incentivise an elucidation of the process, but also demonstrates that amyloid 
fibrillogenesis is not the product of a specific native structure or sequence that has 
been conserved. Rather, it seems that it is a capacity of a protein to adopt erroneous 
conformations that underlies amyloid fibre formation. This has been demonstrated with 
transtheyretin, as inducing its partial misfolding with acidic conditions is seen to 
promote amyloid fibre formation (Colon & Kelly, 1992). Thus, proteins that are 
inherently unstructured, such as Aβ, are seen to readily form amyloid fibrils (Eichner et 
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al, 2011; Sgourakis et al, 2011; Yang & Teplow, 2008). 
 
Despite the shared cross-β fold of amyloid fibrils, there is still a broad diversity of 
conformations available to be adopted at the macromolecular level. This has been 
shown extensively with such techniques as cryo-electron microscopy (cryo-EM) and 
solid-state NMR (ssNMR), which, as shown in figure 1.06, have demonstrated a great 
number of ways in which amyloid fibres may vary. These include the number of proto-
filaments that may constitute a mature fibril (Jimenez et al, 2002), whether parallel or 
anti-parallel β-sheets comprise the cross-β fold (Iwata et al, 2006; Nielsen et al, 2009), 
the periodicity of twists along the fibril (Meinhardt et al, 2009), and a fibre’s axial 
symmetry (Petkova et al, 2005). These variations in structure are significant as they 
may confer differences in a fibre’s physical, chemical and biological properties. This is 
well demonstrated through consideration of the prion protein, for which the tertiary 
structure adopted by the misfolded protein determines the “strain” of prion disease, and 
its related pathology (Prusiner, 1998). Furthermore, it has more recently been shown 
that the conformational stability of a prion strain determines its incubation time (Colby 
et al, 2009).  
 
Though fibril structure is sensitive to sequence, with a single point mutation in Aβ(1-40) 
(the Iowa mutation D23N) switching fibril structure from predominantly parallel to 
predominantly anti-parallel β-sheet, a change in structure which may underlie the 
enhanced pathogenicity of Aβ in those with the mutation (Tycko et al, 2009), 
environment is also an important determinant of fibril structure. It has been shown with 
Aβ(1-40) that a change from agitated to quiescent conditions causes a switch in the axial 
symmetry of fibres from 2-fold to 3-fold, which in turn influences fibres’ potential to kill 
neuronal cell cultures, presumably as different side-chains are exposed, despite 
identical sequences (Paravastu et al, 2008; Petkova et al, 2005). Notably, as for prion 
strains, mature Aβ fibres impart their own structure upon daughter fibres. This explains 
why brain-derived Aβ fibres are not polymorphic, and also provides a potential 
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Figure 1.06 Diversity of Amyloid Fibres. 
(A) It has been shown with ssNMR that growing Aβ(1-40) quiescently results in a 3-fold 
symmetry rather than 2-fold (Paravastu et al, 2008; Petkova et al, 2005). (B) Cryo-EM 
showing amyloid fibrils of insulin containing 2 – 6 proto-fibrils (Jimenez et al, 2002). (C) 
Cryo-EM showing diversity of twist frequency for Aβ(1-40) fibres (Meinhardt et al, 2009). 
Reprinted from (Eichner & Radford, 2011), Copyright (2011), with permission from 
Elsevier. 
 
Figure 1.025 Aβ(1-42) Fibre Formation.Figure 1.026 Diversity of Amyloid Fibres. 
(A) It has been shown with ssNMR that growing Aβ(1-40) quiescently results in a 3-fold 
symmetry rather than 2-fold (Paravastu et al, 2008; Petkova et al, 2005). (B) Cryo-EM 
showing amyloid fibrils of insulin containing 2 – 6 proto-fibrils (Jimenez et al, 2002). (C) 
Cryo-EM showing diversity of twist frequency for Aβ(1-40) fibres (Meinhardt et al, 2009).  
 
Figure 1.019 Diversity of Amyloid Fibres. 
(A) It has been shown with ssNMR that growing Aβ(1-40) quiescently results in a 3-fold 
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explanation for the variations in disease development observed between patients, as it 
has been identified that AD patients with distinct clinical histories possess distinct 
predominant Aβ fibril structures (Lu et al, 2013). The potential for prion-like propagation 
of AD strains has recently been explored through transmission studies, in which 
transgenic mice were inoculated with brain homogenates of patients with sporadic and 
heritable (Arctic and Swedish) forms of AD (Watts et al, 2014). Mice treated with the 
three samples presented two distinct sets of disease behaviours, with Arctic AD 
causing one set of symptoms, and both sporadic and Swedish AD causing the second 
set. This divergent pathology was retained during second passage to mice, 
establishing that Aβ strains have the potential to be serially transmissible. The high-
fidelity preservation of Aβ fibre strains is likely due to the crystal-like seeding through 
which they are formed, in which parent morphology determines daughter morphology. 
 
1.4.5 Amyloid Fibre Formation 
 
A general agreement of the fundamental kinetics for fibre formation has been reached 
in recent years. Fibre growth undergoes a characteristic sigmoidal growth curve, as 
shown in figure 1.05b, in which the rate-limiting step is the nucleation phase. This is a 
stochastic process, in which nuclei consisting of several monomeric units transiently 
form and dissociate, due to the resultant molecular interactions not exceeding the 
entropic cost of association (Schnabel, 2011). This creates a kinetic barrier to the 
commencement of fibre formation, leading to a lag-time analogous to that observed in 
crystallisation; indeed, as for crystallisation, the addition of a seed (in this case 
preformed fibrils) overcomes this barrier and no lag-time is observed (Come et al, 
1993). Following the nucleation phase is the elongation phase.  
 
During the elongation phase, stabilised nuclei act as templates for the further addition 
of monomers, generating nascent fibrils. Mature fibrils are then formed from the 
continuous addition of monomers to the growing fibril ends (Lomakin et al, 1996; Walsh 
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et al, 1999). This gives rise to the exponential period of growth shown in figure 1.05b, 
which ultimately plateaus once a dynamic equilibrium is reached (Wetzel, 2006). It has 
been suggested that the nucleation-elongation model is insufficient, as inclusion of both 
fragmentation and secondary nucleation events have been seen to provide a better 
agreement between computational models and observed data (Knowles et al, 2009; 
Xue et al, 2008). Such steps lead to a greater acceleration of fibril formation during the 
elongation phase, as they increase the number of fibril ends available to which 
monomers may be added. However, now thought to be more significant to disease 
pathology than fibres are small Aβ aggregates, oligomers. Oligomers may serve as 
precursors to fibres, form from fibril fragmentation, or perhaps even compete with fibre 
formation. 
 
1.4.6 Soluble Oligomers 
 
As well as soluble aggregates better correlating with disease progression than larger 
insoluble aggregates (Lue et al, 1999), several studies have directly implicated them in 
disease pathology. For instance, when fibril growth is inhibited with low levels of 
clusterin, Aβ-derived diffusible ligands (ADDLs) form instead, a spectrum of globular 
oligomeric assemblies of 17 – 42 kDa; these have been demonstrated to bind to 
specific cell-surface receptors in neuronal cultures and exhibit neurotoxic potential 
(Lambert et al, 1998). These observations are supported by in vivo research, which has 
shown that in rats, a heterogeneous population of Aβ oligomers, with neither fibres nor 
monomers present, is capable of inhibiting hippocampal long-term potentiation (Walsh 
et al, 2002). Similarly, in mouse models the formation of a 56 kDa oligomer (Aβ*56) has 
been identified as coinciding with onset of behavioural symptoms; this assembly has 
since been isolated and injected into wild type rats, which then also developed memory 
deficits (Lesne et al, 2006).  
 
A greater ability to diffuse, differences in structure, and more substantial exposure of 
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hydrophobic regions have all been suggested to confer the enhanced pathogenicity of 
Aβ oligomers. However, despite there being support for each of these proposals, such 
as the structure of ADDLs enabling its interaction with Fyn, a tyrosine kinase linked 
with apoptosis (Lambert et al, 1998), or evidence that fragmentation of Aβ fibres 
increases cytotoxic potential through an increase in the number of exposed 
hydrophobic ends (Xue et al, 2009), a consensus as to their relative significance has 
not yet been reached. This is partly due to the heterogeneity of oligomeric assemblies, 
which vary dramatically in size, from 8 – 56 kDa (Lesne et al, 2006; Walsh et al, 1999), 
as well as structure, forming annular pore-like assemblies, flexible curved protofibrils, 
or the perfect spheres of the “amylospheroids” (Lasagna-Reeves & Kayed, 2011; 
Matsumura et al, 2011; Walsh et al, 1999). The diversity of oligomers partly arises from 
differences in assembly pathways between Aβ alloforms, the two most notable being 
Aβ(1-40) and Aβ(1-42).  
 
1.4.5 Aβ(1-42) vs. Aβ(1-40) Aggregation 
 
Aβ(1-40) and Aβ(1-42) are of most interest as they respectively represent both the most 
prevalent and most pathological forms of the peptide (Burdick et al, 1992; Lambert et 
al, 1998). The particular significance of Aβ(1-42) in AD has been cemented through 
observation of certain familial forms of the disease, for which the ratio of Aβ(1-40) to Aβ(1-
42) is seen to shift from 9:1 to 7:3 (Citron et al, 1997; Duff et al, 1996; Scheuner et al, 
1996). These familial forms of AD have mutations in either APP itself, or in two proteins 
thought to comprise the γ-secretase complex, presenilin 1 and presenilin 2. These 
mutations all increase production of Aβ(1-42)  relative to Aβ(1-40), and lead to early-onset 
forms of the disease.  
 
It has been suggested that the reason Aβ(1-42)  is more greatly associated with AD than 
Aβ(1-40) is due to its enhanced capacity to form oligomers, as evidenced by the 
demonstration that Aβ(1-42) may form stable trimers/tetramers, a quality not thought to 
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be shared by Aβ(1-40)  (Chen & Glabe, 2006). In addition to this, Aβ(1-42)  aggregates 
more readily than Aβ(1-40), with oligomers forming at a much earlier time-point (Burdick 
et al, 1992; Chen & Glabe, 2006). This difference in the kinetics of self-association is 
partly due to Aβ(1-42) having an additional alanine and isoleucine; the resultant increase 
in hydrophobicity would certainly be expected to lead to a concomitant rise in rates of 
self-association. However, there are also thought to be significant differences in the 
fundamental structures of Aβ(1-42)  and Aβ(1-40). 
 
A comparison between the structures of Aβ(1-42)  and Aβ(1-40) peptides is difficult, as they 
both populate a broad ensemble of conformations. However, a combination of 
molecular dynamic simulations and NMR data sampling provided us early insights 
(Sgourakis et al, 2007; Yang & Teplow, 2008). Initial simulations demonstrated the C-
terminus of Aβ(1-42)  to be more stable than that of Aβ(1-40), with it being able to adopt a 
β-hairpin structure that may facilitate formation of amyloid aggregates (Sgourakis et al, 
2007). This was corroborated by ab initio simulations that incorporated a modular 
organisation of Aβ(1-42)  and Aβ(1-40) peptides to simplify the folding dynamics, with 
residues 1 – 5, 10 – 13, 17 – 22, 28 – 37, and 39 – 40/42 comprising relatively 
independent folding units that are connected by four turn structures (Yang & Teplow, 
2008). As previously, Aβ(1-42)  was observed to form a more stable β-structure than that 
of Aβ(1-40), with the two additional amino acids increasing contacts within the C-
terminus, as well as between the C-terminus and the central hydrophobic cluster, 
enabling Aβ(1-42)  to more readily adopt an amyloid conformation. Differences in fibril 
structure have since been confirmed with ssNMR, revealing Aβ(1-42) to have a triple β-
sheet motif, incompatible with Aβ(1-40) monomers (Xiao et al, 2015); furthermore, a 
recent cryo-EM derived model has demonstrated that the Aβ(1-42) dimers comprising 
Aβ(1-42) fibres possess a kinked c-termini interface, leading to an increase in the number 
of peptide-peptide interactions than in Aβ(1-40) fibres (Schmidt et al, 2015).    
 
These differences in underlying structure are thought to lead to different routes of 
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aggregation for these two peptides. A variety of techniques, including size exclusion 
chromatography, photo-induced crosslinking of unmodified proteins, electron 
microscopy, and dynamic light scattering, have provided evidence that Aβ(1-42) 
fibrillogenesis is preceded by the formation of on-pathway spheroidal pentamer/ 
hexamer oligomeric units, which ultimately rearrange to form fibres, as illustrated in 
figure 1.07. However, for Aβ(1-40) no such oligomeric species were observed (Bitan et al, 
2003). Support for a fundamental disparity in aggregative mechanism has been 
provided through investigations into mixtures of these peptides. For instance, the 
addition of Aβ(1-40) to Aβ(1-42) demonstrably prevents formation of Aβ(1-42) fibres (Jan et al, 
2008), instead stabilising Aβ(1-42) intermediates (Kuperstein et al, 2010). Likewise, the 
presence of Aβ(1-42) is able to significantly frustrate formation of Aβ(1-40) fibres (Chang et 
al, 2013; Jan et al, 2008; Kuperstein et al, 2010). Thus, a diverse population of 
oligomers may form due to variations in the misfolding landscape between different Aβ 
alloforms, but also as different alloforms may influence each other’s aggregative 
pathways. Unfortunately, the exact pathogenic mechanism of these amyloid 
aggregates is still a subject of intense debate. Below I shall discuss several of the most 
well established hypotheses.   
Figure 1.07 Aβ(1-42) Fibre 
Formation. 
A simple model of Aβ(1-42) 
aggregation. Adapted from (Bitan et 
al, 2003). Copyright © 2003, The 
National Academy of Sciences. 
 
 
. 
 
 
Figure 1.022 Aβ(1-42) Fibre 
Formation. 
A simple model of Aβ(1-42) 
aggregation. Adapted from (Bitan et 
al, 2003). 
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1.5 MECHANISMS OF AMYLOID-β PATHOGENICITY 
 
1.5.1 Oxidative Damage 
 
The brain is particularly vulnerable to oxidative stress, due to its great oxygen demand, 
elevated levels of polyunsaturated fats, and high levels of redox transition metals 
(Bazinet & Laye, 2014; Masamoto & Tanishita, 2009; Viles, 2012); thus, oxidative 
damage is a potential mechanism of toxicity in neurodegenerative disease. This is 
underscored by the fact that several markers of oxidative stress are found to be 
present in AD, including protein oxidation, oxidation of DNA, and lipid peroxidation 
(Butterfield et al, 2002; Mecocci et al, 1994; Pamplona et al, 2005). Interestingly, an 
amino acid suggested to be crucial for Aβ neurotoxicity, Met35, is found to be oxidised 
in the brains of AD patients (Dong et al, 2003). The resultant methionine sulfoxide has 
been implicated in the generation of free-radicals in the brain of AD patients (Butterfield 
& Boyd-Kimball, 2005; Hensley et al, 1994), a situation which may be exacerbated as 
the enzyme capable of converting methionine sulfoxide back to methionine, methionine 
sulfoxide reductase, is observed to be diminished in the AD brain (Gabbita et al, 1999; 
Lovell et al, 2000). 
 
Despite it being previously suggested that the generation of radicals by Aβ is oxygen 
dependent but metal independent (Hensley et al, 1994), the current consensus is that 
binding to a redox active metal, such as copper or iron, facilitates the generation of 
hydrogen peroxide and free radicals through Fenton/Haber-Weiss reactions (Huang et 
al, 1999; Liu et al, 2006; Nadal et al, 2008; Opazo et al, 2002). The resultant oxidative 
stress may impact neuronal health in a number of ways, as shown in figure 1.08. Of 
particular significance is the disruption of Ca2+ homeostasis, which causes 
excitotoxicity, disrupts neuronal plasticity, and ultimately leads to cell death. The 
function of mitochondria are also greatly perturbed, as the consequent lipid 
peroxidation disrupts the function of membrane proteins, such as ion-motive ATPases  
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Figure 1.025 Aβ Induced Oxidative Stress.A  
 
 
A  
 
 
Figure 1.026 Aβ Induced Oxidative Stress.A  
 
Figure 1.08 Aβ Induced Oxidative Stress. 
(A) Reactive oxygen species generated by Aβ may impact cell health in a great many ways; 
for instance, lipid peroxidation impacts the function of cell membrane transporters, energy 
metabolism of mitochondria is perturbed, Ca2+ reserves in the endoplasmic reticulum are 
released, and the generation of the neurotoxic aldehyde, 4HNE, may oxidise tau and 
promote its aggregation. Reprinted by permission from Macmillan Publishers Ltd: Nature, 
(Mattson, 2004), copyright (2004). (B) A model for H2O2 production from Aβ-Cu2+. Aβ-Cu2+ 
may be restored by a number of biological reducing agents, such as dopamine and vitamin 
C, the products of which may themselves by toxic. Reprinted from (Opazo et al, 2002). 
 
Figure 1.033 Aβ Induced Oxidative Stress. 
(A) Reactive oxygen species generated by Aβ may impact cell health in a great many ways; 
for instance, lipid peroxidation impacts the function of cell membrane transporters, energy 
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and the electron transport chain (Mattson, 1997).  
 
Though Aβ exerts oxidative stress in vivo, it is not clear whether this is the primary 
mechanism of Aβ neurotoxicity in AD. However, both oxidative stress and impaired 
energy metabolism have been associated with an increase in the amyloidogenic 
processing of APP (Gabuzda et al, 1994); thus, Aβ’s oxidative potential may lead to an 
accumulation of Aβ, and a positive feedback loop of disease progression, regardless as 
to whether oxidation is the crucial factor in AD aetiology. 
 
1.5.2 Aberrant Signalling 
 
Aβ may perturb brain function through interfering with the signalling pathway of N-
methyl-D-aspartate receptors (NMDARs), a glutamate receptor, and in this way reduce 
synaptic transmission, disrupt LTP, and  ultimately result in cell death (Haass & Selkoe, 
2007). It has been observed that exposure of NMDARs to Aβ promotes endocytosis of 
some NMDARs through a mechanism that is dependent on α7 nicotinic-receptors 
(Snyder et al, 2005). This is significant, as NMDAR activation promotes the 
phosphorylation and activation of a transcription factor, cAMP response element 
binding protein (CREB), that activates a number of genes involved in learning, synapse 
formation, and neuronal survival (Riccio et al, 1999; Taubenfeld et al, 2001). Thus, Aβ 
induced uptake of NMDA could inhibit learning, synapse integrity, and neuron survival, 
and in this way contribute towards AD pathology. Conversely, it has also been reported 
that Aβ is capable of elevating NMDAR activity, inducing steady-state NMDAR currents 
(You et al, 2012), supporting the heightened NMDAR activity previously seen in rat 
neurons (Wu et al, 1995). Such a potentiation of NMDAR activity is correspondingly 
harmful to neurons, as the subsequent chronic Ca2+ overload would induce synaptic 
loss (You et al, 2012), also contributing towards AD pathology, though through an 
alternate route. 
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The inconsistency of Aβ action upon NMDARs may in part be due to the α7 nicotinic-
receptors that are required for NMDAR reuptake being non-uniformly distributed 
throughout the brain (Fabian-Fine et al, 2001; Zarei et al, 1999). However, the primary 
reason seems likely to arise from the nature of the NMDAR-Aβ interaction varying with 
subunit composition (Kessels et al, 2013; Li et al, 2011).  
 
With transgenic mouse hippocampal slice cultures, it has been shown that inhibition of 
Aβ’s interaction with NR2B-containing NMDARs prevents tau phosphorylation but does 
not attenuate dendritic spine loss or the elevated levels of caspase-3, whereas 
inhibition of the interaction with NR2A-containing NMDARs prevents loss of dendritic 
spines, down regulates caspase-3, and has no impact on tau phosphorylation 
(Tackenberg et al, 2013). This suggests two pathogenic pathways may originate from 
the interaction of NMDARs and Aβ independently of each other: caspase-3 induced 
apoptosis via NR2A-containing NMDARs, and tau mediated neurodegeneration 
through the NR2B-containing NMDARs. This also highlights the multifaceted nature of 
AD that has made it difficult to determine which mechanism of toxicity, if any, is the 
principal contributor towards AD pathology.  
 
1.5.3 Cell Membranes Disruption 
 
There is substantial support for Aβ exerting its neurotoxicity through a disruption of 
neuronal cell membrane integrity. This has been suggested to occur either through an 
insertion of ion-channel like assemblies of Aβ into the cell membrane (Arispe, 1993; 
Arispe et al, 1996; Jang et al, 2008; Quist et al, 2005), or through lowering the dielectric 
barrier of the membrane itself, through thinning and even puncturing the membrane 
(Kayed et al, 2004; Sokolov et al, 2006; Williams et al, 2010; Xue et al, 2009), 
presumably via the hydrophobic ends of fibrillar aggregates, as seen in figure 1.09 
(Milanesi et al, 2012). For both scenarios, the subsequent loss in regulation of  
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Figure 1.037 Aβ Induced Membrane Distortion.E 
 
Figure 1.030 Aβ Induced Membrane Distortion.E 
 
Figure 1.038 Aβ Induced Membrane Distortion.E 
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Figure 1.039 Aβ Induced Membrane Distortion.E 
Membrane Thinning 
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Figure 1.09 Aβ Induced Membrane Distortion. 
Cryoelectron tomograms of amyloid fibrils (of β2-microglobulin) clearly disrupting the 
membranes of unilam llar vesicles (A-C), and a rendered 3D model of this interaction (D). 
Reprinted from (Milanesi et al, 2012), Copyright © 2015 National Academy of Sciences. 
Scale bar 50 nm. (E) Schematic of three mechanisms through which Aβ is thought to disrupt 
cell membrane integrity. Reproduced from (Zhang et al, 2014), with permission of The Royal 
Society of Chemistry. 
 
Figure 1.041 Aβ Induced Membrane Distortion. 
Cryoelectron tomograms of amyloid fibrils (of β2-microglobulin) clearly disrupting the 
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intracellular ions, particularly Ca2+, would cause synaptic dysfunction and neuronal loss 
(Khachaturian, 1987; Mattson et al, 1992), thus contributing towards AD pathology.  
 
The occurrence of pathological interactions between Aβ and cell membranes is 
physiologically feasible; as Aβ is cleaved from APP at the cell membrane it may retain 
an affinity to the membrane, especially as the amphipathic phospholipids provide an 
extensive surface for Aβ binding (Williams & Serpell, 2011). This interaction has been 
studied extensively, using a range of biophysical techniques, including atomic-force  
microscopy, ssNMR, cryo-EM/tomography, and fluorescence spectroscopy, with 
biomimetic vesicles providing a simplified system that may be stringently regulated. 
Preliminary studies used only single-lipid vesicles, consisting entirely of 
phosphatidylcholine (PC), a neutral lipid that is a major constituent of the outer leaflet 
of the cell membrane (Andrick et al, 1991; Wirtz, 1991). Even in such a simplified 
model, a relationship between the membranes and Aβ is evident, with the vesicles 
dramatically influencing the aggregative properties of Aβ, through an increase in the lag 
time of fibre formation (Sabate et al, 2005). Additionally, early studies established that 
Aβ has the capacity to penetrate the membranes of these minimal models, and that 
vesicles comprised of a single acidic lipid, particularly the highly acidic 
phosphatidylinositol, could induce Aβ to adopt a β-structure in a pH dependent manner, 
as shown with circular dichroism (McLaurin & Chakrabartty, 1997).  
 
The success of these early studies in establishing the importance of the interaction 
between Aβ and cell membranes is particularly striking, as in vivo it is now understood 
that there are additional components that may aid the interaction between membranes 
and Aβ. One such component is cholesterol, an essential constituent of the membrane 
in vivo, but that has also been found to be an important risk factor for AD (Breteler et al, 
1998; Kivipelto & Solomon, 2006). The role of cholesterol in a healthy brain is to 
regulate the fluidity of the cell membrane (Ohvo-Rekila et al, 2002), while also 
decreasing permeability to small solutes (Haines, 2001; Yeagle, 1991). However,  
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Figure 1.10 Lipid Structures. 
From the top to the bottom, structures of phosphatidylcholine, cholesterol, GM1, and 
phosphatidylinositol. Adapted from (Becucci et al, 2014). 
 
 
Figure 1.37 Synaptic Transmission.Figure 1.38 Lipid Structures. 
From the top to the bottom, structures of phosphatidylcholine, cholesterol, GM1, and 
phosphatidylinositol. Adapted from (Becucci et al, 2014). 
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cholesterol has also been seen to aid in the insertion of Aβ into small unilamellar 
vesicles and lipid monolayers, while also promoting the adoption of an α-helical 
structure, presumably inhibiting Aβ aggregation (Ji et al, 2002). This has made it 
somewhat unclear as to whether membrane cholesterol may prevent or augment AD 
pathogenicity.  
 
Evidence that membrane cholesterol is diminished in those with AD (Mason et al, 1992; 
Roth et al, 1995), and the observation that membrane cholesterol inversely correlates 
with Aβ(1-40) induced cell death, of both PC-12 and SH-SY5Y cells (Yip et al, 2001), 
seemingly suggests a protective role. However, it has also been shown that membrane 
cholesterol facilitates the insertion of Aβ(1-42) oligomers into neuronal cell membranes, 
which subsequently induces a rearrangement of the lipid membrane that the authors 
suggest may have an important role in AD, through a disruption of intercellular 
signalling at the synapse (Ashley et al, 2006). Additionally, with both synthetic lipid  
mixtures and vascular smooth muscle cell membranes, Aβ toxicity is observed to be 
proportional to membrane binding, which in turn is dependent on the presence of 
membrane cholesterol; the implied relationship between cholesterol and Aβ toxicity 
was confirmed when a reduction of cholesterol was demonstrated to significantly 
ameliorate the toxic effects of both Aβ(1-40) and Aβ(1-42) (Subasinghe et al, 2003). Thus, 
the relationship between membrane cholesterol and Aβ is highly contentious, and 
though discrepancies may potentially arise in part from differences in cells, Aβ 
alloforms, or the aggregated states of Aβ, this does not resolve all disputes in the 
literature. However, it is clear that cholesterol is a significant factor in determining the 
relationship between Aβ and cell membranes in vivo, so to develop an accurate model 
of Aβ at the cell membrane, it is a necessary constituent to include.      
 
Gangliosides are another important component of the cell membrane in AD aetiology. 
They are a family of glycosphingolipids (consisting of hydrophilic sialic acid moieties on 
a terminal oligosaccharide, and a hydrophobic ceramide tail) that are abundant in the 
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brain, where they comprise 5 – 10 % of neuronal outer membrane leaflets, and are 
important for neuronal plasticity, differentiation and cell adhesion (Fishman & Brady, 
1976; Hakomori, 2003; Mocchetti, 2005). The first ganglioside discovered, and that with 
the highest affinity for Aβ(1-42), is GM1 (Valdes-Gonzalez et al, 2001). Despite initial 
suggestions that GM1 may sequester Aβ and prevent fibre formation (McLaurin & 
Chakrabartty, 1996), it has since been demonstrated that the inclusion of GM1 in lipid 
vesicles increases Aβ fibrillogenesis (Choo-Smith et al, 1997), and may facilitate 
insertion of Aβ into the membrane, potentiating Aβ induced distortion of vesicles, and 
the subsequent increase in permeability (Williams et al, 2010). Thus, GM1 likely has an 
important role in mediating Aβ toxicity, at least at the cell membrane. This is supported 
by the coincident decline of glucosylceramide synthase activity with age (Marks et al, 
2008), which may lead to an increase in the number of gangliosides at the cell 
membrane, as has been shown for transgenic mouse models of AD (Barrier et al, 
2007), and consequently providing more sites for Aβ membrane insertion.  
 
1.6 THE SYNAPSE 
 
1.6.1 During Alzheimer’s Disease 
 
Though in AD we are able to observe dramatic changes in brain anatomy, such as 
extensive neuronal loss, shrinkage of the brain, and expansion of ventricles, it is 
generally accepted that looking at earlier more subtle effects provides a greater 
understanding of disease aetiology; in AD, that means studying synaptic loss is a 
priority (Klyubin et al, 2012; Selkoe, 2002; Selkoe, 2008). Synapses are essential to 
neuronal function, as they enable “communication” between neurons, be it via an 
electrical or chemical signal (Daniel L. Schacter, 2011). This occurs at the synaptic 
cleft, a junction between the synapses of two neurons that is 20 – 30 nm wide, and is 
described in Figure 1.11 (Christopher Moyes, 2008). The widely accepted Hebbian 
theory postulates that it is at the synaptic level that learning occurs, as repeated  
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Figure 1.11 Synaptic Transmission. 
A schematic of synaptic transmission between neurons. Reproduced from (Christopher 
Moyes, 2008), copyright © 2015, Pearson Education Inc. 
 
Figure 1.49 Synaptic Transmission. 
A schematic of synaptic transmission between neurons. Adapted from (Christopher Moyes, 
2008). 
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signalling across a synaptic cleft strengthens the inter-neuron connection, and it is this 
strengthening of connection, LTP, that likely facilitates information storage (Lynch, 
2004).  
 
At early stages of AD there is extensive synaptic loss, with an ~25 – 35 % loss of 
synapses in the cortex 2 – 4 years after diagnosis (Davies et al, 1987). This is not 
simply the result of neuronal loss, as individual cortical neurons are also observed to 
have an ~15 – 35 % reduction in their number of synapses. The importance of synaptic 
loss in AD aetiology is underscored by the observation that it is the best correlate of 
cognitive decline for all stages of AD (Terry et al, 1991). As such, there is much interest 
in the relationship between Aβ and the synapse.  
 
1.6.2 Aβ and the Synapse 
 
Levels of Aβ are estimated to be 0.5 nM at the synapse (Seubert et al, 1992); however, 
it is well established that Aβ monomers do not perturb synaptic function (Klyubin et al, 
2012), and may Instead actually support LTP and learning (Puzzo et al, 2011; Puzzo et 
al, 2008). This has been supported in a range of experiments, that have demonstrated 
the necessity of Aβ to first aggregate for it to be capable of disrupting the synapse 
(Cleary et al, 2005; Klyubin et al, 2008; Klyubin et al, 2005; Shankar et al, 2008).  
 
In several pioneering studies it was clearly shown that Aβ aggregates have the 
capacity to perturb LTP independently of neurodegeneration, using mouse brain slices 
(Lambert et al, 1998), rat brain slices (Wang et al, 2002), and rats (Walsh et al, 2002). 
Subsequent experiments have suggested that Aβ dimers are sufficient to mediate this 
synaptotoxicity (Barry et al, 2011; Li et al, 2009; Li et al, 2011; Shankar et al, 2008), 
and are more potent neurotoxins than larger oligomeric species, such as Aβ*56 (Lesne 
et al, 2006; Shankar et al, 2008). However, more recent evidence has shown that these 
dimers need to assemble themselves into large protofibril-like oligomers before they 
 Page 51 
CHAPTER 1: Introduction 
are able to disrupt LTP (Hartley et al, 2008; O'Nuallain et al, 2010). This highlights the 
difficulty in determining the precise aggregate species responsible for mediating 
synaptic disruption in vivo, as the heterogeneity of Aβ populations and the dynamic 
equilibrium between different aggregate species can lead us to erroneous conclusions. 
Consequently, the relative significance of different aggregative species is still uncertain 
(Klyubin et al, 2012). A more effective route for elucidating how the vast range of Aβ 
aggregates fit into AD aetiology may be to first delineate the role of Aβ ligands that are 
able to influence Aβ’s aggregative landscape. Metal ions, particularly Zn2+ and Cu2+, 
are thought to be particularly important in directing Aβ aggregation in vivo (Faller et al, 
2013; Viles, 2012).  
 
1.6.3 Cu2+ at the Synapse 
 
At the synaptic cleft, Cu2+ has been reported to reach concentrations of 15 – 250 µM 
during depolarisation (Hartter & Barnea, 1988; Kardos et al, 1989). These high fluxes in 
Cu2+ ions are now understood to be indicative of an important role for Cu2+ in regulating 
neuronal transmission (Gaier et al, 2013). It has been shown with rat cortical neurons 
that Cu2+ may inhibit NMDAR induced depolarisation, as well as that of α-amino-3-
hydroxyl-5-methyl-4-isoxazolepropionic acid receptors (AMPARs), another glutamate 
receptor which is upregulated in response to heightened NMDAR activity (Weiser & 
Wienrich, 1996). Notably, the effect of Cu2+ on AMPARs was significantly inhibited by 
the addition of a reducing agent, diothiothreitol, whereas the effect of Cu2+ on NMDARs 
was not influenced by diothiothreitol. This suggests that the mechanism of Cu2+ 
mediated inhibition is different for these two glutamate receptors, being oxidation 
dependent for AMPARs, but oxidation independent for NMDARs. Later studies have 
shown that Cu2+ inhibits NMDAR activity non-competitively, with Cu2+ preferably 
binding agonist-bound receptors, and nullifying excitotoxicity (Schlief et al, 2006; 
Vlachova et al, 1996). A role for Cu2+ in preventing glutamate induced excitotoxicity is 
corroborated by the disease aetiology of Menkes disease, for which Cu2+ deficiency 
 Page 52 
CHAPTER 1: Introduction 
causes seizures and extensive neurodegeneration (Barnes et al, 2005; Donsante et al, 
2011; Kodama et al, 1999).  
 
Menkes disease is also associated with developmental delay (Donsante et al, 2007; 
Kaler, 2011), which may be related to Cu2+ induced inhibition of a second class of 
neurotransmitter receptors: γ-aminobutyric acid (GABA) receptors, specifically the 
GABAA subtype (Sharonova et al, 1998; Trombley & Shepherd, 1996). GABAA 
receptors are Cl- channels, and as such are generally inhibitory; however, they may be 
excitatory when intracellular levels of Cl- are elevated, as is seen in development (Ben-
Ari et al, 1997; Taketo & Yoshioka, 2000). It is at these neurons for which the action of 
Cu2+ on GABAA receptors is thought to be important for developmental onset. 
 
Despite being crucial for proper neuronal functioning, Cu2+ requires tight regulation, 
partly due to the risk of reactive oxygen species generation (Uriu-Adams & Keen, 
2005). However, disruption of the aforementioned neuronal signalling pathways 
through unregulated Cu2+ is also pathogenic, as demonstrated in Wilson’s disease, a 
disease in which Cu2+ levels are elevated, and that leads to extensive 
neurodegeneration, motor impairment, and psychiatric symptoms (Das & Ray, 2006; 
Kodama et al, 2011). 
 
1.6.4 Zn2+ at the Synapse 
 
Zn2+ is another metal ion that has been reported to reach high concentrations at the 
synaptic cleft during depolarisation, typically as much as 100 – 300 µM (Kardos et al, 
1989; Vogt et al, 2000). It is now understood to be an important signalling molecule 
within the nervous system; indeed, glutamatergic neurons, at which the greatest 
reserves of Zn2+ in the brain are co-released with glutamate, are frequently now 
referred to as “zincergic” neurons (Brown & Dyck, 2004; Takeda et al, 2013). However, 
Zn2+ is not limited to influencing glutamate receptors. It has been established that Zn2+ 
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may modulate the activity of almost all known ligand gated ion channels involved in 
neuronal transmission, though with a high degree of specificity for subunit composition 
(Marger et al, 2014; Yuan et al, 2014).  
 
The receptors which are most sensitive to Zn2+ are NMDARs comprised of NR2A 
subunits, which are inhibited by Zn2+ at the nanomolar range in a voltage-independent 
manner (Yuan et al, 2014; Zheng et al, 2001) , demonstrating that Zn2+ binding occurs 
externally from the pore. However, there is also evidence that Zn2+ at micromolar 
concentrations may inhibit a broader range of NMDARs in a voltage-dependent manner 
(Christine & Choi, 1990; Hansen et al, 2014); suggesting that there is a second Zn2+ 
binding site within the pore itself. It is not yet clear the significance of there being two 
sites, though it is clear that Zn2+ is an important modulator of NMDAR activity, and by 
extension, neuronal plasticity (Marger et al, 2014; Vergnano et al, 2014), as well as 
likely being protective against excitotoxicity (Koh & Choi, 1988).  
 
Zn2+ also regulates the family of pentameric four transmembrane receptors which 
nicotinic acetylcholine receptors (nACHR), GABAA receptors, serotonin receptors, and 
glycine receptors are members (Marger et al, 2014). Modulation by Zn2+ of these 
receptors can be highly subtype specific and complex; for instance, α2β2 nACHR 
activity is potentiated by Zn2+ at lower micromolar levels but inhibited at higher 
concentrations, whereas a slightly different subunit composition, α3β2, may only bind 
and be inhibited by Zn2+ (Hsiao et al, 2001). As for NMDARs, it is thought that there are 
two Zn2+ binding sites, one at the interface between subunit extracellular domains, and 
a second site within the pore, which has been supported by the site directed 
mutagenesis of GABAA receptors (Horenstein & Akabas, 1998). 
 
The broad range of neuronal receptors that Zn2+ modulates, including NMDARs and 
glycine receptors, the brain’s major excitatory and inhibitory receptors respectively, 
highlights the significant role of Zn2+ in a diversity of brain functions. This becomes 
 Page 54 
CHAPTER 1: Introduction 
clearer still when one considers the impact of deregulated Zn2+, with elevated levels of 
Zn2+ conferring epilepsy, ischemia and depression to mice (Lee et al, 2000), and Zn2+ 
deficiency causing such effects as depression, odour disorder, and learning impairment 
in humans (Adamo & Oteiza, 2010; Takeda, 2011). However, the complexity of Zn2+ 
regulated neuronal signalling has prevented us from yet completely delineating the 
more subtle effects of Zn2+ dyshomeostasis (Marger et al, 2014).  
 
1.7 METAL IONS AND ALZHEIMER’S DISEASE 
 
1.7.1 Metal Dyshomeostasis and Alzheimer’s Disease 
 
A network of metal binding proteins and transporters regulate the levels of Zn2+ and 
Cu2+ in vivo, which is especially important in the brain, where the levels of these ions 
are particularly high (Que et al, 2008). Within the cell there is almost no free zinc or 
copper, with these ions being carefully regulated through metal binding proteins, such 
as the metallothioneins, low molecular weight cysteine-rich proteins that buffer against 
harmful ion fluxes (Sigel et al, 2009). However, metal ion release and retrieval is also 
crucial for regulating ion levels. For Cu2+, CTR1 mediates reuptake, and release is 
primarily facilitated by the P-type ATPase, ATP7A (Gaier et al, 2013); alternatively, for 
Zn2+, fluxes are largely controlled by ZnT3 transporters, which deliver Zn2+ into synaptic 
vesicles that release Zn2+ into the synaptic cleft upon depolarisation, and ZIP 
transporters, that deliver Zn2+ from the extracellular space into the cytosol (Szewczyk, 
2013).  
 
Despite the many measures controlling metal ion levels in the brain, in patients with AD 
a disruption of Cu2+ and Zn2+ levels is observed. It has been reported that in the 
neuropil there is a 4-fold and 2-fold increase in Cu2+ and Zn2+ respectively, and that in 
the Aβ plaques there are high concentrations of these ions present (Lovell et al, 1998; 
Miller et al, 2006). There are several possible reasons for the diminished integrity of 
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Zn2+/Cu2+ homeostasis. For instance cellular uptake of these metal ions, which is 
energy dependent, may become fatigued with age. Additionally, there is recent 
evidence to implicate the presenilins in Cu2+/Zn2+ transport, providing a direct 
connection between Aβ processing and metal homeostasis (Greenough et al, 2011). A 
further potential factor is that those with AD have reduced levels of metal ion binding 
metallothioneins (Yu et al, 2001). However, despite several possible explanations, it 
cannot yet be said that the mechanism of metal ion dyshomeostasis in AD is fully 
delineated, as the components of Cu2+ and Zn2+ homeostasis, and the interactions of 
these components, is still being clarified (Banci et al, 2010; Kim et al, 2010; Sensi et al, 
2011).  
 
1.7.2 Metal ions and Aβ 
    
It has been well characterised that Cu2+ and Zn2+ may influence Aβ metabolism. For 
instance, Zn2+ has been shown to bind APP, and block Aβ cleavage, as well as inhibit 
γ-secretase activity (Ayton et al, 2013; Stelmashook et al, 2014). The amyloidogenic 
processing of APP is also inhibited by Cu2+ (Bayer et al, 2003), with APP also being 
implicated in Cu2+ homeostasis, promoting the efflux of Cu2+ from the cell (Bayer et al, 
2003; White et al, 1999). Thus, the disrupted reuptake of Cu2+/Zn2+ into neurons, and 
their subsequent accumulation in the synaptic cleft may lead to overproduction of Aβ. It 
has also found that in the synaptic cleft, Zn2+ and Cu2+ may directly bind to Aβ (Adlard 
et al, 2010; Dong et al, 2003), which may in turn further inhibit the reuptake of Cu2+ and 
Zn2+, and lead to even greater Aβ production. Notably, the loss of intracellular Cu+ 
could also lead to neuronal oxidative stress, as superoxide dismutase 1 activity would 
be much reduced (Bayer et al, 2003).  
 
The affinities of Aβ for Zn2+ and Cu2+ at physiological pH are micromolar and picomolar 
respectively (Faller & Hureau, 2009; Sarell et al, 2009; Syme & Viles, 2006), which is 
high enough to be physiologically relevant, due to the high concentrations of these ions 
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during depolarisation and the reported concentration for Aβ of 0.5 nM (Seubert et al, 
1992). Cu2+ binds to Aβ at a 1:1 ratio, with both monomeric and fibrillar Aβ having 
identical coordination geometries (Karr & Szalai, 2008; Sarell et al, 2009). SsNMR and 
pulsed EPR have suggested that Cu2+ coordination does not disrupt amyloid fibril 
structure (Gunderson et al, 2012; Parthasarathy et al, 2011), perhaps as the ligands 
involved in Cu2+ coordination fall just outside the region that constitutes the β-pleated 
core of Aβ fibres (between residues 14 – 40). A great number of studies have been 
carried out to elucidate the binding geometry of Cu2+ to Aβ, and it is now generally 
accepted that Cu2+ forms a tetragonal complex with Aβ involving the three histidines 
(His6, His13, His14), oxygen coordination from Asp1 and Asp7, and the amino group of 
the N-terminus (Damante et al, 2008; Dorlet et al, 2009; Karr & Szalai, 2008; Minicozzi 
et al, 2008; Sarell et al, 2009; Viles et al, 1999). Though some details of coordination 
are still unresolved, there has been increasing evidence to support there being a 
number of interchangeable Cu2+-Aβ complexes, the relative distribution of which is 
influenced by pH (Dorlet et al, 2009; Drew et al, 2009; Sarell et al, 2009; Shin & 
Saxena, 2011). Two complexes that coexist at pH 7.4, typically noted I and II and 
shown in figure 1.11, differ due to a deprotonation at the Asp1-Ala2 amide bond; this 
deprotonation leads to formation of complex II rather than I (Faller et al, 2013).  
 
 Unlike Cu2+, Zn2+ typically forms a tetrahedral complex with Aβ, although 5 and 6 
coordinate complexes are also possible. The three histidine residues along with the 
carboxylate group of Glu11 or Asp1 (possibly with the N-terminal amino group) have 
been identified as the coordination ligands (Danielsson et al, 2007 ; Dorlet et al, 2009; 
Faller, 2009; Sarell et al, 2009; Syme & Viles, 2006). However, as for Cu2+-Aβ, the 
Zn2+-Aβ complex is not a fixed structure, with the model in figure 1.12 representing only 
one possibility. Indeed, the complex has been demonstrated to be in rapid exchange 
(on NMR timescales),  suggesting that the ligands may dynamically exchange (Syme & 
Viles, 2006). Notably, the histidine residues that complex Zn2+ may come from different 
Aβ peptides, producing cross-linked Aβ that may disrupt fibre assembly (Minicozzi et 
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al, 2008; Syme & Viles, 2006). 
 
  
Figure 1.12 Metal Coordination. 
Coordination of Cu2+ (A) and Zn2+ (B) by Aβ. Reproduced with permission from (Faller et al, 
2013) copyright (2013) American Chemical Society.  
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1.8 AIMS OF THIS THESIS 
 
There has been a number of investigations into the effect of Cu2+ and Zn2+ on Aβ 
misfolding; however, there has been little consensus in what has been reported. This 
may in part be due to differences in the Aβ alloform used (1-40/1-42), a lack of 
accounting for which aggregate species were formed, and differences in Aβ to metal 
ion ratios. Throughout this PhD, the aim has been to clarify the influence of Cu2+ and 
Zn2+ on the self-assembly of Aβ, while also providing physiological context. Specific 
aims include:  
 
I. Observe how a range of Cu2+ and Zn2+ concentrations effects Aβ(1-42) and Aβ(1-40) 
self-association, in terms of fibre growth kinetics and assembly structure. 
Chapters 3 and 4. 
II. Establish how Cu2+ influences the kinetics and morphology of aggregation when 
Aβ(1-42) and Aβ(1-40) are mixed together, both at a ratio found in healthy individuals, 
and at a ratio found in those with early-onset AD. Chapter 3.  
III. Identify whether Cu2+ generated Aβ(1-42) aggregates have an enhanced capacity 
to disrupt membrane integrity, a mechanism through which Aβ is thought to 
cause synaptotoxicity in vivo. Chapter 3. 
IV. Discern the mechanism through which trace levels of Zn2+ influence Aβ 
misfolding, and whether glutamate or Cu2+ inhibits Zn2+’s effect upon Aβ, as all 
three are found at the synapse with Aβ. Chapter 4. 
V. Investigate whether the effect of substoichiometric Cu2+ on Aβ(1-40) fibre growth is 
dependent on fibril growth conditions (quiescent vs agitated), due to the 
significant effect growth conditions have upon fibre structure. Chapter 5.  
VI. Determine whether Cu2+ influences the stability of Aβ(1-40) fibres, to ascertain 
whether a reduction in stability may be the mechanism through which Cu2+ 
enhances the toxicity of Aβ(1-40) fibres. Chapter 5. 
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2.1 MATERIALS 
 
2.1.1 Peptide Synthesis and Purification 
 
Lyophilised Aβ(1-40) was purchased commercially from Cambridge Research 
Biochemicals, and Zinser, and lyophilised Aβ(1-42) was purchased from Imperial College 
of London and Zinser. The peptides were synthesised using solid phase F-moc 
chemistry, and HPLC indicated a single peak at the expected molecular mass. The 
peptides were also characterised using 1H NMR which confirmed that Met35 was un-
oxidised. Lyophilised Aβ(1-40) and Aβ(1-42) were stored in the freezer at -20 oC..  
 
2.1.2 Aβ Peptide Sequences  
 
Peptides used were synthesised from human sequences of Aβ(1-40) and Aβ(1-42), for 
which the N-terminus and C-terminus were left as native amino and carboxyl groups 
respectively. The sequences were as follows: 
 
Aβ(1-40) : DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV  
Aβ(1-42) : DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA  
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2.1.3 General Chemicals and Consumables 
 
The chemicals I have used during my PhD have been presented in the table below. 
 
Table 2.01 Chemicals used Throughout PhD 
Chemicals Supplier Molecular Weight 
(g/mol) 
Purity (%) 
/ Grade  
Chloroform BDH - 
Biocehmical 
119.38 ≥ 99 
Cholesterol Sigma - 
Aldrich 
386.65 ≥ 99 
Copper(II)Chloride 
Dihydrate 
Sigma –
Aldrich  
170.48 ≥ 99.99 
Etylenediaminetetraacetic 
acis 
Sigma - 
Aldrich 
292.24 ≥ 99.995 
Guanidinium chloride Sigma – 
Aldrich 
95.53 ≥ 99 
(Brain, Ovine) Ganglioside 
GM1 
Avanti Lipids 1,568.81 ≥ 99 
HEPES (4-(2-hydroxyethyl)-
1-piperazineethanesulfonic 
acid) 
Sigma – 
Aldrich 
238.3 ≥ 99.5 
L-Histidine Sigma – 
Aldrich  
155.5 ≥ 99 
Hydrochloric acid (35 %) BDH - 
Biochemical 
36.46 Spectrosc
opy grade 
Methanol  Sigma – 
Aldrich 
32.04 ≥ 99.93 
(Egg, chicken) 
Phosphatidylcholine 
(chloroform 25 mg/ml) 
Avanti Lipids 770.12 ≥ 99 
Phosphotungstic acid 
hydrate 
Sigma – 
Aldrich  
2880.05 
(anhydrous basis) 
Reagent 
grade 
Potassium Chloride Sigma – 
Aldrich  
70.45 ≥ 99 
Sodium Hydroxide Sigma – 
Aldrich  
40 ≥ 99 
Thioflavin T Sigma – 
Aldrich 
318.87 -   
Zinc chloride  Sigma – 
Aldrich 
136.315 ≥ 98 
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Consumables used during my PhD are displayed in the table below. 
 
Table 2.02 Consumables used Throughout PhD 
Consumables Supplier Specification 
1 cm Path-length Cuvette Hellma 1 ml Volume, made from Quartz 
Supersil 
1 cm Path-length Cuvette Hellma 3 ml Volume, made from Quartz 
Supersil 
0.1 cm Path-length Cuvette Hellma 0.1 ml Volume, made from Quartz 
Supersil 
Falcon® 96 Well Plates Corning Inc. Flat Bottomed, clear Polystyrene 
Mini Extruder Avanti Lipids Made from stainless steel and 
Teflon, comes with 100 nm filters 
Transmission Electron 
Microscopy Grids 
SPI supplies Copper coated, square mesh 
 
2.1.4 Software and Equipment 
 
Software and equipment used to generate data presented in the table below. 
 
Table 2.03 Consumables used Throughout PhD 
Equipment Manufaturer Model Software 
96 Well plate fluorescence 
reader 
BMG Fluostar 
Galaxy 
Fluostar Galaxy 
Ver:4.31.0 
96 Well plate fluorescence 
reader 
BMG Fluostar 
Omega 
Mars Data Analysis 
Software Ver: 2.10 R3 
Circular Dichroism 
Spectrometer 
Applied 
Photophysics 
Chirasca
n 
Applied Photophysics 
Ver:4.2.0 
Single-cell Fluorescence 
Spectrometer 
Hitachi F-2500 FL Solutions 
Application Software 
Transmission Electron 
Microscope 
JEOL JEM-
2010 
Olympus iTEM TEM 
Imaging Software 
Ultraviolet-Visible 
Spectrometer 
Hitachi U-3010 UV Solution Ver: 2.0 
(Data Analysis and 
Presentation Software) 
Synergy 
Software 
- KaleidaGraph Ver: 
4.0.1 
(Spreadsheets, 
Presentations, and Writing) 
Microsoft  - Microsoft Office 2010 
(Referencing Software) Endnote - Endnote x7 
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2.2 THEORY 
 
2.2.1 Absorbance (UV-VIS) Spectroscopy 
 
This technique, UV-Vis spectroscopy, monitors absorbance within both the ultraviolet 
(UV) region, 180 – 400 nm, and visible region, 400 – 800 nm. UV-Vis absorption 
spectroscopy typically depends on the presence of either d-orbital electrons within 
transition metals or π-electrons within the molecule, as these electrons are more 
readily excited from the ground state to a higher energy level. The electronic states of 
particular systems are well defined, such that excitation of a particular electron in a 
given molecule requires a quantised amount of light at a certain wavelength. Thus, it 
follows that absorbance is proportional to molar concentration. It is from this 
understanding that the Beer-Lambert equation is derived: 
 
𝐴𝜆 =  𝜀𝜆. 𝑐. 𝑙         (Eq. 2.01) 
 
The equation shows that absorbance at a specific wavelength (Aλ) is equal to the 
product of concentration (c), path-length (l), and an extinction coefficient (ε). Path-
length is dependent on the cuvette used, whereas extinction coefficient is dependent 
on the electronic states present in the molecule for which concentration is being 
determined.  
 
The linear relationship between a molecule’s absorbance and concentration has 
proven particularly useful for determining concentrations of proteins. An extinction 
coefficient at 280 nm for a particular protein can be determined using the following 
equation:  
 
𝜀280 =  𝜀280
𝑇𝑦𝑟. 𝑁𝑇𝑦𝑟+ 𝑁𝑇𝑟𝑝 . 𝜀280
𝑇𝑟𝑝+𝑁𝑆−𝑆. 𝜀280
𝑆−𝑆    (Eq. 2.02) 
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In this equation, number of chromophores (Nx) are multiplied by their respective 
extinction coefficients (εx), and summed, to give the extinction coefficient of the entire 
protein. The chromophores that contribute to absorbance at 280 nm in proteins are 
tyrosine, tryptophan and disulphide bonds, for which the extinction coefficients are 
1280 M-1cm-1, 5690 M-1cm-1, and 120 M-1cm-1 respectively. As both Aβ(1-40) and Aβ(1-42) 
have only a single tyrosine, they each have an extinction coefficient of 1280 M-1cm-1. 
 
For accurate estimation of protein concentration, it is necessary also to account for light 
scatter that may arise from the presence of aggregates in solution. The amount of 
absorbance at 280 nm that is attributable to light scatter is calculated from the following 
equation:  
 
𝐴𝑠𝑐𝑎𝑡𝑡𝑒𝑟,280 =  10
(2.5𝑙𝑜𝑔𝐴320−1.5𝑙𝑜𝑔𝐴250)     (Eq. 2.03) 
 
Consequently, a 1 cm path-length cuvette was consistently used, the following 
equation was used to determine Aβ concentration (M):  
 
𝑐 =  
𝐴280−10
(2.5𝑙𝑜𝑔𝐴320−1.5𝑙𝑜𝑔𝐴250)
1280
        (Eq. 2.04) 
 
For optimal accuracy, only absorbance values between 0.1 – 1 were used, as the 
theoretical optimal absorbance value is 0.864. Additionally, Quartz cuvettes were used, 
as they do not absorb light in the UV-Vis region. For further reading on absorbance 
spectroscopy, I suggest chapters 13 and 14 by Alex Drake, in volume 22 of “Methods 
in Molecular Biology” (Drake, 1994b). 
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2.2.2 Fluorescence Spectroscopy 
 
Whereas absorption spectroscopy, discussed in the previous section, measures the 
light absorption that occurs in elevating an electron from the ground state to an excited 
state, fluorescence spectroscopy measures light that is released when electrons in an 
excited state return to their ground state. Excited electrons always emit energy when 
returning to the ground state; however, this energy is generally dissipated as heat, with 
only a minority of molecules, fluorophores, releasing this energy as light radiation. 
These fluorophores typically have electrons that are delocalised across conjugated 
double bonds.   
 
As for absorbance spectroscopy, in fluorescence spectroscopy the sample’s electrons 
are excited from a ground state to one of several possible vibrational excited states, as 
shown in figure 2.01. In fluorescence spectroscopy, the light source that is used to 
excite the sample is referred to as the excitation beam. The detector is set 
perpendicular to the excitation beam, so that one may enrich for photons that are a 
product of fluorescence (emission), rather than the excitation beam. The emission 
wavelength is longer than that of excitation and thus of lower energy; this is referred to 
as the Stokes shift, and occurs because an electron loses energy as heat and through 
collisions with other molecules, until it reaches the lowest energy vibrational level of the 
excited state. 
 
Despite fluorescence signal intensity being approximately proportional to fluorophore 
concentration it is difficult to gain machine-independent values between fluorescence 
spectrophotometers. This is because the percentage of fluorescence received by the 
detector is dependent upon the system, which is subject to such variables as detector 
used, the time interval between excitation and detection, and the excitation by the light 
source. Consequently, the units used in fluorescence are generally described as  
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Figure 2.01 Schematic of Fluorescence. 
In fluorescence, electrons are first excited from a ground state to an excited state. 
Energy is lost as heat, as the electron descends from one vibrational level to the next. 
Light radiation occurs as the electron passes from the excited state to the ground 
state; however, this light is of a longer wavelength to that absorbed, due to energy 
lost.  
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arbitrary fluorescence units, or AFU. Fluorescence techniques may be used with 
fluorophores that naturally occur within the molecule; such fluorophores are referred to 
as “intrinsic”, and include tyrosine and tryptophan. Intrinsic fluorophores may be used 
to follow processes that affect their electronic state, and, incidentally, fluorescence. 
Alternatively, fluorescence assays may use “extrinsic” fluorophores; those that are 
added to a sample to provide information. 
 
For a more comprehensive review on the principles of fluorescence spectroscopy, I 
suggest chapter 15 by Paul G. Varley, in volume 22 of “Methods in Molecular Biology” 
(Drake, 1994a), and “The Principles of Fluorescence Spectroscopy” (Lakowicz, 2006).  
 
2.2.3 Fluorophores 
 
Extrinsic fluorescence was relied on in the present investigations, with two different 
fluorescent probes employed to follow two distinct processes. The first of these is 
Thioflavin T (ThT). ThT was used to follow the kinetics of Aβ fibre growth, as in 
interacting with the cross-β structure of amyloid fibres the fluorescence of ThT gains 
intensity and is red-shifted, with the peaks for excitation and emission moving from  
385 nm and  445 nm to approximately 450 nm and 482 nm, respectively (LeVine, 
1993). This is thought to be mediated via the repeating arrangement of the amyloid 
fibre side chains, which generates long grooves parallel to the fibre axis, into which 
ThT molecules may bind (Biancalana & Koide, 2010; Groenning, 2010; Krebs et al, 
2005). When not bound to amyloid fibres, the benzylamine and the benzathiole rings of 
ThT will readily rotate about a central C-C bond. As this rotation is low energy, it may 
quench the excited state of the adjacent aromatic rings, resulting in a minimal 
florescence signal. However, upon ThT binding to the grooves of amyloid fibres, 
movement of the aromatic rings becomes fixed, which reduces quenching, and leads to 
a marked increase in florescence (Biancalana & Koide, 2010; Stsiapura et al, 2007). 
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Though there are other hydrophobic patches capable of influencing ThT fluorescence, 
such as the hydrophobic pockets of human serum albumin (Sen et al, 2009), the 
general dependence of this change in fluorescence on the presence of amyloid fibres 
means that ThT is a useful tool for following the kinetics of fibre formation, especially as 
ThT binds amyloid fibres at a physiologically relevant pH (5 – 9), and that this 
interaction is not disrupted by the presence of salts (LeVine, 1993).    
 
The second fluorescent dye used was calcein, which has excitation and emission 
peaks of 495 nm and 515 nm respectively. At concentrations over 70 mM, calcein is 
self-quenching, a property that makes it valuable as an indicator of lipid vesicle leakage 
(Allen & Cleland, 1980; Patel et al, 2009). In these investigations, high concentrations 
of calcein are encapsulated in vesicles, leading to quenching of calcein fluorescence; 
consequently, calcein leakage may be monitored through increases in fluorescence, as 
once the calcein leaves the interior of the vesicle it is diluted and dequenched. It has 
been previously established that the use of calcein to assess lipid vesicle leakage is an 
effective biomimetic approach for discerning the effects Aβ may have on cell 
membranes in vivo (Pillot et al, 1996; Williams et al, 2010; Williams & Serpell, 2011). It 
was used here to elucidate how Cu2+ ions may modulate the effect of Aβ on lipid-
bilayer permeability.  
 
2.2.4 Transmission Electron Microscopy 
 
Traditional optical microscopy relies on visible light to view objects with the naked eye, 
passing visible light through a series of lenses to grant a magnified view of the sample. 
However, there is a defined limit to the resolution of any microscopy technique. This 
limit is referred to as the diffraction limit (d), and is a function of the source of 
illumination’s wavelength, the numerical aperture of the objective lens (NA), and optical 
aberrations present in the lens. If optical aberrations are considered to be negligible 
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compared to the other variables, as is commonly the case, the following equation may 
be used to determine d (Ariel Lipson et al, 2010):  
 
𝑑 =  
𝜆
2𝑁𝐴
                   (Eq 2.05) 
 
In turn, NA is related to both the refractive index of the medium in which the lens is 
working (n), and the half-angle of the maximal cone of light that may enter/exit the 
lens (θ), through the following equation:  
 
𝑁𝐴 =  𝑛. 𝑠𝑖𝑛𝜃                (Eq 2.06) 
 
This makes it apparent that resolving power is inversely proportional to wavelength, 
and directly proportional to the refractive index of the medium being used. The reason 
that shorter wavelengths improve resolution is that objects that are smaller than a given 
wavelength exert little interference on the source of illumination, and are thus less 
detectable. In turn, higher refractive indexes yield better resolution simply because 
refraction shortens wavelength. Practically, NA cannot exceed 1.4 – 1.6, and, as for 
visible light λ may be approximated to 550 nm, it is clear the resolution of light 
microscopy is limited to ~200 nm; much too large to observe protein structures and 
individual amyloid fibres. To achieve greater resolutions, sources of illumination with 
shorter wavelengths must be used.   
 
As for all matter, electrons have the properties of both waves and particles. This quality 
is referred to as wave-particle duality, and can be demonstrated using the famous 
double-slit experiment, as the wave-like nature of an electron enables it to be 
influenced by both slits (Falkenberg, 2007). The wave properties of electrons are of 
particular interest to the field of microscopy, as not only do electrons have a shorter 
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wavelength than photons, but they may also be accelerated to an appreciable fraction 
of the speed of light to shorten their wavelength even further. Consequently, using an 
accelerated beam of electrons as a source of illumination, electron microscopy has 
much greater resolution than an optical microscope, enabling the visualisation of 
protein structures, with resolutions as high as 50 pm being reported for transmission 
electron microscopy (TEM) (Erni et al, 2009). 
 
For TEM, either a tungsten filament or LaB6 source is connected to a high-voltage 
“electron gun”, under vacuum, which induces electrons to be released through either 
thermionic or field electron emission (Egerton, 2005). The “lenses” which focus the 
electrons into an appropriate beam are provided by electromagnet generated 
electrostatic fields. There are generally three stages of lensing: condenser lenses are 
responsible for primary beam formation, objective lenses focus the beam as it passes 
through the sample, and finally projector lenses expand the beam onto an imaging 
device, be it film or a fluorescent phosphor screen, so as to visualise how the electron 
beam interacted with the sample.  
 
To increase contrast, an electron opaque material is often used as a negative stain. 
Such stains should have a sufficiently high electron density to disperse the electron 
beam, and also readily adsorb to biological material. Negative staining also has the 
additional benefit of preserving structural details if the electron beam were to damage 
the biological material. Phosphotungstic acid (PTA) was chosen as its not radioactive, 
as is uranyl acetate, and its adsorption to biological matter is well established 
(Quintarelli et al, 1971). 
 
For further reading into the theory of TEM and the other methods of electron 
microscopy, I recommend Egerton’s “Physical Principles of Electron Microscopy” 
(Egerton, 2005). 
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Figure 2.02 Schematic of Transmission Electron Microscopy. 
In TEM, electrons are emitted from an electron gun, and then focused through a 
series of “lenses”, each being an electromagnetically generated magnetic field. 
The condenser lens is involved in initial beam formation, the objective lens in 
focusing the beam as it passes through the specimen, and the projector lens 
enlarges the image for capturing on a detector. 
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2.2.5 Circular Dichroism 
 
Circular dichroism (CD) utilises the fact that plane polarised light may be split into both 
left (L) and right (R) polarised light, of equal intensity, as shown in figure 2.03, with R 
polarised light rotating in a clockwise direction, and L polarised light rotating counter-
clockwise direction. CD is a form of absorption spectroscopy specifically for chiral 
chromophores, as chiral molecules, such as most amino acids (and incidentally 
proteins), differ in their absorbance spectrum for R and L polarised light, with greater 
degrees of asymmetry accentuating this discrepancy. Plotting the difference in 
absorption for R and L polarised light yields a CD spectrum; such spectra have a broad 
range of applications, including determining the secondary structure of proteins 
(Nakanishi et al, 1994). 
 
It is well established that important characteristics of a protein’s secondary structure 
may be investigated using CD,  as it readily determines the fraction that is α-helical, in 
a β-sheet conformation, present in a β-turn, or forming a random coil structure 
(Greenfield, 2006; Whitmore & Wallace, 2008). To do so, the Far-UV region is used, 
where absorbance is dominated by transition of the polypeptide backbone’s amide 
groups’ n and π electrons to the π 
* excited state. These transitions are influenced by 
the conformation of the polypeptide backbone; thus, CD spectra produced are 
indicative of secondary structure present, with each secondary structure being 
associated with a particular spectrum, as shown in figure 2.04. 
 
CD gives much less information than X-ray crystallography and NMR. Unlike these 
methods, which both may provide atomic resolution data, CD cannot say which amino 
acids are involved with particular structural motifs, or how the secondary structures are 
organised. However, CD is a much quicker technique which requires much less protein 
and data processing. It can also be carried out at a range of conditions making it 
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Figure 2.03 Schematic for the Generation of Circularly Polarised Light. 
The basic components used to generate circularly polarised light in a CD 
spectrometer. The circularly polarised light is then alternately passed through a 
sample, and the difference in absorbance is detected using a photomultiplier.  
 
 
Figure 2.04 Representative 
CD Spectra for Protein 
Secondary Structures. 
This figure shows ellipticity 
(differential absorbance of 
circularly polarised light) for 
different secondary 
structures at a range of 
wavelengths. Reprinted from 
(Greenfield & Fasman, 
1969). Copyright (1969) 
American Chemical Society. 
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invaluable for assessing how protein structure changes as a function of temperature, 
pH, salinity, or with the addition of denaturants, such as guanidinium chloride. For a 
review on CD, refer to chapter 16 of “Methods in Molecular Biology”, volume 22 (Drake, 
1994c). 
 
2.3 GENERAL EXPERIMENTAL METHODS 
  
2.3.1 Buffer and pH Measurements 
 
UHQ water (10-18 Ω-1 cm-1 resistivity) was used for all solutions. HEPEs was used, for its 
low affinity to metal ions, and its physiological effective pH range (6.8 – 8.2) (Dawson, 
1986). The pH was adjusted using small aliquots of 10-100 mM NaOH or HCl. It was 
found that with HEPEs buffer a stable pH was maintained throughout the course of the 
experiments.   
 
2.3.2 Aβ Solubilisation and Concentration Determination 
 
Background 
 
For these investigations, it is important that in solubilising Aβ a homogenous population 
of monomers is ensured. The propensity for Aβ to self-associate via hydrophobic 
interactions makes this difficult, particularly when the pH approaches the isoelectric 
point of Aβ, 5.3. Unfortunately, Aβ produced via F-moc (N-(9-fluorenyl) 
methoxycarbonyl) chemistry removes the tert-butyloxycarbonyl protecting group with 
trifluoroacetate (Englund et al, 2004). The difficulty this presents is that the 
trifluoracetate remains bound to the peptide, meaning that when Aβ is solubilised it will 
generate an acidic environment. Consequently, when Aβ is later added to a buffer of 
physiological pH (7.4), the solution would pass through the isolelectric point, 
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temporarily maximising Aβ aggregation and precipitation. This in turn has been shown 
to yield Aβ solutions which present highly variable kinetic behaviours and fibril 
morphologies (Wood et al, 1996). One method to avoid this is to use NaOH to create 
basic conditions (~10.5) for solubilising Aβ, effectively preventing the problems that 
would occur if Aβ were to pass through its isoelectric point (Fezoui et al, 2000; Teplow 
et al, 2006). 
 
Using NaOH has been found to be as effective at reducing aggregates and variability 
as both hexaflouroisopropanol (HFIP), an organic cosolvent, and dimethylsulfoxide 
(DMSO), a chaotropic agent (Hortschansky et al, 2005; Lashuel et al, 2003). Both HFIP 
and DMSO are also common approaches to Aβ solubilisation found in the literature 
(Chen & Hung, 2001; Stine et al, 2003; Zagorski & Barrow, 1992); however, the 
presence of these solvents may influence fibrillogenesis, exacerbating the variability 
common to fibre growth studies (Faller et al, 2013; Shen & Murphy, 1995), and 
compromising the physiological relevance of in vitro studies. Additionally, they may 
disrupt the lipid membranes that used. For these reasons, the NaOH method was 
chosen as most appropriate to solubilise Aβ. 
 
Protocol 
 
Aβ(1-40) and Aβ(1-42) were solubilised at a concentration of 0.7 mg/ml in water at pH 10.5, 
and then left at 5 oC over 48 – 72 hours. Samples were then centrifuged for 10 minutes 
at 16,000 x g at 5 oC, to remove any precipitates that may seed aggregation. It is clear 
that solubilised preparations of Aβ were essentially seed-free as at pH 7.4 solubilised 
Aβ preparations typically have a lag-phase of at least 70 hours when agitated, and 
several weeks in the absence of shaking. Final Aβ concentration was determined using 
the Tyrosine absorbance at 280 nm, ε280 = 1280 M-1 cm-1, and correcting for any light 
scatter with absorbance values at 320 nm and 350 nm. A 1 cm path-length cuvette and 
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UV-spectrometer was used to determine these values, and the Beer-Lambert law (Eq 
2.03) used to calculate the concentration.  
 
2.3.3 Fibril Growth Assay 
 
The kinetics of amyloid formation were monitored using binding of ThT to amyloid 
fibres, which induces ThT to fluoresce at 482 nm; this signal is typically directly 
proportional to the amount of amyloid fibrils present. BMG-Galaxy and BMG-Omega 
FLUOstar fluorescence 96-well plate readers were used for the measuring of ThT 
fluorescence. Fluorescence readings were typically taken every 30 mins, following 30 
seconds of orbital agitation. Fluorescence excitation and emission detection were at 
440 nm and 490 nm respectively.  
 
Fibre growth kinetics are sensitive to a number of factors, including pH, concentration, 
agitation, ionic strength and temperature; consequently, measures were taken to 
reduce variance in these parameters. All fibre growth experiments were incubated at 
30 0C, in 30 mM HEPEs buffer, typically in 160 mM NaCl. The pH, a critical factor in 
rate of fibre growth, was adjusted to pH 7.4, and variation between samples was 
measured to be 0.05 pH units or less. Two molar equivalents of ThT was added to 
samples at the start of the experiment.  
 
2.3.4 Curve Fitting 
 
Growth Curve Analysis 
 
Conversion of essentially monomeric Aβ to Aβ fibres follows a characteristic growth 
curve, consisting of first a lag-phase (nucleation) and then a growth phase (elongation). 
A growth curve can be fitted to the data, to obtain a number of empirical parameters, 
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using the following equation (Uversky et al, 2001): 
 
𝑌 =  (𝜐𝑖 + 𝑚𝑖x) +  
𝜐𝑓+𝑚𝑓𝑥
1+𝑒𝑥𝑝
−(𝑥−𝑥0 𝜏⁄ )
                         (Eq 2.07)          
      
Y represents fluorescent intensity, and x represents time. Initial fluorescence intensity 
is represented by I, f represents the final fluorescence intensity. A number of kinetic 
parameters may be extracted with this equation; for instance, x0 is the time at which 
half maximal fluorescence is reached (t50), the apparent fibre growth rate (kapp) is 
obtained by 1/ and the lag-time (tlag) may be determined by x-2This equation allows 
for a slope in the initial and final parts of the growth curve, (i +mix), (f+mfx), rather 
than forcing these to be horizontal. 
 
Unfolding Curve Analysis 
  
GdnCl denaturation curves were fitted using a modified Hill equation, shown below: 
 
𝑦 = 𝑦𝑚𝑖𝑛 +  
𝑦𝑑𝑖𝑓𝑓[𝐷]
𝑛
[𝐷50%]𝑛+[𝐷]𝑛
                  (Eq 2.08) 
 
In this equation, Y represents signal intensity, Ydiff = Ymax – Ymin, D is the concentration 
of GdnCl, D50% is the concentration of GdnCl at which half of the protein is unfolded, 
and n represents the Hill coefficient (Crowhurst et al, 2002). 
  
2.3.5 Large Unilamellar Vesicle Preparation 
 
Large unilamellar vesicles (LUVs) were created as has been previously described 
(Williams et al, 2010). A lipid mixture of phophatidylcholine (PC), cholesterol, and 
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monosialotetrahexosylganglioside (GM1), at a ratio of 68:30:2 by weight in a glass 
phial, solubilised to 5 mg/ml in a 2:1 mixture of chloroform and methanol. The mixture 
was then left overnight, to enable solvent to evaporate, leaving behind a lipid film. Lipid 
films were rehydrated to a concentration of 10 mg/ml, with 200 mM calcein, aqueous 
buffer at pH 7.4 with 50 mM HEPES; this mixture was left for 2 hours, with vortexing 
every 15 minutes. Next, the lipid mixture was passed through an extruder once, with a 
100 nm polycarbonate filter, so as to generate vesicles with a uniform range of 
diameters. To remove non-encapsulated calcein from the LUVs the samples were 
centrifuged for 4 mins (at 16,000 g), the supernatant discarded, and resuspended in 
aqueous buffer (30 mM HEPES, 160 mM NaCl, pH 7.4). This centrifugation was 
repeated four times. After the final centrifugation, LUVs were resuspended to 5 mg/ml, 
in buffer. 
 
2.3.6 Vesicle Dye Release Assay 
 
The effect of Aβ samples on membrane integrity was assessed through release of 
calcein from large unilamellar vesicles (LUVs) using a 96-well plate readers, to facilitate 
statisitical quantification of dye release. Calcein is largely self-quenching when 
encapsulated within the vesicles, giving a strong fluorescent signal upon release.  
Readings were taken every 30 minutes following 30 seconds of mild agitation, and 
temperature maintained at 30 oC. Final readings were taken after 12 days. Samples 
were excited at 485 nm, and fluorescent emission was recorded at 520 nm, with 10 μM 
EDTA being added before final fluorescence readings were taken, to tightly chelate any 
Cu2+ ions, which have been shown to be capable of quenching calcein fluorescence. 
LUVs were diluted to 1 mg/ml for this experiment, while, concentration of Aβ(1-42) was 10 
µM, and concentration of Cu2+ was 4 µM. Each fluorescence measurement is 
presented as a percentage of maximum possible calcein release, determined by the 
addition of the detergent triton, to a final triton concentration of 10 ml/l. 
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2.3.7 Circular Dichroism 
 
CD spectra were recorded at 25° C on a circular dichroism spectrometer instrument 
between 180 and 260 nm, with sampling points every 0.5 nm, using a 1 cm or 0.1 cm 
path-length cuvette. Three scans were recorded and averaged, and zeroed at 260 nm. 
An averaged baseline spectrum subtracted from each spectrum. This was followed by 
a 2 nm window smoothing. 
 
2.3.8 Visualising Aβ Aggregate Species with Transmission Electron Microscopy  
 
Aliquots of Aβ samples from the fibre growth assays, or aliquots of LUV samples, were 
added to flow-discharged carbon-coated 300-mesh using the droplet method, with 
UHQ H2O washes before and after addition of stain. Phosophotungstic acid (2 % w/v), 
adjusted to pH 7.4, was used to negatively stain the sample. Typically selected images 
shown are representative of ~ 30 images that were taken over 30 – 60 minutes, across 
at least 10 fields. Images were recorded using a JEOL JEM-1230 electron microscope 
operated at 80 kV.  
 
The TEM images of LUVs and Aβ aggregates were not discernibly different to images 
recorded with cryoelectro-tomography (Milanesi et al, 2012), suggesting that the stain 
did not disrupt their respective morphologies. This was confirmed using the calcein dye 
release assay which showed no difference in dye release in the presence or absence 
phosphotungstic acid. 
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Figure 2.05 Optical Path in Fluorescence Spectroscopy. 
Single-cell fluorescence (A) and multi-well fluorescence (B) are largely the same, 
other than the fact that the former uses monochromators rather than filters, and the 
latter detects the emission above the plate, rather than at 90o, as in single-cell 
fluorescence (adapted from (Lakowicz, 2006)). 
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 2.3.8 Single Cell Fluorescence 
 
A single cell fluorescent spectrophotometer was used to monitor ThT fluorescent 
spectrum. Samples were excited at 440 nm, and emission readings taken from 420 nm 
to 600 nm. The spectrometer used was temperature controlled, and maintained the 
temperature at 30 0C unless stated otherwise. A 1 cm path-length cuvette was used, 
and for each sample three readings were taken, which were then averaged. From this 
a baseline was subtracted; the baseline was an aqueous solution of 30 mM HEPEs,   
20 μM ThT, and 160 μM NaCl. For these experiments, preformed Aβ(1-40) fibre samples 
were used, which were prepared as described in 2.3.3.    
 
2.3.9 Statistical Analyses 
 
When directly comparing two samples, statistical significance (p < 0.05) was 
determined using a two-tailed student’s t-test, for which the null hypothesis is rejected 
when difference between means is several fold greater than the standard error  
 (depending on degrees of freedom) (Abramowitz, 1965; Student, 1908). However, 
when comparing whether there were differences in the means of more than two 
samples, ANOVA was used. ANOVA was developed by R. A. Fischer (Fisher, 1921), 
and essentially generalises the t-test to a group, without the associated increase in 
false positives that would occur if one were to use multiple t-tests. As ANOVA just 
states whether there is a significant difference within the total set, it is necessary to 
carry out a follow up test to determine which specific samples are different from each 
other, typically a post-hoc-test. Fisher’s Least Significant Difference (LSD) was used, 
which though similar to carrying out a series of t-tests, has greater power, as it 
computes the collated standard deviation from all groups, rather than just the two being 
compared at that moment. Additionally, because an ANOVA test is required to be 
significant to carry out Fisher’s LSD, false positives are also reduced.  
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3.1 ABSTRACT  
 
Metal ion homeostasis is disrupted in the brains of sufferers of Alzheimer’s disease and 
causes heightened AD phenotype in animal models. Here it is illustrated that 
substoichiometric Cu2+ effects the misfolding pathway of Aβ(1-40), and the more toxic 
Aβ(1-42), in markedly different ways. Cu2+ accelerates Aβ(1-40) fibre formation, in contrast, 
for Aβ(1-42) substoichiometric levels of Cu2+ almost exclusively promote the formation of 
oligomeric and protofibrillar assemblies. Indeed, mature Aβ(1-42) fibres are disassembled 
into oligomers when Cu2+ is added. These Cu2+ stabilised oligomers of Aβ(1-42) interact 
with the lipid-bilayer, disrupting the membrane and increasing permeability. The 
investigation of Aβ(1-40)/Aβ(1-42) mixtures with Cu2+ revealed that Aβ(1-40) neither 
contributed nor perturbed formation of Aβ(1-42) oligomers, though Cu2+-Aβ(1-42) will 
frustrate Cu2+-Aβ(1-40) fibre growth. Small amounts of Cu2+ accentuates differences in 
the propensity of Aβ(1-40) and Aβ(1-42) to form synaptotoxic oligomers, providing an 
explanation for the connection between disrupted Cu2+ homeostasis and elevated Aβ(1-
42) neurotoxicity in AD.  
 
3.2 INTRODUCTION 
 
It is generally accepted that Aβ aggregation mediates AD neurotoxicity; specifically, 
there is considerable evidence to suggest that small diffusible oligomers of Aβ(1-42), 
rather than fibres are the dominant toxic form (Lambert et al, 1998; Lesné et al, 2006; 
Walsh et al, 2002; Yankner & Lu, 2009). A major unanswered question remains the 
precise mechanism by which oligomeric Aβ exerts its toxic effect. Although 
controversial, one popular hypothesis involves the disruption of cell membranes at the 
synapse. Ultimately, Aβ might lead to thinning, puncture the lipid-bilayer, or form ion 
channels or pores (Demuro et al, 2005; McLaurin & Chakrabartty, 1996; Milanesi et al, 
2012; Quist et al, 2005; Williams & Serpell, 2011), all of which could cause synaptic 
dysfunction, membrane leakage and, finally, loss of cellular ion homeostasis. 
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AD is a multifactorial disease; however, the central question of what induces Aβ to 
enter into an amyloidogenic cascade remains unclear (Ballard et al, 2011; Hardy & 
Selkoe, 2002). A possible determinant of Aβ self-association in vivo are metal ions 
(Viles, 2012). Indeed metal ion homeostasis is disrupted in AD patients, with the levels 
of Cu2+ in the neuropil increased 4-fold, where Cu2+ ions are found concentrated in 
plaques, directly bound to Aβ  (Dong et al, 2003; Lovell et al, 1998; Miller et al, 2006). 
Disrupted Cu2+ homeostasis has been demonstrated to potentiate disease pathology in 
drosophila (Sanokawa-Akakura et al, 2010; Singh et al, 2013) and rabbit models 
(Sparks & Schreurs, 2003) of AD. Likewise, clioquinol, a Cu2+/Zn2+ chelator, has been 
found to reduce Aβ deposition while improving the general health of mouse models 
(Cherny et al, 2001), although, unfortunately, these beneficial effects, have not been 
replicated in human trials (Prana, 2014). In humans, a recently identified mutation 
(D7H) for early-onset Alzheimer’s disease has been found to grant Aβ a greater affinity 
for Cu2+/Zn2+, and exaggerate the effects of Zn2+/Cu2+ on Aβ aggregation (Chen et al, 
2012). AD pathology is also influenced by prion protein interactions (Laurén et al, 2009; 
Younan et al, 2013), which have recently been linked to Aβ binding Cu2+ (You et al, 
2012), further emphasising a potential significance of Cu2+ in AD. 
 
A significant role for Cu2+ ions in AD is supported by the observation that Aβ has a 
picomolar affinity for Cu2+ (Sarell et al, 2009). As Aβ levels are estimated to be greater 
than 0.5 nM at the synapse (Seubert et al, 1992), Aβ would be expected to be able to 
compete with other metal chelators for the binding of Cu2+ ions, especially during 
depolarisation, when Cu2+ is reported to reach concentrations of 15 – 250 µM within the 
synaptic cleft (Hartter & Barnea, 1988; Kardos et al, 1989). 
 
Cu2+ has been shown to bind with a full (1:1) stoichiometric complement with a similar 
affinity to both monomeric Aβ and mature Aβ fibres (Sarell et al, 2009). Potentially, 
metal ion coordination might influence the Aβ misfolding pathway and synaptic toxicity 
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in a number of ways, including altering the structure of oligomer and fibre assemblies, 
and the kinetics of formation, as well as generation of reactive oxygen species via a 
redox active Cu2+ or Fe3+ (Viles, 2012). It has been known for more than a decade that 
binding of Cu2+ and Zn2+ is able to promote aggregation of Aβ (Atwood et al, 1998; 
Bush et al, 1994). However, these initial studies did not make the distinction between 
amorphous aggregates and neurotoxic species, and subsequent studies using the 
amyloid fibre specific fluorophore ThT suggested that Cu2+ only promotes formation of 
amorphous aggregates, and inhibits both fibre formation and cytotoxicity (Raman et al, 
2005; Yoshiike et al, 2001). These observations seemingly conflict with animal models 
which state the significance of Cu2+ in AD pathology (Cherny et al, 2001; Sanokawa-
Akakura et al, 2010; Singh et al, 2013; Sparks & Schreurs, 2003). An explanation for 
this conflict has been proposed, as a study using both ThT and TEM has shown that at 
more physiologically relevant substoichiometric levels, Cu2+ accelerates Aβ(1-40) fibre 
growth, whereas suprastoichiometric levels promote amorphous aggregation and 
inhibit fibre growth (Sarell et al, 2010). It was observed that different stoichiometric 
levels of Cu2+ also affect the ability of Aβ(1-42) to form ThT binding aggregates (Smith et 
al, 2007). However, the relationship between Cu2+ ions and Aβ misfolding is still 
controversial, with reports of Cu2+ preventing Aβ(1-42) fibre formation at 
suprastoichiometric (Smith et al, 2007), but also, more recently, at substoichiometric 
levels (Sharma et al, 2013; Tougu et al, 2009). There are reports of Cu2+ promoting 
amorphous aggregates rather than Aβ(1-42) fibres (House et al, 2009; Jiang et al, 2012; 
Mold et al, 2013; Pedersen et al, 2011); however, others have reported elevated Aβ(1-42) 
cytotoxicity with substoiciometric Cu2+ (Sharma et al, 2013; Smith et al, 2007).   
 
The aim of this investigation was to obtain a more complete picture of Cu2+-Aβ(1-40)/Aβ(1-
42)  interactions. This study demonstrates that many seemingly conflicting observations 
surrounding Aβ aggregation may be attributed to Cu2+ influencing Aβ(1-40) and Aβ(1-42)  
very differently, as well as the significant distinction between substoichiometric and 
suprastoichiometric Cu2+ exposure. It is shown that although Cu2+ accelerates Aβ(1-40) 
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fibre formation, Cu2+ stabilises Aβ(1-42) oligomers and protofibrils to such an extent that 
fibres are largely absent. These two distinct Cu2+ promoted pathways are also present 
for mixtures of Aβ(1-40) plus Aβ(1-42) found in vivo. The TEM images, and a dye release 
assay with large unilamellar vesicles (LUVs) show marked disruption of membrane 
structure and permeability, compared to Cu2+ free fibres of Aβ(1-42), providing an 
explanation for increased Alzheimer’s pathology in the presence of Cu2+  ions (Cherny 
et al, 2001; Sanokawa-Akakura et al, 2010; Singh et al, 2013; Sparks & Schreurs, 
2003). It has been suggested that distinct pathways of fibre assembly occur for Aβ(1-40) 
and Aβ(1-42), and these may account for differences in their cytotoxicity (Bitan et al, 
2003). It is demonstrated here that small substochiometric amounts of Cu2+ heighten 
the differences in assembly between Aβ(1-40) and Aβ(1-42), as for only Aβ(1-42), Cu2+ 
promotes almost exclusive generation of protofibrils and oligomers. 
  
3.3 RESULTS 
 
3.3.1 Copper and Aβ(1-42) Oligomer Assembly  
 
The well-established amyloid-binding ThT fluorescence assay was used, as well as 
TEM, to examine the fibre formation kinetics and assembly of Aβ(1-42) over a range of 
Cu2+ concentrations. Aβ fibre growth progresses through a nucleation-dependent 
pathway; formation of an oligomeric nucleus precedes elongation into mature fibrils 
(Jarrett & Lansbury, 1993; Roychaudhuri et al, 2009). This classic pattern of fibre 
formation can be seen for Aβ(1-42) without Cu2+ present, with the lag time for nucleation 
being 58 ± 3 hours, and half maximal fluorescence being reached at 70 ± 3 hours (Fig. 
3.01). Cu2+ was found to inhibit Aβ(1-42) fibre formation in a concentration dependent 
manner. With as little as 0.1 equivalents of Cu2+, the lag time of fibre formation was 
increased to 89 ± 2 hours, and t50 was increased to 98 ± 2 hours (a two tailed unpaired 
t test confirms that these increases are significant with > 99 % confidence). For 0.4   
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Figure 3.01 Aβ(1-42) Fibre Growth with Cu2+. 
(A) Aβ(1-42) fibre growth, monitored by Thioflavin T fluorescence, with no Cu2+ (red), 0.1 
equivalence of Cu2+ (green) and 0.4 equivalence of Cu2+ (blue). (B) Aβ42 fibre growth with 
no Cu2+(red) and 10 equivalence of Cu2+ (purple). Fibre growth was carried out at pH 7.4, 
with 10 µM Aβ(1-42), 30 mM HEPES, 10 mM NaCl and agitation, at 30 oC. There where at 
least six individual wells for each condition. (C – D) Samples taken directly after 120 hrs of 
incubation for TEM, negatively stained with phosphotungsic acid. The images show that 
fibres formed without Cu2+ (C), oligomers formed with 0.4 equivalence of Cu2+ (D), and 
amorphous aggregates formed with 10 equivalence of Cu2+ (E). Scale bar is 200 nm. 
 
 
Figure 3.01 Addition of Cu2+ to Preformed Aβ(1-42) Fibres.Figure 3.02 Aβ(1-42) Fibre 
Growth with Cu2+. 
(A) Aβ(1-42) fibre growth, monitored by Thioflavin T fluorescence, with no Cu2+ (red), 0.1 
equivalence of Cu2+ (green) and 0.4 equivalence of Cu2+ (blue). (B) Aβ42 fibre growth with 
no Cu2+(red) and 10 equivalence of Cu2+ (purple). Fibre growth was carried out at pH 7.4, 
with 10 µM Aβ(1-42), 30 Mm HEPES, 10 mM NaCl and agitation, at 30 oC. There where at 
least six individual wells for each condition. (C – D) Samples taken directly after 120 hrs of 
incubation for TEM, negatively stained with phosphotungsic acid. The images show that 
fibres formed without Cu2+ (C), oligomers formed with 0.4 equivalence of Cu2+ (D), and 
amorphous aggregates formed with 10 equivalence of Cu2+ (E). Scale bar is 200 nm. 
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mole equivalents of Cu2+, fibre growth was largely prevented, and for 10 equivalents of 
Cu2+, fibre growth was completely abolished. This experiment has been repeated a 
number of times, at a range of Aβ(1-42) concentrations (5 – 20 µM) and NaCl 
concentrations (5 – 160 mM), with similar results. Thus, preliminary data, showing ThT 
florescence in the presence of substoichiometric Cu2+ and Aβ(1-42), previously reported 
as supplemental information (Sarell et al, 2010), is not supported by this study. 
 
The species of Aβ(1-42) aggregate formed was characterised with TEM (Fig. 3.01). TEM 
images showed that for Aβ(1-42), in the absence of Cu2+, amyloid fibres dominate the 
TEM grids after 120 hours incubation, with a typical straight unbranched morphology of 
10 – 20 nm thickness (depending on the number of filaments stacked together), and 
typically many microns in length. However, at 0.4 equivalents of Cu2+, very few fibres 
were observed, with Aβ(1-42) chiefly existing as a variety of oligomeric species, ranging 
from 10 – 30 nm circular oligomers to “curly” protofibrillar oligomers of 10 – 20 nm 
thickness, and 30 – 100 nm length.  
 
Different species of aggregate is observed for 10 equivalents of Cu2+, with Aβ(1-42) 
primarily forming amorphous aggregates, of 100 – 1000 nm, dense staining, and  no 
repeating structure. Thus, the results show that substoichiometric levels of Cu2+ 
promote Aβ(1-42) oligomer formation, whereas suprastochiometric levels favour 
formation of amorphous aggregates. These observations were made consistently, over 
numerous Cu-Aβ(1-42) preparations and TEM grids.  
  
It is also notable that the influence of Cu2+ on Aβ(1-42) oligomer formation does not occur 
in a stoichiometric manner. Less than half a mole equivalents of Cu2+ relative to Aβ(1-42) 
is able to almost completely inhibit fibre formation, and even as little as 0.1 mole of 
Cu2+ causes substantial delays in fibre formation, extending the amount of time that 
Aβ(1-42) molecules exist as oligomers. Indeed, TEM indicates that even at just 0.1 molar 
equivalent of Cu2+ the majority of assemblies observed are protofibrils rather than   
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fibres. Thus, a single Cu2+ ion can influence the assembly of a number of Aβ(1-42) 
molecules, promoting and stabilising oligomer and protofibril populations over fibres. 
 
The next question, was whether Cu2+ was able to influence preformed Aβ(1-42) fibres. For 
this, 0.4 molar equivalents of Cu2+ was added to Aβ(1-42) that had been incubated for 100 
hours at 30 oC, and for which ThT fluorescence reported completed growth of amyloid 
fibrils. It was found that once Cu2+ was added, ThT signal rapidly dropped (within 60 
mins) by ~ 40 % as shown in Fig. 3.02. TEM showed that when substoichiometric Cu2+ 
was added to fully formed Aβ(1-42)  fibres, the predominant species of aggregate formed 
Figure 3.03 Addition of Cu2+ to Preformed Aβ(1-42) Fibres. 
(A) Aβ(1-42) fibre growth (monitored by Thioflavin T fluorescence) with no Cu2+ . (B) Aβ(1-42) fibre 
growth with 0.4 mole equivalence of Cu2+ added after 100 hours. Fibre growth was carried out 
at pH 7.4, with 10 µM Aβ(1-42), 30 Mm HEPES, 160 mM NaCl and agitation, at 30 oC. There 
were five individual wells for each condition.  (C – F) samples observed by TEM, negatively 
stained with phosphotungsic acid. These images show 10 µM Aβ(1-42)  incubated for 385 hours, 
without Cu2+ (C,E), and then for a further 15 hours after 3.2 µM Cu2+ was added (D, F), where 
fibres are observed to have disassembled into oligomers. Scale bar 400 nm (E, F) and scale 
bar 200 nm (C, D). 
 
Figure 3.02 Addition of EDTA to Cu2+ Generated Aβ(1-42) Oligomers. 
(A) Aβ(1-42) fibre growth (monitored by Thioflavin T fluorescence) with no Cu2+ . (B) Aβ(1-42) fibre 
growth with 0.4 mole equivalence of Cu2+ added after 100 hours. Fibre growth was carried out 
at pH 7.4, with 10 µM Aβ(1-42), 30 mM HEPES, 160 mM NaCl and agitation, at 30 oC. There 
were five individual wells for each condition.  (C – F) samples observed by TEM, negatively 
stained with phosphotungsic acid. These images show 10 µM Aβ(1-42)  incubated for 385 hours, 
without Cu2+ (C,E), and then for a further 15 hours after 3.2 µM Cu2+ was added (D, F), where 
fibres are observed to have disassembled into oligomers. Scale bar 400 nm (E, F) and scale 
bar 200 nm (C, D). 
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very much resembled the oligomers generated when monomeric Aβ(1-42) is incubated 
with Cu2+; protofibril-like oligomers of 10 – 20 nm thickness, 30 – 100 nm length. The 
same observation was made when substoichiometric levels of Cu2+ was added to more 
“mature” Aβ(1-42)  fibres; those that had been incubated a further 48 hours. In addition, 
different substoichiometric levels of Cu2+ were added; 0.4, 0.6, 0.8 mole equivalents. All 
ratios showed a similar reduction in ThT signal, of ~ 40 %. It is clear Cu2+ not only 
delays Aβ(1-42) from forming fibres, but maintains Aβ(1-42) in a protifibrillar form, and even 
reverts fibres back to oligomers. 
 
To assess whether the protofibril-like oligomers formed by Aβ(1-42) in the presence of 
Cu2+ would persist following Cu2+ removal, they were exposed to EDTA, a very tight 
Cu2+ chelator. The results illustrate that upon removal of Cu2+ with EDTA, Aβ(1-42) 
resumes typical amyloidogenecity, rapidly forming fibres with no lag time, as 
determined by ThT fluorescence, shown in Fig. 3.03.  After the addition of EDTA, TEM 
images indicate the formation of the typical long unbranched fibres.  
Figure 3.03 Addition of EDTA to Cu2+ Generated Aβ(1-42) Oligomers. 
(A) This figure shows averaged Aβ(1-42) Thioflavin T fluorescence, for mature fibres grown with 
no Cu2+ (red and orange), and with 0.3 mole equivalents of Cu2+ (blue). At 250 hours, 10 μM 
EDTA was added to half the samples (orange and light blue). Once Cu2+ was stripped from Aβ(1-
42), fibres were able to form. Fibre growth was carried out at pH 7.4, with 10 µM Aβ(1-42), 30 mM 
HEPES, 160 mM NaCl and agitation, at  30 oC. Traces shown are an average of four individual 
wells for each condition. (B) TEM image of Aβ(1-42) that has been incubated with 0.3 mole 
equivalents of Cu2+ for 250 hours, and then for 100 hours with EDTA. Scale bar is 200 nm.  
 
 
Figure 3.04 Addition of EDTA to Cu2+ Generated Aβ(1-42) Oligomers. 
B 
 
B 
A 
 
A 
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3.3.2 Copper and Aβ(1-40) Fibre Assembly 
 
 The behaviour of Aβ(1-40) in the presence of substoichiometric amounts of Cu2+ 
significantly differs from Aβ(1-42). Rather than completely inhibiting fibre formation, 0.4 
equivalents of Cu2+ markedly accelerates Aβ(1-40) fibre formation (Fig. 3.04). In the 
absence of Cu2+, Aβ(1-40) fibre growth had a lag time of 84 ± 7 hours, and a t50 of 91 ± 7 
hours, and addition of just 0.4 equivalents of Cu2+ halved both lag time and t50, to 40 ± 
1 hours and 45 ± 1 hours respectively. A two tailed unpaired t-test confirms that these 
increases are significant with > 95 % confidence. In contrast, 10 molar equivalents of 
Cu2+ ions prevents Aβ(1-40) prevented from forming fibres. This confirms the previous 
observation, that for Aβ(1-40), substoichiometric levels of Cu2+ accelerate fibre formation, 
while suprastoichiometric levels of Cu2+ prevent fibre formation (Sarell et al, 2010). 
 
The striking differences in behaviour of Aβ(1-40) and Aβ(1-42) in the presence of Cu2+ is 
also apparent from the TEM images, see Fig. 3.04. It was observed that for Aβ(1-40) 
without Cu2+ and for Aβ(1-40) grown with 0.4 equivalents of Cu2+, fibres predominate; 
there was no discernible difference in morphology for these two samples, both being 10 
– 20 nm thick, typically > 1000 nm long, and with twists at regular intervals, with 
periodicity ranging from 30 – 300 nm. With 10 equivalents of Cu2+ it was found that 
amorphous aggregate formation is favoured, with no regular structure, and a greatly 
variable size, and dense staining. Many images supporting this behaviour were 
observed. 
 
3.3.3 Effect of Cu2+ on fibre growth for mixtures of Aβ(1-42) and Aβ(1-40) 
 
Following the observation that Cu2+ influences the misfolding pathway of the two 
alloforms, Aβ(1-42) and  Aβ(1-40), in strikingly differing ways, the question arose, as to how 
substoichiometric Cu2+ would influence mixtures of the two peptides, as is the case in 
vivo. When the total concentration of peptide was kept at 10 μM (Aβ(1-42) + Aβ(1-40)),   
 Page 92 
CHAPTER 3: Cu2+ Accentuates Distinct Misfolding of Aβ(1-40) and Aβ(1-42) 
Peptides, and Potentiates Membrane Disruption 
  
Figure 3.04 Aβ(1-40) Fibre Growth with Cu2+. 
(A) Aβ(1-40) fibre growth (monitored by Thioflavin T fluorescence) with no Cu2+ (red), 0.4 
equivalence of Cu2+ blue) and 10 equivalence of Cu2+ (green). Fibre growth was carried out at 
pH 7.4, with 10 µM Aβ(1-42), 30 mM HEPES, 160 mM NaCl and agitation, at 30 oC. At least four 
individual wells for each condition. (B – D) samples observed by TEM, negatively stained with 
phosphotungsic acid, show that fibres formed without Cu2+ (B) and with 0.4 equivalence of Cu2+ 
(C), but amorphous aggregates formed with 10 equivalence of Cu2+ (D). Scale bar is 400 nm. 
 
 
Figure 3.06 Aβ(1-40):Aβ(1-42) Fibre Growth with Cu2+.Figure 3.07 Aβ(1-40) Fibre Growth with 
Cu2+. 
(A) Aβ(1-40) fibre growth (monitored by Thioflavin T fluorescence) with no Cu2+ (red), 0.4 
equivalence of Cu2+ blue) and 10 equivalence of Cu2+ (green). Fibre growth was carried out at 
pH 7.4, with 10 µM Aβ(1-42), 30 Mm HEPES, 160 mM NaCl and agitation, at 30 oC. At least four 
individual wells for each condition. (B – D) s mples observed by TEM, negatively stained with 
phosphotungsic acid, show that fibres formed without Cu2+ (B) and with 0.4 equivalence of Cu2+ 
(C), but amorphous aggregates formed with 10 equivalence of Cu2+ (D). Scale bar is 400 nm. 
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It was found that a higher ratio of Aβ(1-42) relative to Aβ(1-40) (in the presence of Cu2+) 
caused decrease in the intensity of the final fluorescent signal, as seen in Fig. 3.05A. 
This reduction appeared to be due to a decrease in the total Aβ(1-40) concentration, 
rather than an interaction between the two peptides. This is strongly supported by the 
second experiment, in which concentration of Aβ(1-40) was kept constant, at 10 µM, as 
the concentration of Aβ(1-42) increased from 0 – 10 µM. As can be seen in Fig. 3.05B, 
addition of Aβ(1-42) to Aβ(1-40), in the presence of Cu2+, did not decrease the final 
fluorescent signal, as would be expected if Aβ(1-40) formed oligomers with Aβ(1-42), nor did 
fluorescent signal increase, as would be expected if Aβ(1-42) formed mature fibres with 
Aβ(1-40). This data strongly suggests that at equilibrium (indicated by a plateau in the 
ThT signal) Cu2+-Aβ(1-40) and Cu2+-Aβ(1-42) are distinct, with essentially all Aβ(1-40) forming 
fibres and all Aβ(1-42) forming oligomers, in the presence of Cu2+. This is supported by 
the TEM images; as can be seen in Fig. 3.06, in a mixture of Aβ(1-42) and Aβ(1-40), 
species representative of Aβ(1-40) fibres and species representative of Cu2+-Aβ(1-42) 
oligomers are both observed.  
 
However, although the two peptides appear to adopt two distinct final misfolded states 
in the presence of Cu2+, with Cu2+-Aβ(1-40) forming fibres and Cu2+-Aβ(1-42) forming 
oligomers, there is clear interaction between the two misfolding pathways. As illustrated 
in Fig. 3.05C, the presence of Aβ(1-42) is able to dramatically frustrate growth of Aβ(1-40) 
fibres in the presence of Cu2+. Aβ(1-40) fibre growth, with 0.4 equivalents of Cu2+, had a 
t50 of 38 ± 4 hours, and a lag time of 27 ± 5 hours; addition of just 0.3 mole equivalents 
of Aβ(1-42)  (which is the Aβ(1-40): Aβ(1-42) ratio found in those with familial Alzheimer’s 
disease) almost doubled t50 and lag time, to 62 ± 2 hours and 50 ± 1 hours respectively. 
A two tailed unpaired t-test confirms that these increases are significant with > 99 % 
confidence.  
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Figure 3.05 Aβ(1-40):Aβ(1-42) Fibre Growth with Cu2+. 
(A) Fibre growth for Aβ(1-40):Aβ(1-42)  mixtures with 0.4 molar equivalents Cu2+, monitored by 
Thioflavin T fluorescence. Total (Aβ(1-40) + Aβ(1-42)) peptide concentration was kept at 10 µm. 
Fibre growth was monitored for an Aβ(1-40):Aβ(1-42) ratio of 10:0 (red), 9:1 (green), 7:3 
(purple), 5:5 (blue), and 0:10 (grey)  There were four individual wells for each condition (B) 
Fibre growth for Aβ(1-40):Aβ(1-42)  mixtures with 0.4 mole equivalents Cu2+, monitored by 
Thioflavin T fluorescence. Aβ(1-40) concentration was maintained at 10 µm, and Aβ(1-42) 
ranged from 0 – 10 µm. Fibre growth was monitored for an Aβ(1-40):Aβ(1-42) ratio of 10:0 (red), 
9:1 (green), 7:3 (purple), 5:5 (blue), and 0:10 (grey), There were six individual wells for each 
condition.  Fibre growth was carried out at pH 7.4, 30 Mm HEPES, 10 mM NaCl and 
agitation, at 30 oC. (C) t50 of fibre growth (time for 50 % of fluorescence to be reached), for 
mixtures where Aβ(1-40) concentration was maintained at 10 µm. Aβ(1-42) is observed to 
frustrate Aβ(1-40) fibre growth in the presence of 0.4 mole equivalents of Cu2+. Error bars 
indicate S.E.M (n = 6). The statistical significance of differences from 100 % Aβ(1-40) was 
determined using a two-tailed unpaired t-test. * = P < 0.005 ** = P < 0.0005. 
 
 
Figure 3.08 Images of Aβ(1-40):Aβ(1-42) Mixtures with Cu2+.Figure 3.09 Aβ(1-40):Aβ(1-42) Fibre 
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3.3.4 Effect of Cu2+ on Aβ(1-42) lipid membrane structure and permeability  
 
A popular hypothesis suggests that Aβ synaptotoxicity is the result of cellular 
membrane interactions and disruption. The question was therefore asked as to how 
Cu2+ binding to Aβ(1-42) might influence the interaction between Aβ(1-42) and lipid 
membranes, as the presence of Cu2+ facilitates the study of an almost exclusively 
oligomeric/protofibrillar population, which are stable over long periods of time. Using 
TEM, the interaction of liposomes with Aβ(1-42) fibres was observed, and compared to 
the effects of Cu2+ generated oligomers on the lipid-bilayer, as shown in Fig. 3.07. In 
the absence of Aβ(1-42), smooth, spherical vesicles, of 50 – 250 nm in diameter were 
observed. It was found that in the presence of Aβ(1-42) fibres, some large unilamellar 
vesicles (LUVs) were distorted from their regular spherical appearance where they 
made contact with Aβ(1-42) fibres, particularly at their ends, as has recently been 
observed for amyloid fibres of β2-microglobulin (Milanesi et al, 2012). TEM of LUVs in 
the presence of Cu2+ generated Aβ(1-42) oligomers and protofibrils show markedly more 
distortions of the vesicle membrane, shown in Fig. 3.07. Notably, the short curly 
morphology of the oligomers and protofibrils, penetrate the membrane and disrupt the 
membrane more readily, leading to much greater distortion of the LUVs than that 
typically observed with Aβ(1-42) fibres. In particular, there are complete breakages / 
discontinuations in the lipid-bilayer, highlighted in Figure 3.07, which were not observed  
Figure 3.06 Images of Aβ(1-40):Aβ(1-42) Mixtures with Cu2+. 
(A – E). Aβ(1-40):Aβ(1-42) samples, incubated with 0.4 mole equivalence of Cu2+, at a ratio of 
1:0 (A), 9:1 (B), 7:3 (C), 1:1 (D), and 0:1 (E) . All samples were stained with phosphotungstic 
acid. Scale bar is 200 nm. 
 
 
Figure 3.010 LUVs in the Presence of Aβ(1-42) Fibres and Cu2+ Generated 
oligomers.Figure 3.011 Images of Aβ(1-40):Aβ(1-42) Mixtures with Cu2+. 
(A – E). Aβ(1-40):Aβ(1-42) samples, incubated with 0.4 mole equivalence of Cu2+, at a ratio of 
1:0 (A), 9:1 (B), 7:3 (C), 1:1 (D), and 0:1 (E) . All samples were stained with phosphotungstic 
acid. Scale bar is 200 nm. 
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Figure 3.07 LUVs in the Presence of Aβ(1-42) Fibres and Cu2+ Generated oligomers. 
LUVs, after ~120 hours of incubation, in the absence of Aβ(1-42)  (A – E), in the presence of 
Aβ(1-42) fibres (F – J) and in the presence of Cu2+ generated Aβ(1-42) oligomers (K – O). Arrows 
indicate protofibril interactions with the lipid-bilayer that cause rupturing of the liposome. 
Samples were observed by TEM, using phosphotungstic acid negative staining. The scale 
bar is 100 nm, except for E, J & O, here the scale bar is 250 nm.  
 
 
Figure 3.012 Liposome permeability in the presence of preformed Aβ(1-42) fibres and 
Cu2+ generated oligomers.Figure 3.013 LUVs in the Presence of Aβ(1-42) Fibres and 
Cu2+ Generated oligomers. 
LUVs, after ~120 hours of incubation, in the absence of Aβ(1-42)  (A – E), in the presence of 
Aβ(1-42) fibres (F – J) and in the presence of Cu2+ generated Aβ(1-42) oligomers (K – O). Arrows 
indicate protofibril interactions with the lipid-bilayer that cause rupturing of the liposome. 
Samples were observed by TEM, using phosphotungstic acid negative staining. The scale 
bar is 100 nm, except for E, J & O, here the scale bar is 250 nm.  
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with Aβ(1-42)  fibres. In addition, there are a greater number of oligomers observed 
relative to Aβ(1-42) fibres, from the same concentration of Aβ(1-42) monomers. 
 
A dye release assay was used with LUVs to quantitatively measure the influence of 
Aβ(1-42) fibres and Cu2+ generated Aβ(1-42) oligomers on membrane permeability. Calcein 
dye release from LUVs was measured by monitoring fluorescence every 30 mins. 
Typically, in the absence of Aβ the LUVs remained stable for more than 300 hours with 
negligible dye release. It was found that incubation of LUVs with Cu2+ generated Aβ(1-42) 
oligomers results in significantly greater release of calcein than when LUVs are 
incubated with Aβ(1-42) fibres alone, Fig. 3.08. Furthermore, both samples of Aβ(1-42) 
induced significantly greater fluorescence release than control (LUVs in the absence of 
Aβ), as determined by a one-way analysis of variance (ANOVA) followed by Fisher’s 
least significant difference (LSD) post-hoc test. 
Figure 3.08 Liposome permeability in the presence of preformed Aβ(1-42) fibres and Cu2+ 
generated oligomers. 
Both Aβ(1-42) fibres, and Aβ(1-42) oligomers generated with 0.4 molar equivalents of Cu2+, disrupt 
liposome permeability significantly more than their respective controls, as shown through 
greater release of the fluorescent dye calcein. Cu2+ generated Aβ(1-42) oligomers significant 
more dye release than Aβ(1-42) fibres after 12 days. The concentration of LUVs and Aβ(1-42) were 
1 mg/ml and 10 μM respectively. Fluorescence was measured after a 280 hour incubation, 
following addition of 10 μM EDTA. Results were presented as a percentage of maximum 
fluorescence after triton addition, 10 ml/l. Samples were incubated at pH 7.4, and 30 oC. Error 
bars indicate S.E.M (n = 5 – 6 ) * = P < 0.05, ** = P < 0.0001. Statistical significance was 
determined using ANOVA, followed by Fisher’s LSD post-hoc test. 
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3.4 DISCUSSION 
 
In these investigations, it was have found that substoichiometric levels of Cu2+ 
influence the misfolding pathways of Aβ(1-40) and Aβ(1-42) in markedly distinct ways. For 
Aβ(1-40), Cu2+  accelerates the rate of fibre formation, but had little influence on the 
morphology or amount of fibres generated. The mechanism by which Cu2+ increases 
rate of Aβ(1-40)  fibre growth has been suggested to originate from the addition of the 
two positive charges making Aβ more neutral in overall net charge at pH 7.4, and 
consequently more prone to self-association (Sarell et al, 2010). However, for Aβ(1-42), 
Cu2+ greatly reduced fibre number, instead promoting formation of oligomers and short 
“curly” protofibrils. These typically transient forms of Aβ were surprisingly stable in the 
presence of substoichiometric Cu2+, over a period of weeks at 30 oC. Furthermore, 
preformed mature fibres of Aβ(1-42) rapidly dissociated in the presence of Cu2+, also 
generating oligomers and protofibrils, indicating that in the presence of 
substoichiometric Cu2+, protofibrilar and oligomeric assemblies are the 
thermodynamically stable form of Cu2+ loaded Aβ(1-42).  
  
It is significant that Cu2+ is able to promote formation of Aβ(1-42) oligomers over fibres, as 
studies suggest that Aβ oligomers are the primary mediator of synaptotoxicity in AD 
(Lambert et al, 1998; Lesné et al, 2006; Walsh et al, 2002; Yankner & Lu, 2009). This is 
supported by the observation that soluble, diffusible forms of Aβ monomers and small 
oligomers, better correlates with cognitive impairment and synaptic dysfunction than 
the number of larger aggregates (Lue et al, 1999; Wang et al, 1999). The differing 
structures of fibres and oligomers and the extent of exposed hydrophobic residues may 
be key to oligomer cytotoxicity. 
 
Cu2+ could contribute to AD pathology through binding to Aβ(1-42) and promoting 
oligomer formation. This is supported by TEM images of the oligomer-liposome 
interaction and the vesicle permeability assay, which both indicate that Cu2+ generated 
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oligomers / protofibrils of Aβ(1-42) profoundly influence lipid membrane structure and 
integrity. Consequently, it appears that the increased AD phenotype in animal models 
for which copper homeostasis is disrupted (Cherny et al, 2001; Sanokawa-Akakura et 
al, 2010; Singh et al, 2013; Sparks & Schreurs, 2003) and in cell culture (Opazo et al, 
2002; Sarell et al, 2010; Sharma et al, 2013; Smith et al, 2007) is at least in part due to 
Cu2+ dramatically altering the distribution between fibre and oligomer for Aβ(1-42), and 
these Cu2+ generated oligomers having a more marked effect on membrane integrity 
than Aβ(1-42) in the absence of Cu2+. Additionally, as at neutral pH, the contribution of 
two positive charges upon Cu2+ binding to Aβ makes Aβ more neutrally charged 
overall, this may facilitate greater penetration of the hydrophobic lipid-bilayer.  
       
It was surprising that just two amino acids at the C-terminus of Aβ (Ile, Ala) that are not 
directly involved in Cu2+ coordination (Dorlet et al, 2009; Drew et al, 2009; Sarell et al, 
2009) have such a profound influence on the extent of oligomer formation. The marked 
difference in the effect Cu2+ has on the two Aβ alloforms may arise from distinct 
differences in the pathway to fibril assembly (Bitan et al, 2003; Chen & Glabe, 2006). 
Unlike Aβ(1-40), it is believed Aβ(1-42) fibre growth proceeds through an initial stage of 
oligomerisation, in which pentamer / hexamer units are formed that ultimately 
reassemble to form fibres (Bitan et al, 2003). It may be possible that Cu2+ binding 
stabilises these otherwise transient species that are more readily formed by Aβ(1-42), 
conceivably by cross-linked inter-molecular coordination (Hane et al, 2013), promoting 
a more thermodynamically stable oligomer rich population of Aβ(1-42). Substoichiometric 
levels of Cu2+ were sufficient to promote almost exclusive formation of oligomers and 
protofibrils; thus, the data suggests that a single Cu2+ ion is sufficient to alter the 
stability of a number of Aβ(1-42) molecules in an oligomeric form. Interestingly, recent 
studies using ssNMR suggest differences in secondary structure between fibres and 
oligomers occur in the N-terminus of Aβ(1-42) (residues 3 – 14) (Haupt et al, 2012). It is 
these residues that adopt a β-strand structure in the oligomer structure but not in fibres. 
This is significant, as it is these N-terminal residues that are directly involved in Cu2+ 
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coordination, via His 6, His 13, and His 14 (Sarell et al, 2009). 
 
In vivo, there is a mixture of Aβ(1-40) and Aβ(1-42) present, the ratio of which increases 
from 9:1 to 7:3 in familial forms of Alzheimer’s disease (Citron et al, 1997; Duff et al, 
1996; Scheuner et al, 1996). How these two peptides influence the misfolding of the 
other is a subject of intense interest. It appears Aβ(1-42)  is able to frustrate the fibre 
formation of Aβ(1-40) (Chang et al, 2013; Jan et al, 2008; Kuperstein et al, 2010; 
Pauwels et al, 2012). The observations for Cu2+ loaded mixtures of Aβ(1-40) and Aβ(1-42) 
provides a fascinating insight. The data suggests that in the presence of Cu2+, Aβ(1-42) 
can frustrate Aβ(1-40) fibre formation, prolonging the time that Aβ(1-40) spends as 
prefibrillar oligomers, but ultimately only Cu2+-Aβ(1-40) forms fibres, while Aβ(1-42) forms 
stable protofibrils and oligomers. 
 
The present study illustrates that Cu2+ accentuates differences in the self-assembly 
pathways for Aβ(1-42) and Aβ(1-40). This suggests the significance of Aβ(1-42) in AD 
aetiology could be related to its very different aggregation properties in the presence of 
Cu2+ ions released at the synapse. Thus, the elevated levels of Cu2+ that occur with 
age (Barnham & Bush, 2008) may serve as an important factor in AD onset,  through 
stabilising neurotoxic oligomeric species of Aβ(1-42). Supporting a role for Cu2+ in AD, a 
recent unbiased screen indicated that copper binding compounds, clioquinol in 
particular, ameliorated Aβ toxicity in a yeast model of Alzheimer’s disease (Matlack et 
al, 2014). Indeed, the investigations show that chelation of Cu2+ from Aβ(1-42) results in 
the rapid conversion of Aβ(1-42) oligomers to the less neurotoxic amyloid fibres.  
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4.1 ABSTRACT 
 
One factor that is thought to have a significant role in AD aetiology is Zn2+ homeostasis, 
which is disrupted in the brains of AD sufferers, and has been shown to modulate AD 
symptoms in animal models. In this study, itwas investigated how the kinetics of Aβ 
fibre growth are affected at a range of Zn2+ concentrations, and transmission electron 
microscopy was used to characterise the aggregate assemblies formed. It was 
demonstrated that for Aβ(1-40) and Aβ(1-42) as little as 0.01 mole equivalents of Zn2+ is 
sufficient to greatly perturb the formation of amyloid fibres irreversibly. Instead, Aβ(1-40) 
assembles into short rod-like fibrils that pack tightly together into ordered stacks, 
whereas Aβ(1-42) forms short crooked assemblies that knit together to form a mesh of 
disordered tangles. The data suggests that a small number of Zn2+ ions are able to 
influence a great many Aβ molecules through the rapid exchange of Zn2+ between Aβ 
peptides. As high levels of both Zn2+ and Aβ are found at glutamatergic neurons, it was 
demonstrated that glutamate does not modulate the effect of Zn2+ upon Aβ misfolding, 
indicating that observations are physiologically relevant. Surprisingly, although Cu2+ 
binds to Aβ ten-thousand times tighter than Zn2+, the effect of Zn2+ on Aβ assembly 
dominates in Cu2+/Zn2+ mixtures, suggesting trace levels of Zn2+ must have a profound 
effect on extracellular Aβ accumulation.  
 
4.2 INTRODUCTION 
 
The pathology of AD is characterised by the misfolding of amyloid-β, and its 
subsequent aggregation into oligomers, fibres and plaques (Ballard et al, 2011). 
However, it is not clear what promotes the initial misfolding of Aβ in sporadic AD, or 
what promotes aggregation of the neurotoxic oligomers and fibres over benign 
amorphous aggregates (Ballard et al, 2011; Hardy & Selkoe, 2002). One possibility is 
that aggregation is influenced through the elevated levels Zn2+ (Bush et al, 1994), for 
which levels in the neuropil are increased 2-fold in patients with AD (Lovell et al, 1998).  
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Zn2+ is an important intracellular signalling molecule that is thought to be crucial for 
synaptic plasticity, learning, and memory (Ceccom et al, 2014; Fukada et al, 2011; Lin 
et al, 2001). In the brain, large reserves of free Zn2+ are found to be stored in the 
presynaptic vesicles of glutamatergic neurons, transported there by Zinc transporter-3 
(ZnT3) (Assaf & Chung, 1984; Howell et al, 1984; Nydegger et al, 2010; Qian & 
Noebels, 2006). These stores of Zn2+ exit the vesicles with glutamate following 
neuronal depolarisation, and are reported to bind and regulate the function of a range 
of neurotransmitter receptors, including NMDA-type glutamate receptors (Paoletti et al, 
2009). A general consensus has been reached that the affinity of Zn2+ for Aβ at pH 7.4 
is within the range 1 – 20 μM (Faller & Hureau, 2009); though this is a relatively 
moderate affinity, the high levels of Zn2+ at the synapse, especially during 
depolarisation, when Zn2+  is reported to reach concentrations of up to  100 – 300 µM 
(Frederickson, 1989; Vogt et al, 2000), would be expected to facilitate the binding of 
Zn2+ to Aβ in vivo (Noy et al, 2008). 
 
There is much evidence to support Zn2+ homeostasis being associated with AD 
pathology. It has been found that a Cu2+/Zn2+ chelator, PBT2, decreases soluble Aβ 
levels and improves cognition in a transgenic mouse model of AD (Adlard et al, 2008), 
and in another study, it has been found that for two transgenic mouse models of AD 
(Tg2576 and TgCRND8), a Zn2+ enriched diet is associated with potentiated 
Alzheimer’s-like spatial memory impairment, as well as a reduction in Aβ plaque 
deposition, potentially increasing soluble Aβ levels (Linkous et al, 2009). Conversely, 
others have reported that Zn2+ supplementation for 3 x TG-AD transgenic mice actually 
attenuated disease pathology, delaying hippocampal-dependent memory deficits and 
preventing the mitochondrial dysfunction observed in untreated 3 x TG-AD transgenic 
mice (Corona et al, 2010). Likewise, mice depleted of synaptic Zn2+ through a ZnT3 
knockout mutation present age-dependent memory impairments similar to those 
observed in AD models (Lee et al, 2002); this is particularly significant as the authors 
 Page 104 
CHAPTER 4: Rapid Exchange of Zn(II) Enables Trace Levels to Influence Aβ 
Misfolding and Dominate Assembly Outcomes in Cu2+/Zn2+ Mixtures 
found that ZnT3 levels also decline in humans with aging, particularly those with AD 
(Adlard et al, 2010). Similarly, in drosophila models of AD, tight control of copper and 
zinc availability ameliorates disease phenotype (Hua et al, 2011). It is thought that Zn2+ 
influences AD pathology through direct binding to the Aβ peptide.   
 
Metal ions binding to Aβ may alter the kinetics of on-pathway amyloid fibre formation, 
or alternatively, promote formation of off-pathway aggregates (House et al, 2004; Viles, 
2012). Initially, it was thought that Zn2+ promoted formation of off-pathway, amorphous 
aggregates (Ha et al, 2007; Raman et al, 2005; Yoshiike et al, 2001); however, it has 
subsequently been reported that Zn2+ can cause Aβ to form annular protofibrils (Chen 
et al, 2012; Chen et al, 2011). A comprehensive study has shown that Zn2+ induces 
Aβ(1-40) to rapidly form disc shaped oligomers that are highly toxic to primary cell 
culture, but may then further aggregate to form non-toxic assemblies (Solomonov et al, 
2012); while others have suggested that Zn2+ induced amorphous aggregation 
destabilises oligomers entirely (Garai et al, 2007). Conversely, it was recently reported 
that trace levels of Zn2+ are able to slow Aβ(1-40) fibre growth without affecting the 
number of fibres ultimately formed (Abelein et al, 2015). Consequently, though many 
studies agree that Zn2+ has a profound effect on Aβ misfolding, which aggregate 
species develop from the Aβ-Zn2+ interaction is still controversial and not fully 
understood.  
 
A great amount of research has highlighted the importance of controlling  Zn2+ levels in 
the brains of AD sufferers and those at risk of developing the disease, while 
emphasising that both an excess of Zn2+ and Zn2+ deficiency may be pathogenic 
(Adlard et al, 2008; Adlard et al, 2010; Corona et al, 2010; Garai et al, 2007; Linkous et 
al, 2009; Solomonov et al, 2012). Thus, it is of great importance to understand how Aβ 
is influenced by Zn2+ at a full range of concentrations, and whether glutamate may 
affect the Aβ-Zn2+ interaction, particularly as Zn2+ is released at the synapse with 
glutamate (Assaf & Chung, 1984; Howell et al, 1984; Nydegger et al, 2010; Qian & 
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Noebels, 2006). In this study, both ThT fluorescence and TEM have been use to clarify 
the influence of Zn2+ on Aβ self-association, for both Aβ(1-42) and Aβ(1-40) alloforms, at a 
range of physiologically relevant conditions, including very low substoichiometric levels 
of Zn2+.  
 
The interaction of a second divalent metal ion, Cu2+, with Aβ has also generated a lot of 
attention (Viles, 2012). Cu2+ is also released at the synapse during depolarisation 
(Kardos et al, 1989), and has a 50 pM affinity for Aβ (Sarell et al, 2009). It has been 
previously shown that while substoichiometric Cu2+ accelerates Aβ(1-40) fibre formation 
(Sarell et al, 2010), Cu2+ stabilises protofibrillar/oligomeric assemblies of Aβ(1-42), and 
can even rapidly convert Aβ(1-42) fibres to protofibrillar/oligomeric assemblies (Matheou 
et al, 2015). Here, the effect of a range of Cu2+ and Zn2+ mixtures on Aβ assemblies 
were investigated, as both are present extracellularly at the synapse, and share 
histidine coordinating ligands (Alies et al, 2013; Silva & Saxena, 2013). It was 
demonstrated that trace levels of Zn2+ (0.01 mole equivalents) profoundly influences 
the misfolding pathways of both Aβ(1-42) and Aβ(1-40). The data suggests this may occur 
through a rapid exchange mechanism, or potentially through Zn2+ exerting longer-range 
intermolecular influence,  that enables Zn2+ to exert more influence over Aβ assembly 
than Cu2+ in Zn2+/Cu2+ mixtures, despite the latter having a much higher affinity for Aβ. 
 
4.3 RESULTS 
 
4.3.1 Zn2+ and Aβ(1-42) Aggregation  
 
The ThT fluorescence assay was used to examine the fibre formation kinetics of Aβ(1-42) 
at a range of Zn2+ concentrations, with TEM being used to examine the species of 
aggregates formed. The fibre growth of Aβ progresses through a nucleation-dependent 
pathway, for which formation of an oligomeric nucleus precedes elongation of Aβ into 
mature fibrils (Jarrett & Lansbury, 1993; Roychaudhuri et al, 2009). This classic 
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 pattern of fibre formation is observed for Aβ(1-42) in the absence of Zn2+, while at 2 mole 
equivalents, Zn2+ is found to abolish ThT binding amyloid assembly (Fig 4.01A), as has 
been observed by others (Chen et al, 2012; Chen et al, 2011; Garai et al, 2007; House 
et al, 2004; Raman et al, 2005; Sarell et al, 2010; Solomonov et al, 2012; Viles, 2012; 
Yoshiike et al, 2001). The next aim, was to determine whether much lower levels of 
Zn2+ are also capable of influencing Aβ(1-42) misfolding. The effect of substoichiometric 
levels of Zn2+ on Aβ(1-42) fibre growth was investigated, and it was found that as little as 
0.01 mole equivalents of Zn2+ is sufficient to greatly perturb Aβ(1-42) fibre growth (Fig 
4.01B), even though at any one time ~ 99 % of Aβ molecules will not be bound to Zn2+. 
Figure 4.01 Aβ(1-42) Fibre Growth with Zn2+. 
A. Aβ(1-42) fibre growth, monitored by Thioflavin T fluorescence, with no Zn2+ (red) and 2 
equivalents of Zn2+ (blue). B. Aβ(1-42) fibre growth with no Zn2+ (red), 0.01 equivalents of Zn2+ 
(orange), and 0.05 equivalents (green). C. Aβ(1-42) fibre growth with glutamate and Zn2+. No 
Zn2+ (red); 0.01 equivalents of Zn2+ (orange); 0.05 equivalents of Zn2+ (green), and 2 
equivalents of Zn2+ (blue). Ratio of Zn2+:glutamate; 1:2. As little as 0.01 equivalents of Zn2+ 
strongly inhibited ThT fluorescent fibre formation. Fibre growth was carried out at pH 7.4, with 
10 μM Aβ(1-42), 30 mM HEPES, 160 mM NaCl and mild agitation, at 30 oC. (N = 6 traces). 
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In vivo, Zn2+ is co-released with glutamate, thus, whether glutamate may modulate the 
effect of Zn2+ upon Aβ(1-42) self-association was an important question. The ThT data 
shows that in the presence of two-fold as much glutamate as Zn2+, 0.01 mole 
equivalents of Zn2+ is still sufficient to greatly impede Aβ(1-42) fibre growth (Fig 4.01C). 
  
The morphology of the Aβ(1-42) assemblies formed were characterised using TEM, 
figure 4.02. The images show that in the absence of Zn2+, Aβ(1-42) predominantly formed 
amyloid fibres, with a typical straight unbranched morphology of 10 – 20 nm thickness 
(depending on the number of filaments stacked together), and many microns in length. 
However, as little as 0.05 equivalents of Zn2+ visibly influences the population of 
aggregates that develop, with Aβ(1-42) generally forming very disjointed crooked fibril-
like assemblies, 10 nm thick and 50 – 200 nm long, that are non-ThT binding. These 
short fibrous aggregates self-associate to form large disorderly tangles which are not 
observed in the absence of Zn2+. These tangles were 100 – 1000 nm, densely stained, 
and had no repeating structure. At 2 equivalents of Zn2+ large disorderly tangles, 
resembling those observed for 0.05 equivalents of Zn2+, predominated. The TEM 
images also demonstrate that the influence of Zn2+ on Aβ(1-42) aggregation is not altered 
by the presence of glutamate (Fig. 4.02E-H). Thus, the results show that both 
substoichiometric and suprastoichiometric levels of Zn2+ promote Aβ(1-42) to form 
disorderly tangles, rather than growth of amyloid fibrils, and that this may be relevant in 
vivo, as it was found that glutamate does not prevent this affect. These observations 
were made consistently, over numerous Zn2+-Aβ(1-42) preparations and TEM grids.  
  
4.3.2 Zn2+ and Aβ(1-40) Aggregation  
 
It has previously been observed that the effect of Cu2+ on Aβ(1-42) and Aβ(1-40) differs 
substantially (Matheou et al, 2015). Consequently, ThT fluorescence was used to 
investigate how Aβ(1-40) amyloid fibre growth is influenced by Zn2+, at a range of Zn2+  
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concentrations (Fig. 4.03). It was observed that for Aβ(1-40), as for Aβ(1-42), 2 equivalents 
of Zn2+ essentially abolished ThT signal, suggesting that it greatly inhibits amyloid fibre 
growth. Additionally, as for Aβ(1-42), as little as 0.01 equivalents of Zn2+ was able to 
inhibit growth of Aβ(1-40) fibres, according to ThT fluorescence. It was also demonstrated 
that these low levels of Zn2+ were able to perturb Aβ(1-40) fibre growth even in the 
presence of glutamate (Fig. 4.03B). 
 
Using TEM, the species of Aβ(1-40) aggregates formed in the presence of varying levels 
of Zn2+ was characterised. It was found that there are apparent differences between 
Aβ(1-40) and Aβ(1-42) assembly in the presence of low levels of Zn2+, but not for 
suprastoichiometric levels (Fig. 4.04). The images show that in the absence of Zn2+, 
Aβ(1-40) forms typical straight unbranched amyloid fibres, 10 – 20 nm thick and many 
microns in length. The presence of 0.05 equivalents of Zn2+ greatly reduces the number  
Figure 4.02 TEM Images of Aβ(1-42) with Zn2+ and Glutamate. 
A-H. Representative TEM images of Aβ(1-42) samples, incubated with no Zn2+ (A), 0.05 
equivalents of Zn2+ (B-C), 2 equivalents of Zn2+ (D), 4 equivalents of glutamate (E), 0.05 
equivalents of Zn2+ (F), 0.4 equivalents of Zn2+ (G), and 2 equivalents of Zn2+ (H). E – H also 
have glutamate present; ratio Zn2+:glutamate is 1:2. All samples were stained with 
phosphotungstic acid. Scale bars are 250 nm. 
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Figure 4.03 Aβ(1-40) Fibre Growth with Zn2+. 
A. Aβ(1-40) fibre growth, monitored by Thioflavin T fluorescence, with no Zn2+ (red), 0.05 
equivalents of Zn2+  (orange), 0.2 equivalents of Zn2+ (green), 0.4 equivalents of Zn2+ (blue) 
and 2 equivalents of Zn2+ with (purple). B. Aβ(1-40) fibre growth with Zn2+ and glutamate, where 
the Zn2+:glutamate ratio is 1:2. No Zn2+ (red), 0.01 equivalents of Zn2+ with (orange), 0.05 
equivalents of Zn2+ (green), and 0.4 equivalents of Zn2+ (blue). Fibre growth was carried out at 
pH 7.4, with 10 μM Aβ(1-40), 30 mM HEPES, 10 mM NaCl and agitation, at 30 oC. (N = 4 – 6 
traces). 
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of mature amyloid fibres that form, and, unlike for Aβ(1-42), promotes the formation of 
short rod-like fibres, which are 10 – 20 nm thick, 50 – 200 nm long, and pack closely 
together, to form stacks 50 – 300 nm thick (Fig. 4.04B). These stacks were observed at 
greater number for 0.2 equivalents of Zn2+ (Fig. 4.04C). For 2 equivalents of Zn2+, a 
similar effect as for Aβ(1-42) was observed, as large disordered tangles predominate. 
These tangles were found to be 100 – 1000 nm, densely stained, and to have no 
repeating structure (Fig. 4.04D).  
 
Notably, it was found that the presence of glutamate did not influence the morphology 
of Zn2+ induced Aβ(1-40) aggregates (Fig 4.04E-H). Thus the differences in behaviour 
between Aβ(1-40) and Aβ(1-42) at low levels of Zn2+ could potentially be relevant in vivo. 
These observations were made consistently, over numerous Zn2+-Aβ(1-42) preparations 
and TEM grids.     
Figure 4.04 TEM Images of Aβ(1-40) with Zn2+ and Glutamate. 
A-H. Representative TEM images of Aβ(1-40) samples, incubated with no Zn2+ (A), 0.05 
equivalents of Zn2+ (B), 0.2 equivalents of Zn2+(C), 2 equivalents of Zn2+ (D), 4 
equivalents of glutamate (E), 0.05 equivalents of Zn2+ (F), 0.2 equivalents of Zn2+ (G), 
and 0.4 equivalents of Zn2+ of glutamate and 0.8 equivalents of glutamate (H). All 
samples were stained with phosphotungstic acid. Scale bars are 250 nm. 
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4.3.3 Adding and Removing Zn2+ from Aβ Assemblies at Equilibrium  
 
The effect of adding Zn2+ to mature, preformed Aβ(1-40) fibres was investigated. Using a 
ThT assay (Fig. 4.05A), it was found that after adding 0.4 mole equivalents of Zn2+ to 
the preformed fibres, ThT fluorescence stayed constant following a further 100 hours of 
incubation, suggesting that Zn2+ does not readily dissociate fully formed amyloid fibres. 
This was corroborated by TEM data, figure 4.05B, which showed that the mature Aβ(1-
40) fibres to which Zn2+ was added retained a typical amyloid fibre structure, and did not 
adopt the structural features characteristic of monomeric Aβ(1-40) incubated with Zn2+, of 
short rod-like assemblies. 
 
  
Figure 4.05 Zn2+ Added to Mature Aβ(1-40) Fibres. 
A. Aβ(1-40) fibre growth, monitored by Thioflavin T fluorescence, to which buffer (red) and 0.4 
equivalents of Zn2+ (blue) was added at 250 hours. Fibre growth was carried out at pH 7.4, with 
10 μM Aβ(1-42), 30 mM HEPES, 10 mM NaCl and agitation, at 30 oC. (N = 3 Traces).             
B. Representative TEM image of mature Aβ(1-40) fibres, which after fibre growth were incubated 
with 0.4 equivalents of Zn2+  for 100 hours. The addition of Zn2+ to mature fibres has no effect 
on morphology. Samples were stained with phosphotungstic acid. Scale bar is 250 nm. 
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Figure 4.06 EDTA Added to Aβ Fibres Incubated with Zn2+. 
A. Aβ(1-40) fibre growth, monitored by Thioflavin T fluorescence, for samples with no Zn2+ (red),  
0.05 equivalents of Zn2 (green), and 0.4 equivalents of Zn2+ (blue), to which 50 µM EDTA was 
added at 250 hours. (n = 3). B. Representative TEM image of Aβ(1-40) incubated with 0.4 
equivalents Zn2+, to which 50 μM EDTA was added after 250 hours, and incubated for a further 
100 hours.  C. ThT fluorescence for Aβ(1-42) with no Zn2+ (red),  1 equivalents of Zn2+ (green), 
and 2 equivalents of Zn2+ (blue), to which 50 µM EDTA was added at 265 hours. (n = 6)         
D. Representative TEM image of Aβ(1-42) incubated with 2 equivalents Zn2+, to which 50 μM 
EDTA was added after, and incubated for a further 70 hours. fibre growth was carried out at pH 
7.4, with 10 μM Aβ, 30 mM HEPES, 10 mM NaCl and agitation, at 30 oC. Samples also 
contained glutamate, at a Zn2+: glutamate ratio of 1:2. Samples were stained with 
phosphotungstic acid. Scale bar is 500 nm. Once Aβ(1-40) or Aβ(1-42) form Zn2+ induced 
aggregates EDTA has little effect. 
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In addition to this, the question was asked as to whether aggregates formed in the 
presence of Zn2+ would persist in the absence of Zn2+. For this investigation, EDTA (a 
strong Zn2+ chelator) was added to both Aβ(1-42) and Aβ(1-40) samples which had 
previously been incubated with Zn2+ (Fig. 4.06). The data suggest that removal of Zn2+ 
from Aβ does not enable resumption of amyloid fibre formation, as ThT signal did not 
increase following EDTA addition. The TEM confirmed that the aggregate species 
formed when monomeric Aβ is incubated with Zn2+ persist once Zn2+ is removed with 
EDTA. This data suggests that Zn2+ promotes formation of aggregates that are off-
pathway to amyloid fibre formation. Interestingly, even the short rod structures (formed 
with Aβ(1-40) + Zn2+), whose gross morphology is reminiscent of amyloid fibres, do not 
seed the formation of ThT binding fibres once Zn2+ is removed by EDTA (Fig. 4.06B). 
Notably, regardless of Zn2+ inducing off-pathway Aβ aggregates, Zn2+ induced 
assemblies have similarly high β-sheet content to Aβ incubated in the absence of Zn2+ 
(Fig. 4.07).  
Figure 4.07 Circular Dichroism Spectra of Aβ Samples Incubated with Zn2+. 
A. Aβ(1-40) incubated with either no Zn2+ (red) or 0.05 mole equivalents of Zn2+ (blue). B. Aβ(1-
42) incubated with either no Zn2+ (red) or 0.05 mole equivalents of Zn2+ (blue). CD readings 
were taken using a 0.1 cm path-length cuvette, and 20 μM Aβ samples were used, incubated 
with 5 mM HEPEs, at pH 7.4, under agitated conditions for over 200 hours.  
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4.3.4 Aβ Seeding with Zn2+  
 
It is notable that the influence of Zn2+ on Aβ formation does not occur in a 
stoichiometric manner; the data here have shown that even as little as 0.01 equivalents 
of Zn2+ substantially perturbs fibre formation. Thus, it is evident that a single Zn2+ ion 
can influence the assembly of many Aβ molecules, promoting and stabilising alternative 
assemblies rather than ThT binding amyloid fibres. This could occur through two 
potential mechanisms (Fig. 4.08): a seeding mechanism, in which Zn2+ binding causes 
an Aβ nucleus to adopt a conformation capable of recruiting monomeric Aβ to form the 
non-typical assemblies that have been observed here, or a dynamic exchange model, 
in which the rapid exchange of Zn2+ between Aβ molecules allows a greater number of 
Aβ molecules to be influenced by low levels of Zn2+ than one may otherwise expect.  
Figure 4.08 Mechanisms through which a Little Zn2+ May Affect Much Aβ. 
Less than half a mole Zn2+ is required to abolish Aβ fibre growth in favour of alternative 
aggregative pathways. This may be because Zn2+ induces a conformational change in Aβ that 
nucleates non-fibrillar aggregation (A), or because Zn2+ is rapidly exchanged between Aβ 
peptides (B).   
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To investigate which mechanism is more likely, a seeding experiment (Fig. 4.09) 
analogous to the protein misfolding cyclic amplification experiments used for studying 
prion proteins (Barria et al, 2012) was carried out. In this experiment, monomeric Aβ 
was incubated with 0.4 mole equivalents of Zn2+ for a week, which was then used to 
seed a subsequent experiment, consisting of 10 % seed and 90 % monomeric Aβ, 
which in turn was incubated for a week and used to seed a further experiment. 
 
This was repeated until there was only 0.0004 mole equivalents of Zn2+ present in the 
final experiment. It was found that ThT fluorescent signal generally increased between 
experiments, and by the final experiment the ThT fluorescence had approximately 
returned to that observed for monomeric Aβ incubated without Zn2+. Supporting the 
ThT data, the TEM images demonstrate that Aβ aggregate species formed in later 
seeding experiments closely resembles the Aβ fibres produced in the absence of Zn2+.  
 
As the concentration of Zn2+ was reduced in sequential seeding experiments, Zn2+ 
induced aggregate species became less evident; this suggests that the dynamic 
exchange mechanism more accurately models how a small number of Zn2+ ions 
influence a large number of Aβ molecules. If a seeding mechanism was taking place, 
the Zn2+ induced aggregate species formed in the initial experiments would be able to 
promote formation of similar aggregates in sequential experiments, regardless of 
reductions in Zn2+ levels.  
 
4.3.5 The Effect of Cu2+ and Zn2+ Mixtures on Aβ Misfolding  
 
The presence of Cu2+ has also been shown to influence fibre formation (Bush, 2003; 
Chen et al, 2012; Chen et al, 2011; Faller et al, 2013; Matheou et al, 2015; Sarell et al, 
2010; Viles, 2012). Additionally, both divalent metal ions are released at the synapse 
and are thought to chelate to Aβ via its histidine residues (Sarell et al, 2009). 
Consequently, it is striking that not only does Zn2+ influence Aβ fibre formation at much  
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Figure 4.09 Aβ and Zn2+ Cross-
Seeding Experiment. 
A, Maximal ThT fluorescence of 
Aβ(1-40)  (red) and Aβ(1-42) (blue) with 
0.4 equivalents of Zn2+, which after 
a week was used to seed 
monomeric Aβ (1st seeding), which 
in turn was also used to seed 
monomeric Aβ (2nd seeding), which 
again was used to seed monomeric 
Aβ (3rd seeding). Seeds were 10 % 
of final volume. Fluorescence is 
presented as a percentage of ThT 
fluorescence for mature Aβ(1-40)  and 
Aβ(1-42) fibres grown in the absence 
of Zn2+. Fibre growth was carried out 
at pH 7.4, with 10 μM Aβ, 30 mM 
HEPES, 10 mM NaCl and agitation, 
at 30 oC. B – J. Representative TEM 
images of mature Aβ(1-42) fibres (A), 
Aβ(1-42) grown with 0.4 equivalents of 
Zn2+ (B), 1st seeding for Aβ(1-42) (C), 
2nd seeding for Aβ(1-42) (D), mature 
Aβ(1-40) fibres (G), Aβ(1-40) grown with 
0.4 equivalents of Zn2+ (H), 1st 
seeding for Aβ(1-40) (I), 2nd seeding 
for Aβ(1-40) (J). Samples were stained 
with phosphotungstic acid. Scale 
bars are 500 nm. Zn2+ generated 
assemblies could not seed similar 
assemblies once Zn2+ was diluted. 
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lower equivalents than Cu2+, but that it does so in a markedly different way. This is 
most evident for Aβ(1-40), for which substoichiometric Cu2+ accelerates fibre formation 
(Matheou et al, 2015; Sarell et al, 2010), while Zn2+ prevents fibre formation. To answer 
the question as to whether either of these metal ions could modulate or mask the 
other’s effect, ThT fluorescence was used to follow Aβ(1-40) fibre growth in the presence 
of a variety of Cu2+:Zn2+ mixtures. As is apparent in figure 4.10A, even when there was 
only a quarter as much Zn2+ as there was Cu2+, the effect on fibre aggregation of Zn2+ 
predominated. In particular, ThT signal is reduced four-fold, and there is no 
acceleration in fibre growth. As the concentration of Zn2+ (100 – 300 μM) is generally 
thought to be higher than that of Cu2+ (15 – 250 μM) at the synapse (Hartter & Barnea, 
1988; Kardos et al, 1989), the data suggests that in vivo the effect of Zn2+ may exert 
the greater influence on Aβ misfolding. This is supported by the TEM data, figure 
4.10B; here the assembly outcome for mixtures of Zn2+ and Cu2+ (0.2 and 0.4 
equivalents respectively) appears to be dominated by the presence of Zn2+. Aβ(1-40) 
assembled into short fibril-like rods, that packed together in bundles, as is observed 
when Aβ(1-40) is incubated with Zn2+ in the absence of Cu2+.   
Figure 4.10 Aβ(1-40) Fibre Growth with Mixtures of Cu2+ and Zn2+. 
A. Aβ(1-40) fibre growth, monitored by Thioflavin T fluorescence, with no metal ions (red), 0.4 
equivalents of Cu2+ (blue), 0.4 equivalents of both Cu2+ and Zn2+ (green), 0.4 equivalents of 
Cu2+ and 0.2 equivalents of Zn2+(purple), and 0.4 equivalents of Cu2+ and 0.1 equivalents of 
Zn2+ (orange). Fibre growth was carried out at pH 7.4, with 10 μM Aβ(1-40), 30 mM HEPES, 10 
mM NaCl and agitation, at 30 oC. (N = 3 – 6 Traces). B. Representative TEM image of Aβ(1-40)  
incubated with 0.4 mole equivalents of Cu2+ and 0.2 equivalents of Zn2+. Samples were 
stained by phosphotungstic acid. Scale bar 200 nm. Assembly outcome is dominated by 
presence of Zn2+. 
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DISCUSSION      
 
4.4.1 Trace Zn2+ and Aβ Fibre Assembly 
 
 Here, it has been demonstrated that suprastoichiometric levels of Zn2+ completely 
abolish Aβ fibre growth, as has previously been reported (Garai et al, 2007; Ha et al, 
2007; Raman et al, 2005; Sarell et al, 2010; Yoshiike et al, 2001), and induces Aβ(1-40) 
and Aβ(1-42) to form disordered tangled aggregates. As little as 0.01 mole equivalents of 
Zn2+ has also been shown to significantly influence the misfolding pathway of both Aβ(1-
40) and Aβ(1-42). It is notable that the marked influence of such very low amounts of Zn2+ 
on Aβ assembly is even more remarkable when one considers the affinity of Zn2+ for 
Aβ. The effect is observable with 100 nM of Zn2+, but Zn2+ affinity for Aβ is much 
weaker, ~ 10 μM, thus only a fraction of the 0.01 mole equivalents of Zn2+ will be bound 
to Aβ at any one time.  It was surprising that a single Zn2+ ion can influence the 
aggregation of so many Aβ molecules, as each Zn2+ ion can only be bound to one or 
two Aβ molecules, at any one time. Ineed, Zn2+ cross-linking Aβ is insufficient to 
explain the very low substoichiometric amount of Zn2+ that effects fibre formation. 
 
There are a number of potential mechanisms through which trace levels of Zn2+ could 
influence large numbers of Aβ molecules. For instance, the length of fibres may be 
restricted by Zn2+ bound Aβ peptide, capping the ends of fibres and limiting fibril length, 
or introducing sharp kinks into the fibre (Fig. 4.11). However, the stoichiometric ratio of 
Zn2+ to Aβ does not correlate clearly to fibre length. An alternative explanation could be 
the rapid exchange of Zn2+ between Aβ peptides. For fibrillogenesis, Aβ monomers 
need to adopt a specific conformation to bind to a growing fibre (Sgourakis et al, 2007; 
Srabasti Acharya, 2015; Yang & Teplow, 2008); however, Zn2+ may rapidly exchange 
between Aβ peptides, restricting the population of conformations typically available to 
them, and preventing the necessary conformation forming. These transient interactions 
with Zn2+ may also restrict fibril length or introduce kinks (Fig. 4.11).  
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A third possibility would be that Zn2+ binding promotes the formation of a unique seed, 
which may direct downstream Aβ aggregation through a template mechanism, though 
the seeding experiment showed this to be unlikely. Instead the data supports a 
dynamic exchange of Zn2+ between Aβ peptides as the most credible of these 
possibilities; this is consistent with 1H NMR data that suggest a rapid exchange of Zn2+  
between Aβ peptides (Danielsson et al, 2007 ; Syme & Viles, 2006). It is also notable 
that the data demonstrates that Zn2+ induced off-pathway assemblies do not readily 
form fibres, even once Zn2+ is removed. Interestingly, although assemblies generated 
with Zn2+-Aβ(1-40) have a weak ThT fluorescence, studies using ss-NMR suggest the 
basic cross-β structure is maintained (Mithu et al, 2011), which is supported by the CD 
data presented here. 
 
The data show that trace levels of Zn2+ influence Aβ(1-40) and Aβ(1-42) misfolding in 
distinct ways; with Aβ(1-40), Zn2+ induces formation of short rod-like structures that stack 
together in bundled structures, whereas with Aβ(1-42), Zn2+ typically promotes the 
formation of short crooked disordered fibrous assemblies that knit together. Solomonov 
et al. has shown that at 2 hours, Zn2+ promotes formation of disk shaped oligomers    
10 nm in diameter (Solomonov et al, 2012); however, the structures presented here 
represent Zn2+-Aβ at equilibrium. The dissimilarity in how substoichiometric levels of 
Zn2+ influence Aβ(1-40) and Aβ(1-42) isoforms may arise from differences in the fibril 
assembly pathways (Bitan et al, 2003; Chen & Glabe, 2006), as Aβ(1-42) fibre growth is 
believed to be nucleated by pentamer / hexamer oligomer units not formed in Aβ(1-40) 
fibrillogenesis (Bitan et al, 2003). Additionally, differences in the kinetics of aggregation 
for Aβ(1-40) and Aβ(1-42), may be a contributor, as Aβ(1-42) aggregates much more readily 
than Aβ(1-40) (Burdick et al, 1992). 
 
The data presented here compliment a number of studies already in the literature. For 
instance, it has been well established, with ThT fluorescence, TEM, and atomic force 
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microscopy, that Zn2+ greatly perturbs amyloid fibril growth (Chen et al, 2012; Chen et 
al, 2011; Garai et al, 2007; Ha et al, 2007; Klug et al, 2003; Raman et al, 2005; 
Solomonov et al, 2012), and that metal ions, such as Zn2+ and Cu2+, may influence 
Aβ(1-40) and Aβ(1-42) aggregation in markedly different ways (Chen et al, 2012; Chen et 
al, 2011; Sarell et al, 2010), as has been observed here. However, it has also been 
demonstrated here that levels of Zn2+ as low as 0.01 mole equivalents are sufficient to 
profoundly inhibit Aβ(1-40) and Aβ(1-42) fibre formation, and that this may occur through a 
rapid exchange of Zn2+ between Aβ molecules.  
 
  
Figure 4.11 Schematics of Zn2+ Induced Aggregation. 
A. Binding of Zn2+ to Aβ peptide in rapid exchange prevents a large number of Aβ molecules 
from forming fibres. A single Zn2+ ion may influence a great number of Aβ peptides through 
capping the ends of fibres, and inducing formation of bundles of short rods (B) or crooked 
assemblies (C). Scale bars, 200 nm. 
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Though this is supported by previous atomic-force microscopy data (Innocenti et al, 
2010), it does not agree with a recent study on Aβ(1-40) using ThT binding, which found 
that though low levels of Zn2+ retarded fibre growth, 0.0125 – 0.125  mole equivalents 
of Zn2+ did not reduce the final amount of fibres formed (Abelein et al, 2015). This may 
be because the growth conditions used differed between experiments, as they used 
quiescent conditions, which generates fibres with differing biophysical properties to 
those grown under agitated conditions, as for our experiment (Paravastu et al, 2008; 
Petkova et al, 2005). The different observations may also arise from their use of 
phosphate buffer, as phosphate is known to co-precipitate with Zn2+ (Bachra & van 
Harskamp, 1970; Kejnovsky & Kypr, 1998), and may result in overestimation of the 
concentration of available Zn2+ ions in solution.  
 
Several experiments were carried out to contextualise the results to an in vivo 
environment. In vivo, Zn2+ is released at the synapse with glutamate (Assaf & Chung, 
1984; Howell et al, 1984; Nydegger et al, 2010; Qian & Noebels, 2006), so it was 
important to determine whether glutamate modulated the effect of Zn2+ upon Aβ. 
Glutamate did not prevent Zn2+’s affect, indicating glutamate’s affinity, Kd1 = 600 μM at 
pH 7.4 (Dawson, 1986), for Zn2+ is not sufficient to prevent Zn2+ influencing Aβ 
assembly. Additionally, as levels of Zn2+ fluctuate in the brain with depolarisation 
(Kardos et al, 1989; Vogt et al, 2000), it was of interest to observe the effect of Zn2+ 
upon preformed mature fibrils and also the reversibility of Zn2+ induced aggregation. It 
was found that Zn2+ did not influence mature Aβ fibrils, nor did removal of Zn2+ enable 
aggregates formed with Zn2+ to revert and form fibres. This suggests the misfolding 
pathway of Zn2+ induced aggregate species is distinct from that of amyloid fibril growth; 
in contrast, protofibril assemblies of Aβ(1-42) generated by the presence of Cu2+ will 
rapidly seed fibre formation upon Cu2+ chelation (Matheou et al, 2015). 
 
 
 
 Page 122 
CHAPTER 4: Rapid Exchange of Zn(II) Enables Trace Levels to Influence Aβ 
Misfolding and Dominate Assembly Outcomes in Cu2+/Zn2+ Mixtures 
4.4.2 Contrasting and Dominating Influence of Zn2+ of Cu2+ in Fibre Assembly  
 
Another divalent metal ion that is thought to be important in AD pathology is Cu2+ 
(Matheou et al, 2015; Sanokawa-Akakura et al, 2010; Sarell et al, 2010; Singh et al, 
2013; Sparks & Schreurs, 2003; Viles, 2012). Interestingly, although the two divalent 
metal ions share a number of the same coordination ligands (Alies et al, 2013; 
Danielsson et al, 2007 ; Faller & Hureau, 2009; Minicozzi et al, 2008; Sarell et al, 2009; 
Silva & Saxena, 2013; Syme & Viles, 2006), there are marked differences in the 
influence of Zn2+ and Cu2+ on Aβ misfolding, as outlined in Table 4.1. In particular, 
substoichiometric Cu2+ much more markedly accentuates differences in Aβ(1-40) and 
Aβ(1-42) misfolding, as substoichiometric Cu2+ abolishes Aβ(1-42) fibre growth but 
accelerates Aβ(1-40) fibre growth (Matheou et al, 2015; Sarell et al, 2010), while 
substoichiometric Zn2+ prevents fibre growth for both alloforms. A further difference 
between Zn2+ and Cu2+ is the amount that is required to disrupt Aβ misfolding, with Zn2+ 
having a much greater influence at lower levels than Cu2+. In particular, the influence of 
Cu2+ on Aβ assemblies is only apparent at stoichiometries of greater than 0.25 
(Matheou et al, 2015; Sarell et al, 2010), 25 times greater than the 0.01 levels of Zn2+ 
required to disrupt fibre growth. 
 
The differences in the effects of Cu2+ and Zn2+ may in part be due to differences in their 
on/off exchange rate with Aβ. Furthermore, unlike Cu2+, Zn2+ is capable of forming 
flexible open coordination geometries with Aβ (Minicozzi et al, 2008), which enable 
Zn2+ to mediate Aβ cross-linking (Minicozzi et al, 2008; Sarell et al, 2010), while Cu2+ 
does not promote Aβ cross-linking at the concentrations used (Drew et al, 2009; Syme 
et al, 2004). Finally, it may also be that a single Zn2+ binding exerts longer-range 
intermolecular influence across an Aβ assembly than Cu2+ (or affects larger, specific, 
aggregates), enabling Zn2+ to affect Aβ aggregation at an exceptionally low 
substoichiometry, as it is the larger assembly that is essentially the Zn2+’s binding 
partner. As the dose-dependent effect of Zn2+ upon Aβ aggregation would be  
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proportional to the size of any such aggregate, future quantitative analysis of Aβ fibre 
kinetics at a range of Zn2+ concentrations could provide valuable insights into what 
sized Aβ assembly a single Zn2+ ion is able to influence.  
 
As both Cu2+ and Zn2+ are elevated in AD, and both metal ions are released at the 
synapse, but differ in their relationship to Aβ, the present study sought to determine the 
net effect when Aβ(1-40) was incubated with mixtures of Zn2+ and Cu2+. It was surprising 
that when both ions were present, Cu2+ had little influence upon Aβ(1-40) fibre growth. 
Although the affinity of Cu2+ for Aβ is much higher than Zn2+ (by more than 5 orders of 
magnitude), 50 pM and 10 μM respectively (Danielsson et al, 2007 ; Sarell et al, 2009), 
the rapid exchanging of Zn2+ between Aβ molecules may enable Zn2+ to influence a 
large number of Aβ peptide conformations, explaining Zn2+ induced aggregation 
dominating Aβ assembly outcomes in mixtures of substoichiometric Cu2+ and Zn2+. 
Alternatively, differences in the size of the aggregates that Cu2+ and Zn2+ influence may 
facilitate Zn2+ determining assembly outcomes. Either way, these results highlight that 
Zn2+ may be important in AD pathology, not only through directly influencing Aβ 
misfolding, but through attenuating the effect of other factors, such as Cu2+. For 
Table 4.01 Aβ Aggregate Species in the Presence of Metal Ions. 
This table shows the predominant species of Aβ aggregate formed upon reaching equilibrium, 
after 200 hours, in the presence of Zn2+ and Cu2+, at pH 7.4, with 10 μM Aβ, 30 Mm HEPES, 
10 mM NaCl and agitation, at 30 oC. 
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instance, in vivo, Cu2+ levels may become elevated, but have no effect due to a 
dominant influence of Zn2+, or alternatively, Cu2+ levels may remain stable, but changes 
in Zn2+ levels result in an associated change in the relationship between Cu2+ and Aβ. 
The fact that substoichiometric levels of Zn2+ influence Aβ misfolding differently to 
suprastoichiometric levels, and that Zn2+ may influence the effect of Cu2+, provides an 
explanation as to why Zn2+ supplementation has been found to both attenuate and 
potentiate Alzheimer’s like symptoms in animal studies (Adlard et al, 2008; Adlard et al, 
2010; Corona et al, 2010; Linkous et al, 2009), as not only is Aβ misfolding extremely 
sensitive to Zn2+, but also to the ratio of Aβ and Zn2+, as well as its interplay with Cu2+. 
 
To conclude, since the first suggestion that Zn2+ can influence Aβ aggregation (Bush et 
al, 1994), both Zn2+ and Cu2+ homeostasis has been implicated in AD pathology, 
through a number of animal studies (Adlard et al, 2008; Adlard et al, 2010; Linkous et 
al, 2009; Sanokawa-Akakura et al, 2010; Singh et al, 2013; Sparks & Schreurs, 2003). 
Additionally, Zn2+ is prevalent at the glutamatergic neurons, that are in fact often 
described as zincergic neurons (Brown & Dyck, 2004; Takeda et al, 2013), and found 
to be greatly diminished in AD (Butterfield & Pocernich, 2003). This study highlights the 
many variables to be considered in delineating the role of Zn2+ and Cu2+ in AD 
pathology, as effect will be dependent on Aβ isoform, metal ion-Aβ stoichiometry, and 
relative metal ion concentrations. This complexity is underscored by finding that shifts 
of 0.01 equivalents of Zn2+ (100 nM) are sufficient to change the misfolding landscape 
of Aβ. However, a complex system also provides many routes for intervention, in this 
particular case, chelation/supplementation of Zn2+/Cu2+ could provide such a route. A 
high-throughput screening in a yeast model of Aβ toxicity found that a Zn2+/Cu2+ 
chelator, clioquinol, ameliorated Aβ toxicity (Matlack et al, 2014). Clioquinol has also 
been found to inhibit Aβ deposition and ameliorate symptoms, in a mouse model of AD 
(Cherny et al, 2001), further emphasising the potential importance of regulating metal 
homeostasis in Alzheimer’s disease.  
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5.1 ABSTRACT 
 
With substoichiometric Cu2+, Aβ(1-40) forms fibres much more rapidly, and with an 
elevated pathogenicity. However, it is not clear how these fibres may differ in their 
physical properties, or how dependent their formation is on environment. As amyloid 
fibril stability has been linked to toxicity, Aβ(1-40) fibre stability was compared, with and 
without Cu2+. In the presence of the denaturant guanidinium chloride, a protein 
denaturant, it was found that the fibres did not differ in their stability with Cu2+ present, 
but did appear to dissociate at surprisingly low concentrations of denaturant. In 
contrast, Aβ fibres were found to retain their ThT fluorescent structure at 90oC, 
indicating that they have a high thermal stability. It was also found that Cu2+ increases 
rate of Aβ(1-40) fibre growth under both agitated and quiescent conditions, despite 
distinct Aβ(1-40) fibril morphologies forming in these two environments. These 
investigations suggest that increased rate of fibre formation is a general property of the 
Cu2+-Aβ(1-40) interaction, independent of fibre morphology, and that Cu2+ does not 
confer an increase in Aβ(1-40) toxicity through a reduction in fibre stability. 
 
5.2 INTRODUCTION 
 
It is well established, at least for mammalian prion protein, that amyloid fibre stability is 
correlated with toxicity (Colby et al, 2009). This is illustrated by the high degree of 
covariance found between prion fibre stability and incubation time of prion disease 
pathology in mice; with the most stable fibres possessing the longest incubation time, it 
is suggested that a fibre’s stability is inversely related to its toxicity (Colby et al, 2009). 
This is supported by work demonstrating that amyloid fibril fragmentation increases 
cytotoxicity (Xue et al, 2009; Xue et al, 2010). Thus, factors associated with AD 
pathology may impact disease aetiology through decreasing Aβ fibril stability, and 
leading to a concurrent increase in Aβ toxicity. 
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A particularly significant characteristic in AD is the alteration of metal ion concentration 
and homeostasis in the brain (Barnham & Bush, 2008), specifically Cu2+ ions. Chapter 
3 demonstrated that Cu2+ accentuates differences in the aggregative properties of Aβ(1-
40) and Aβ(1-42), accelerating Aβ(1-40) fibre growth, while stabilising Aβ(1-42) oligomers 
(Matheou et al, 2015). This was also found to increase the pathogenic potential of Aβ(1-
42), presumably due to the greater toxicity of oligomers over fibres (Lambert et al, 1998; 
Lue et al, 1999). However, it has been previously reported that Cu2+ may also increase 
the cytotoxicity of Aβ(1-40) fibres (Sarell et al, 2010). Consequently, the hypothesis was 
advanced that Cu2+ may reduce Aβ(1-40) fibre stability, and in doing so, heighten fibril 
toxicity. To evaluate this hypothesis, fibril stability was investigated, with both chemical 
(Guanidinium Chloride (GdnCl)), and thermal denaturation, using ThT fluorescence and 
circular dichroism (CD) to measure fibre dissociation. 
 
A caveat to generating amyloid fibres in vitro is that they may differ in morphology from 
amyloid fibres in vivo (Paravastu et al, 2008; Petkova et al, 2005). To establish that the 
increased rate of fibre growth with Cu2+ ions is not dependent on fibre morphology, the 
growth conditions of fibres were altered, growing them quiescently rather than in 
agitated conditions; this has been shown to switch fibril structure from a 2-fold to a 3-
fold axial-symmetry (Petkova et al, 2005). The overall purpose of this study was to 
clarify how Cu2+ may influence Aβ(1-40) fibre properties, stability in particular, and how 
this may relate to AD progression in vivo. 
 
5.3 RESULTS 
 
5.3.1 Stability of Fibres in the Presence of Guanidinium Chloride 
 
Prompted by the observation that, in the case of mammalian prions, fibril stability (ΔG 
of disassembly as measured by midpoint of unfolding in the presence of a chemical 
denaturant) is related to toxicity (Colby et al, 2009), this study sought to compare the 
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stability of fibres generated with Cu2+ and those generated without Cu2+, to delineate 
whether a change in Aβ(1-40) fibre stability may be responsible for the potentiation of 
Aβ(1-40) fibre toxicity (Sarell et al, 2010). To obtain insight into the stability of fibres, they 
were exposed to a range of concentrations of GdnCl, a chemical denaturant, and 
followed fibre dissociation through measuring loss of ThT fluorescence, using a single-
cell fluorescent spectrophotometer.  
 
It was expected that the present would have a stability typical of globular proteins, or 
perhaps a higher stability. However, it was instead found that dissociation of fibres 
begins at ~ 0.03 M GdnCl, and ends by 1 M GdnCl with a midpoint of ~0.24 M GdnCl. 
This is illustrated in Figure 5.01, with ThT fluorescence signal for Aβ(1-40) fibres dropping 
from 900 AFU to 400 AFU with 1 M GdnCl.  
 
Comparison of the normalised unfolding curves for Aβ(1-40) fibres generated with and 
without Cu2+ present appear essentially identical. This is emphasised by the similarity 
of the transition midpoints for the two fibres, 0.23 ± 0.009 M for fibres generated 
without Cu2+, and 0.25 ± 0.014 M for fibres generated with Cu2+. Curves were fitted as 
discussed in chapter 2 (Eq. 2.04).  
 
A source of concern, was that despite no further dissociation occurring at > 1 M GdnCl, 
there was still a persistent fluorescent signal contributing ~30 – 50 % of the max 
fluorescence. It was determined that this could either be some erroneous artefact, 
perhaps from a scattering of the excitation beam, or, alternatively, be due to the 
presence of a durable sub-population of Aβ(1-40) fibres, capable of enduring an ever 
increasing concentration of GdnCl. The observation that Aβ(1-40)  fibres should undergo 
a significant dissociation at a relatively low concentration of GdnCl was surprising, as 
amyloid fibrils are commonly found to be resistant to conditions that would denature 
most other proteins (Meersman & Dobson, 2006). A further source of concern was that 
GdnCl may interfere with ThT fluorescent signal. Consequently, verification of the 
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results with an alternative method for detecting the presence of β-sheet fibres was 
needed; for this, CD was used. 
 
CD provides information on the secondary structure of a protein, and as β-sheet 
structures possess a negative peak at 217 nm, one is able to follow the dissociation of 
β-sheeted amyloid fibrils by measuring loss of signal at 217 nm. CD spectra were 
recorded in the presence and absence of 0.5 M GdnCl, because at this concentration 
of GdnCl, the fluorescence data (Fig 5.01b) would suggest, 80 % of amyloid fibres are 
dissociated if the persistent fluorescent signal is merely an artefact; however, if the 
continued fluorescent signal is instead due to a durable sub-population of fibres, one 
would expect only ~ 40 % loss of signal at 0.5 M GdnCl.  As can be seen in figure 5.02, 
the addition of 0.5 M GdnCl caused a very marked 80 % drop in signal at 217 nm. This 
supports the fluorescent data, suggesting that relatively small amounts of GdnCl (1 M) 
will completely disassemble fibres.   
Figure 5.01 Stability of Aβ Fibres when Exposed to Guanidinium Chloride. 
(A) Using a single-cell fluorescent spectrophotometer and measuring fluorescence at      
489 nm, it was found that Aβ(1-40) fibres generated with 0.5 mol eq Cu2+ (red trace) and 
without Cu2+ (blue trace) begin to dissociate at ~0.03 M GdnCl. Additionally, loss of 
fluorescence plateaus at ~1.2 M GdnCl. (B) This figure shows the data normalised to 
both maximal and minimal ThT fluorescence. The transition midpoints for these curves 
are 0.23 M (with Cu2+) and 0.25 M (without Cu2+).  
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Figure 5.02  TEM images of Guanidinium Chloride Treated Aβ Fibres. 
This figure shows representative TEM images of Aβ(1-40), in the absence of GdnCl (A), and 
in the presence of 0.5 M GdnCl (B). TEM images were stained with phosphopungstic acid. 
Scale bars are 500 nm.   
 
 
A B 
Figure 5.03 Verifying the Susceptibility of Aβ Fibres to Chemical Denaturation. 
This figure shows the CD spectra (215 – 255 nm) of Aβ(1-40)  fibres (grown with 60 µM 
amyloid-β, 30 mM HEPES, 5 mM NaCl, and 120 µM ThT) which had either been exposed 
to 0 M GdnCl, or 0.5 M GdnCl. CD readings were taken using a 0.1 cm path-length 
cuvette. A complete spectrum was obtained for fibres exposed to no GdnCl, showing a 
peak at 217 nm that corresponds to their β-sheet structure. For fibres exposed to 0.5 M 
GdnCl, GdnCl interfered with readings below ~220 nm; however, the data provides a 
reasonable estimate that the signal has dropped by ~ 80 %. 
 
 
 
 Page 131 
CHAPTER 5: The Effect of Cu2+ on Aβ(1-40) Fibre Stability 
The two CD samples were examined under TEM (Fig. 5.03), revealing the profound 
effect that 0.5 M GdnCl has upon Aβ(1-40) fibre integrity. It was found that in the 
presence of 0.5 M GdnCl, although a fibrous structure is maintained, the fibres lose 
their definition, no longer obviously being composed of distinct filaments with regular 
twists. Additionally, they appear much more diffuse, which is reflected by an increase in 
their width, expanding to be 20 – 50 nm wide, as opposed to 10 – 20 nm wide.   
 
5.3.2 Thermal Stability of Amyloid-β Fibres 
 
The investigations with GdnCl and Aβ(1-40) fibres prompted further probing of their 
stability. It was decided to assess how susceptible Aβ(1-40) fibres were to thermal 
denaturation, using ThT fluorescence. For this, a sample was placed in a water bath, 
and once it had incubated at the desired temperature for 5 minutes, was placed in a 
fluorescent spectrophotometer, cooled down to the initial temperature (10 oC), and a 
ThT fluorescence reading was taken. All fluorescent measurements were recorded at 
10 oC, as fluorescence intensity may be temperature dependent. It was reasoned that 
thermal disassembly of fibres will happen rapidly (within 5 minutes), as the process of 
fibre disassembly is similar to the thermal unfolding of a globular protein, but that 
reassembly of Aβ into fibres would be slow, taking many hours in quiescent conditions. 
It was found that the fluorescent spectra of the sample was essentially unaltered with 
heating, as illustrated in Figure 5.04; additionally, the insert highlights that there was 
found to be no significant trend between fluctuations in fluorescence intensity and rising 
temperature. This suggests that Aβ fibres are stable at temperatures up to 90 oC.  
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Figure 5.04  Aβ Fibres are Resistant to Thermal Denaturation 
This figure shows fluorescent spectra for fibres (grown from 10 µM Aβ(1-40) with agitation) 
upon successive exposure to increasing temperatures. Samples were heated in a water 
bath to reach the desired temperature for 5 mins, and then cooled back down to 10 oC. 
The sample was then excited at 440 nm, and readings were taken from 420 nm to 600 nm 
in a fluorescent spectrophotometer. The insert summarises how the intensity of 
fluorescence at 489 nm changed with temperature.  
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5.3.3 Cu2+ Accelerates Fibre Growth under both Quiescent and Agitated 
Conditions  
 
Fibres were grown using a 96-well plate assay, for which the binding of ThT to Aβ fibrils 
is used to monitor the kinetics of fibre formation. Fibres were initially generated using 
the same conditions as previously used (Sarell et al, 2010), with readings being taken 
every 30 min, and the plate undergoing 30 s of agitation prior to each fluorescence 
measurement. The concentration of Aβ(1-40) was 10 µM, with either no Cu2+ or half 
molar equivalence of Cu2+. As shown in figures 5.05a and 5.05b, Cu2+ clearly influences 
fibre growth kinetics under these conditions, and a comparison of the median time 
needed to reach half-maximal ThT intensity (t50) for fibres grown with Cu2+ (t50  = 73 
hour median) and without Cu2+ (t50  = 126 hour median) supports the previous 
observation that Cu2+ approximately halves the t50 of Aβ fibre growth (Matheou et al, 
2015; Sarell et al, 2010).  
 
To assess whether the effect of Cu2+ on fibre growth kinetics was dependent upon fibre 
morphology, fibres were generated with no agitation; this changes fibre symmetry from 
2-fold to 3-fold (Petkova et al, 2005). As growing fibres quiescently also greatly 
increases the time for fibres to form, the time between readings was changed to 2.8 
hours. As illustrated in Figures 5.05C and 5.05D, Cu2+ still markedly influences fibre 
growth kinetics when fibres are grown quiescently, with the median t50 of fibre growth 
falling from 795 hours, for fibres grown without Cu2+, to 565 hours, for fibres grown with 
Cu2+. These results provide evidence to suggest that the manner in which Cu2+ alters 
the kinetics of Aβ fibre growth is not wholly dependent upon fibril structure.  
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Figure 5.05 The Effect of Cu2+ on Aβ(1-40) Fibre Growth. 
Fibre growth curves for 10 µM Aβ(1-40), with 0.5 mol eq Cu2+ (red traces) and 
without Cu2+ (blue traces) are shown. Fibres were grown with 20 µM ThT, 30 mM 
HEPES and 160 mM NaCl, at 30 oC and a pH of 7.4.ThT fluorescence is 
normalised to maximal fluorescence, and for each condition there are 20 
representative traces from one 96-well plate. Figures A and B show samples that 
were agitated for 30 seconds every 30 mins; at these conditions, the median t50 for 
fibre growth was 73 hours with Cu2+ and 126 hours without Cu2+. Figures C and D 
show samples that were grown without agitation; at these conditions, the median 
t50 for fibre growth was 565 hours with Cu2+ and 795 hours without Cu2+. 
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5.4 Discussion 
 
Here, the resistance of Aβ(1-40) fibres to both chemical and thermal denaturation has 
been investigated. Amyloid fibres are generally thought to be extremely resistant to 
thermal denaturing conditions, such as the amyloid fibres of insulin and Ure2p, both of 
which require over 100 oC for complete dissociation (Arora et al, 2004; Baxa et al, 
2004). However, as discussed in a review on the pressure-temperature stability of 
amyloid fibres (Meersman & Dobson, 2006), amyloid fibres are thought to be relatively 
sensitive to chemical denaturation, in contrast to their high temperature resistance. 
Indeed, previous work with Aβ fibres has shown that < 1 M GdnCl causes substantial 
destabilisation of Aβ fibres (Chen et al, 2011; Lee et al, 2007). Although the data in this 
chapter is rather preliminary, the data suggests that Aβ may form fibres that are at 
once very resistant to thermal denaturation, while being highly sensitive to chemical 
denaturation. This supports the notion that though Aβ fibrils are thermodynamically 
stable, this stability is exceptionally dependent upon hydrophobic interactions 
(Meersman & Dobson, 2006), as evidenced by the Aβ(1-40) fibres readily dissociating in 
the presence of GdnCl, a chaotropic salt that increases the solubility of Aβ (Meersman 
& Dobson, 2006; Sawyer & Puckridge, 1973).  
 
To determine whether generating Aβ(1-40) fibres in the presence of Cu2+ altered fibre 
stability, chemical denaturation was used, as Cu2+ has been found to dissociate Aβ(1-42) 
fibres (Matheou et al, 2015). Additionally, it has been found that amyloid fibre stability 
may influence fibre toxicity (Colby et al, 2009). It was found there was no significant 
difference in the sensitivity of the fibres to chemical denaturation, suggesting that the 
increase in toxicity conferred by Cu2+ ions is not associated with fibre stability. Thus, in 
this case, the heightened toxicity appears to come from elsewhere, potentially from 
Cu2+ redox activity, resulting in the generation of hydrogen peroxide and hydroxyl 
radicals, through Fenton/Haber-Weiss reactions (Huang et al, 1999; Liu et al, 2006; 
Opazo et al, 2002). This investigation, has also clarified the extent to which Cu2+ 
 Page 136 
CHAPTER 5: The Effect of Cu2+ on Aβ(1-40) Fibre Stability 
accentuates differences in Aβ(1-42) and Aβ(1-40), as Cu2+ induces Aβ(1-42) fibres to rapidly 
dissociate into oligomers and protofibrils, as discussed in chapter 3, but has no 
apparent impact on Aβ(1-40) fibre stability.  
 
In these investigations, it was also demonstrated that Cu2+ decreases the time taken for 
Aβ(1-40) to form fibres, for fibres generated both with and without agitation. This is 
significant, as fibres grown under these two conditions differ in their morphology 
(Petkova et al, 2005). Consequently, the results suggest that the means by which Cu2+ 
influences fibre growth kinetics is not dependent upon fibril structure, but instead arises 
from the interaction between Cu2+ and Aβ independently of final fibre structure, perhaps 
because binding of Cu2+ causes Aβ to approach its isoelectric point, and as a result 
become more prone to self-association (Sarell et al, 2010). Establishing that the 
accelerating effects of Cu2+ upon Aβ fibre formation is independent of fibre structure, 
strongly supports the notion that Cu2+ binding is capable of influencing Aβ fibril 
properties in vivo, regardless of differences in endogenous fibril morphology. Thus, 
delineating the mechanisms through which Cu2+ accentuates differences between Aβ(1-
40) and Aβ(1-42) misfolding, as well as how it potentiates Aβ cytotoxicity, could help 
elucidate AD aetiology. 
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For a disease that is expected to afflict 1 in 85 people by 2050 (Prince et al, 2009), the 
underlying mechanisms of AD pathology are still fairly contentious; however, it is 
generally accepted that the misfolding and self-association of Aβ peptide in the brain is 
the primary event in disease onset. In particular, it is the assembly of Aβ into cross-β 
amyloid fibrils, and the formation of intermediate oligomeric species, that are thought to 
mediate disease pathology (Hardy & Higgins, 1992; Selkoe, 1991). Unfortunately, even 
with this knowledge we have still been unable to develop any effective treatments for 
this prevalent disease. Thus, it is now necessary to identify events that precede 
amyloid fibrillisation, as in doing so we would expand our window of 
diagnosis/intervention, while also increasing the number of drug targets to choose 
from.  
 
One such event may be the dyshomeostasis of metal ions, as levels of Zn2+ and Cu2+ 
are found to be increased in the neuropil of AD patients, 2-fold and 4-fold respectively, 
and these metal ions are found directly bound to Aβ plaques (Dong et al, 2003; Lovell 
et al, 1998; Miller et al, 2006). Furthermore, a number of studies with mice and 
drosophila AD models have implicated Zn2+ and Cu2+ homeostasis as important 
determinants of disease phenotype (Adlard et al, 2008; Adlard et al, 2010; Corona et 
al, 2010; Hua et al, 2011; Linkous et al, 2009; Sparks & Schreurs, 2003). Unfortunately, 
the corresponding biophysical studies have often been conflicted (Faller et al, 2013; 
Viles, 2012). Early studies suggested that Zn2+ and Cu2+ induced the assembly of non-
toxic amorphous aggregates (Raman et al, 2005; Yoshiike et al, 2001), and thus were 
not considered relevant to disease pathology. However, it has since been shown that 
when using substoichiometric levels of Cu2+ rather than the elevated levels previously 
used, Aβ(1-40) fibre formation is not only retained, but is accelerated, and with a 
potentiated cytotoxicity (Sarell et al, 2010), suggesting that the relationship between 
metal ions and Aβ self-assembly may be more complex than first thought. Furthermore, 
although previously it has been suggested that the affinities of Aβ for Zn2+ and Cu2+ are 
not sufficiently tight for their interaction to be significant in vivo, a combination of more 
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accurate affinity measurements, plus an appreciation for the high fluxes of Zn2+ and 
Cu2+ that occur at the synapse, has led to a general consensus that both Aβ-Zn2+ and 
Aβ-Cu2+ interactions likely occur at the synapse (Faller & Hureau, 2009; Frederickson, 
1989; Hartter & Barnea, 1988; Kardos et al, 1989; Sarell et al, 2009; Viles, 2012; Vogt 
et al, 2000). The broad aim of this thesis was to further elucidate the potential role of 
metal ions in Aβ self-assembly and pathogenicity, looking at the metal ions Zn2+ and 
Cu2+, and the Aβ alloforms Aβ(1-40) and Aβ(1-42). 
 
There is special interest in Aβ(1-42), as it is the alloform most greatly implicated in AD, 
due to its elevation in early onset familial AD (Citron et al, 1997; Duff et al, 1996; 
Scheuner et al, 1996), as well as possessing a greater readiness to aggregate 
(particularly into soluble oligomers) and damage neurons (Burdick et al, 1992; Chen & 
Glabe, 2006; Lambert et al, 1998). During this thesis, it was found that the relationship 
between Cu2+ and Aβ(1-40) differs dramatically to that between Cu2+ and Aβ(1-42), as 
although suprastoichiometric levels of Cu2+ induces both Aβ(1-42) and Aβ(1-40) to form 
amorphous aggregates, substoichiometric levels of Cu2+ accelerate Aβ(1-40) fibre 
formation while causing Aβ(1-42) to form protofibrillar/oligomeric assemblies. 
Interestingly, chelation of Cu2+ enables Aβ(1-42) to resume fibril formation, and 
correspondingly, addition of Cu2+ to mature Aβ(1-42) fibres caused them disassemble into 
oligomers, suggesting these oligomeric species to be “on-pathway” to fibre formation. It 
was found that Cu2+ induced stabilisation of these intermediate oligomeric species 
enhanced the pathogenic potential of Aβ(1-42), as Cu2+-Aβ(1-42) assemblies were seen to 
more greatly perturb the lipid membranes of artificial vesicles. These investigations 
suggest that Cu2+ may accentuate differences between Aβ(1-40) and Aβ(1-42) in vivo, a 
possibility that is reinforced by the observation that when Aβ(1-40) and Aβ(1-42) are mixed, 
as they would be in vivo, and incubated with Cu2+, the aggregation of Aβ(1-40) and Aβ(1-
42) remain distinct. 
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To substantiate the potential significance of Cu2+ to AD aetiology in vivo, these 
investigations sought to establish whether the effect of substoichiometric Cu2+ on Aβ(1-
40) fibrillisation was dependent upon structure, as the structure of Aβ fibrils in AD 
patients is polymorphic (Lu et al, 2013; Watts et al, 2014). To obtain differing fibrillar 
structures fibres were grown in both agitated and quiescent conditions, which has been 
demonstrated to yield fibres that differ in their axial symmetry (Paravastu et al, 2008; 
Petkova et al, 2005). Additionally, as it was found Cu2+ destabilised Aβ(1-42) fibres, and 
that a reduction in fibril stability has been associated with an increase in disease 
pathology (Colby et al, 2009; Xue et al, 2009), an investigation was undertaken to 
determine whether Cu2+reduced the stability of Aβ(1-40) fibres. It was found that 
substoichiometric Cu2+ accelerated formation of ThT binding fibres under both 
quiescent and agitated conditions, while not influencing fibril stability, suggesting that 
Cu2+ has a general effect on Aβ(1-40) fibre formation that is limited to fibril kinetics. This 
emphasises observation that Cu2+ influences the misfolding of Aβ(1-42) and Aβ(1-40) in 
considerably different ways, while also supporting the notion that Cu2+ may influence 
Aβ in vivo.  
 
During this thesis, it has been found that trace levels of Zn2+ are able to have a 
profound effect on Aβ self-association through rapid exchanging between Aβ peptides, 
with as little as 0.01 mole equivalents dramatically influencing fibre growth. Additionally, 
the aggregate species that formed in the presence of substoichiometric levels of Zn2+ 
(stacks of rods for Aβ(1-40) and disordered tangles for Aβ(1-42)) were different to those 
formed in the presence of Cu2+. This suggested that the influence of Zn2+ upon Aβ 
aggregation is fundamentally different to that of Cu2+. Indeed, it was determined Zn2+ 
induced aggregation to be irreversible, and mature Aβ fibres to be unperturbed by the 
addition of Zn2+. This suggests that Zn2+ induced aggregates are thermodynamically 
isolated from Aβ fibres, representing an “off-pathway” aggregate formation. This differs 
to the inter-conversion seen when Cu2+ is added/stripped from Aβ aggregates. The 
difference between Cu2+ and Zn2+ may arise due to differences in coordination 
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geometry, affinity, ability to induce Aβ crosslinking, and/or the on/off rate of chelation 
(Faller et al, 2013; Viles, 2012). The difference between Cu2+ and Zn2+ may be 
significant in vivo, as it was demonstrated that Zn2+’s effect on Aβ overpowers that of 
Cu2+, at physiological levels of these ions. Thus, a shift in Zn2+ levels may cause a 
corresponding shift in Cu2+’s capacity to induce oligomer formation.  
 
This investigation into the relationship between metal ions and Aβ misfolding has 
demonstrated a number of distinct pathways that may be induced with Cu2+ and Zn2+, 
pathways that are dependent upon Aβ alloform, which metal ion is used, and the metal 
ion to Aβ ratio. Indeed, the multitude of pathways may explain some previous 
disagreements in the literature (Faller et al, 2013; Viles, 2012). The results have also 
made it evident that Aβ aggregation is highly sensitive to small amounts of Cu2+ and 
Zn2+, with substoichiometric levels able to completely abolish fibre growth, and Cu2+ 
able to disassemble fully formed Aβ(1-42) fibres. This is particularly significant, as it has 
been seen that soluble oligomers better correlate with disease progression than larger 
insoluble aggregates. Thus, Cu2+ dyshomeostasis may serve as a trigger for advancing 
AD, as a surge in Cu2+ may disassemble amyloid fibres into smaller oligomers (if 
Cu2+/Zn2+ dyshomeostasis are not themselves a primary cause of Aβ aggregation). In 
the future, it would be useful to more thoroughly characterise Cu2+/Zn2+ induced 
aggregate species, using atomic-force microscopy and X-ray diffraction. It would also 
be good to more accurately assess their pathogenic potential, using primary neuronal 
cultures to assess their effects on synaptic health.  
 
A role for these metal ions in Aβ self-assembly opens up the potential of metal 
chelation therapies. However, it is significant that the chelators that have been 
investigated thus far chelate both Zn2+ and Cu2+ (Adlard et al, 2008; Faux et al, 2010; 
Grossi et al, 2009). As it has been found that these metal ions have contrasting effects, 
and that the effect of Zn2+ may overpower that of Cu2+, it may be necessary to invest in 
the development of more specific chelators. Furthermore, as Cu2+ and Zn2+ may also 
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exacerbate AD pathology through alternative mechanisms, such as an increased 
release of Zn2+ and Cu2+ from the cell promoting Aβ cleavage from APP (Ayton et al, 
2013; Bayer et al, 2003; Stelmashook et al, 2014), Cu2+ inducing Aβ redox activity 
(Huang et al, 1999; Liu et al, 2006; Nadal et al, 2008; Opazo et al, 2002), and disrupted 
Zn2+ signalling damaging memory function and leading to neuronal excitotoxicity (Koh 
& Choi, 1988; Marger et al, 2014; Vergnano et al, 2014), it is clear that Cu2+ and Zn2+ 
have both an important and complex role in AD pathology, that expands beyond Aβ 
misfolding. Future studies will have to consider the broad range of in vivo interactions 
that these metal ions participate in to accurately delineate how they may influence AD 
aetiology. 
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